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Abs tract 
Bronchia l  asthma i s  described as a relative ly  common and hetero ­
geneous di sorder . Th e comp l exity o f  the pathophysiological  process 
and the myriad of et io logical  and prec ipitating factors are d i scus sed . 
Such factors include : heredity,  a l lergies , and psycho l ogical  prec�pi­
tants . The pos i t ion i s  tak en that regard l ess  of  what caused the 
ini t ia l  onset of  symptoms , psychological  factors may contribute to 
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the  intractabil ity and severity of  the disorder . The ut i l ity of  Be ­
havior Therapy Techniques such as : Re l axat ion Therapy , Biofeedback ­
Assi sted Re laxation Therapy , and Systemati c  Desens i t i zat ion ; as adj unct 
strategie s for the treatment of  bronchial  asthma i s  di scussed . It i s  
concluded that whi l e  each of  these arousal  reduc ing strategies can re­
sult in stat i s t i ca l ly  and c l inica l l y  signi fi cant improvement , their 
usage may be restri cted by such variab l es as : asthma type (intrinsic  
versus extrins i c ) ; asthma severity (nonsevere versus severe ) ;  
treatment type (menta l  versus muscul ar relaxation ) ; and persona l ity 
type (on l y  two of  nine panic-fear subtypes) . The obj ec tives of  the 
current invest igat ion were twofo l d .  F i rst , this study was propo sed as 
an attempt to reconfirm the ut i l ity of re laxat ion therapy as an adjunct 
strategy for the treatment of bronchi a l  asthma . Second , it was i nten­
ded to examine specific psychological and i l lness variab les which cou l d 
potential ly be usefu l  in predicting respons iveness/unrespons iveness to 
relaxation therapy . The variab les  under considerat ion in thi s study 
were asthma severity and panic - fear persona l i ty type . F i fteen asthma­
t i c s  (pr imar i l y  of the extrins i c  type ) o f  varying degrees of  severity 
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and panic- fear personal i t y  types were treated in  groups with  5 sessions 
of re l axation therapy . Resul t s  on self-report , pulmonary funct ion,  and 
physican ratings partial l y  confirmed the ut i l i ty of rel axat ion therapy for 
treating this popu lation .  The results  were only suggestive o f  the im­
portance of severity and panic- fear variab l e s  in  predicting successfu l /  
unsuccessfu l  response t o  such a treatment s trategy . The results  are 
discussed in terms o f :  1 )  Treatment Imp l i cations ; 2) The use of  
Psychologica l and il l ness variabl es as se l ect ion criteria ;  and 3 )  the 
necess ity of  further and l arger scale investi gations to examine these 
important i ssue s . 
INTRODUCTION 
Asthma : Facts About the Disorder 
Bronchia l  asthma is a re l ative l y  common disorder , with estimates of 
its  incidence ranging from one to five percent of the genera l popul ation 
(Graham et a l . ,  196 7 ;  Knapp and Wel l s ,  1 9 78 ; Wil l iams , 1973 ) . The pre ­
valence o f  this disorder among chil dren has been estimated as high as 
fifteen percent (Wil l iams , 1973 ) . Prob l ems associated with asthma resul t 
in mil l ions of  do l l ars being  spent each year on medical  care and addi­
tional mi l l ions lost  due to absenteeism from emp l oyment (Dirks et a l . ,  
1980 ; Go l d ,  1976 ) . Symptoms of  asthma can range in severity from a mild  
wheeze  to severe status asthmaticus which can result  in death (Ol ton and 
Noonberg ,  1 980 ) . While  the death rate associated with bronchial asthma 
is not high (i . e . , it has been estimated at one to two per/200 , 000; 
Wi l l i ams , 1973 ) , it certainly  underscores the fact that asthma is an 
il lness which must  be dea l t  with serious l y .  
Asthma has been described a s  a heterogeneous disorder which "defies 
easy categorization (Dirks , et al . ,  1979a,  p .  7 1 ) " .  Precise definitions 
of this disorder have been cal led "el usive" (Ol ton and Noonberg , 1980)  
and " impossib l e  to develop" (Go l d ,  1976 , p .  203) . Gross  ( 1 980)  offers 
several reasons why a precise definition of asthma remains so e lusive . 
He s tates : the "etio logy or etio logies are obscure , the c l inical  picture 
is diverse , and the pathophysio logic mechanisms are seeming ly  mul tiple  
(p . 203) . "  
Symptoms 
The symptoms genera l ly associat ed with asthma inc l ude : dyspnea 
(shortness  of breath ) ;  wheezing ; coughing ; tightness of chest ; and ob­
structed expiration . These symptoms are the result  of narrowed intrapul -
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monary airways (Scadding , 1976 ; Scadding , 1977 ) . Thi s  narrowing of 
air passages is the resu l t  o f :  
"edema (an accumu l at i on of  excess watery fluid i n  
the t i ssues )  of  the (bronchi a l )  wal l s , increased 
mucuous secretion , spasm of  the bronchial  musc les , 
or the co l l apse of  the posterior wal l s  of  the trachea 
and bronchi during certain types of  forced exp iration 
( Purce l l  & Wei ss , 1 9 7 0 ,  p .  597) . "  
Whi le the symptom comp lex experienced by mos t  asthmatics  is  s imi l ar ,  
onset may b e  associated with , or i n  reaction t o  several di fferent factors . 
These  incl ude : respiratory infection ; exercise ; a l l ergies ; environmenta l  
po l l utant s ; co ld  air ;  and emotional distress (American Lung Association , 
1977 ; Evans , 1 979 ; Wi l l iams , 1973) . I t  is  easy to see how such diversi ty 
"defies easy categori zation . "  
Symptom presentation may a l so  di ffer in terms of  course and degree 
of impairment . For examp l e ,  certain asthmatics  have what has been cal led 
episodic asthma . That is , in the absence of an actual asthma attack , 
their breathing capacity may be no di fferent than non-asthmatics . Thus , 
decreased respiratory abi l ity i s  temporary and returns essential l y  to 
normal l eve l s  once the attack is  over . Certain other asthmatics , however , 
have been described as having more persi stent and intractab l e  asthma . 
That i s , even in the absence of  an actual attack , their respiratory 
ab i l i ty i s  chronica l l y  at a subnormal leve l . In the face of an attack , 
breathing capacity is  reduced st i l l  further and does not return to normal 
l eve l s  once the attack subsides (Ol ton & Noonberg , 1980 ; Scadding , 1976 ; 
Scadding ,  1 977 ) . 
The presence and severity of  as thmatic symptomato l ogy i s  general ly 
asses sed through the use of a variety of  measures of  pulmonary function . 
Some of the more common ly  used measures inc lude : Peak Expiratory F low 
3 
Rate (PEFR); Forced Expiratory Vo l ume in one-second (FEV1); Forced Vital 
Capacity (FVC ) ;  and Maximal Mid-Expiratory F l ow Rate OMMEFR) ; (a comp l ete 
description of  these  measures can be found under the heading of  "Pulmo ­
nary Function"  i n  the Method section of  this paper) . In  general , narrow­
ing of the airways wi l l  result  in decreased values  of the above measures 
(Cherniack , 1977; Gol d ,  1 976) . 
C l inical  Subtypes 
A lthough the c l inical picture associated with bronchial asthma has 
been described as "diverse" (Gross , 1980) , asthmatics  can usua l l y  be 
c l a s s i fi ed by subtype according to rel i ab le  c l inical criteri a .  Such 
distinctions are important in that treatment regimens which are high l y  
e ffective with one subtype may be of l imited uti l ity for another . The 
two maj or asthmatic subtypes are intrinsic  and extrinsic  asthma (Scadding , 
1 976; Scadding , 1977 ) . 
Certain as thmatics  have been cal led "extrinsic"  because their attacks 
( i . e . , impaired breathing) occur in response to specifi c ,  usua l l y  readi ly  
identi fi ab l e ,  external agents . These external agents come under the 
heading of a l l ergies and inc lude : po l len; dust ; animal  dander ; and envi ­
ronmental pol lutants . The specific al lergy or a l l ergies whi ch affect a 
given individua l can be easi l y  identi fied via an antigen skin test (i . e . , 
this process involves p lac ing drops of spec ific a l l ergens upon a s l i ghtly 
scratched skin surface . Those al l ergies which show a posi tive (wheal 
and f lare) reaction are identi fied as the culprits ) . 
Wi thin the category of  extrinsic asthma , two further subtypes have 
been ident i fied . These are atopic and non-atopic extrinsic asthma . 
Atopics - can be grouped together because the bronchial hypersensi ti vi ty 
which they experience in response to a number of di fferent a l l ergens is 
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uniformly  mediated by a specific immunoglobin ( IgE) . I t  has been sug­
gested that this I gE mediated hypersensitivity is genetical ly determined 
becaus e atopic asthmatics tend to have a famil y  history of asthma and 
other atopic disorders such as hay fever , rhinitis , and eczema ( Edfors ­
Lub s ,  1 97 1 ;  Leigh and Mar l ey ,  1967 ) . Non- atopies , on the other hand , have 
neither an IgE-mediated hypersensitivity nor an identifiabl e  family 
history of asthma (Scadding , 1977) .  Both are inc l uded in the category of 
extrinsic because the external agents and immunogl obins which mediate 
bronchial hypersensitivity are readily identifiabl e .  Other commonal ities 
shared by atopic and non- atopic extrinsics Cl,re: age at onset tends to 
be ear ly ;  symptoms tend to be seasona l (e. g . , pol len and ragweed count 
tend to be higher in the summer), a l though they may be perrenial (i .  e. , 
year round) in certain cases (i . e . , as a function of hypersensivity to a wide 
range of a l l ergens ) ; in general , symptoms subside in response to broncho­
dil ators such as isoprotereno l ;  and fina l ly ,  impairment in respiratory 
ability tends to be temporary and episodic . 
The other major  category of  asthmatics has been labe l l ed "intrinsic " .  
Instrinsics differ from extrinsics  in several ways . First , external pre­
cipitants cannot be identified (i . e . , instrinsics  respond negatively  to 
antigen skin tests for a l lergies ) .  Second , ons et of asthma tends to be in 
adult  l ife . Third , family  his tory of  atopic disorders (e . g . , hay fever) 
is not general ly found causing investigators to question the ro l e  heredity 
may p lay among cases of intrinsic as thma (Scadding , 1976 ) . Fourth , 
symptoms/occurrence of attacks are genera l ly perrenial (i . e . , nonseasona l ) . 
Fifth ,  respiratory impairment is usua l l y  chronic , persistent and intrac ­
tab l e  and the prognosis is general l y  not as favorabl e  as it is for 
extrinsics . Sixth ,  intrinsics , "  as a rule ,  do not improve dramatica l l y 
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in response to bronchodilators and the treatment of  choic e ,  more times 
than not , is s teroid therapy . And final ly ,  certain intrinsics  have been 
found to be aspirin sensitive , whereas , no such sensitivity has been 
associated with extrinsic asthma . 
Ano ther area where differences have been found between intrinsics 
and extrinsics is in the psychol ogical  l iterature . For examp l e ,  instrin­
sics have been described as being : more "cerebral "  (i . e . , obsessive) 
than extrinsics (Cohen , 1 977 ) ; more introverted and having more "psychic 
disturbances" than extrinsics  (Teiramaa , 1 979a ; Teiramaa , 1978a , b and c ) ; 
and responding more favorabl y  to anxi ety reduction strategies such as 
progressive mus c l e  re l axation (Phil lip et  a l . ,  1 972 ) . 
In spite of the above differences between intrinsic and extrinsic 
asthmatics , there are important similarities . Firs t ,  intrinsics and 
extrinsics can be equa l l y  severe . Second ,  both can resul t  in chronic , 
persistent pulmonary demis e .  Fina l l y ,  intrinsics and extrinsics , in 
severe cases , are treated with a simil ar medical  regimen (i . e . , steroid 
therapy ) . 
Pathophysiology 
While  the symptom comp l ex experienced by the maj ority of  asthmatics 
may be simil ar (e . g . , shortness of breath , wheezing) , attempting to iden­
tify a singul ar phys io logical  mechanism at the root of these symptoms is 
a difficul t  task . As stated ear l ier , the '�athophysiol ogic mechanisms 
(of asthma) are seemingly  mul tip l e  (Gross , 1980 ; p .  203 ) . "  A l though a 
comp lete description of the physio l ogical  mechanisms invo lved in bronchial 
asthma is beyond the scope of this investigation , some understanding of  
these mechanisms is  required to more fu l ly appreciate the heterogeneity 
and comp lexity of this disorder . 
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In general ,  bronchoconstriction and bronchodi l at ion occ ur as a func-
tion of  the  antagonistic  activities  of  the  two maj or subdivi sions  of  the 
autonomic nervous system .  Thes.e subdivisions are the parasympathetic 
(PNS) and sympathetic  (SNS) nervous systems (Lang , 1 972 ;  Wenger e t  a l . ,  
1956 ) . PNS innervation is associated with bronchoconstriction and acety-
l choline activity . SNS innervation , on the other hand , can result  in 
either bronchoconstriction or di l ation depending upon which adrenergic 
receptor sites  are s timulated by catecholamine (e . g . , norepinephrine) 
act ivity . St imulation of the Alpha-adrenergic  receptors resul t s  in 
bronchoconstriction whi l e  s timulation of  the Beta-adrenergic  receptors 
produces di l at ion .  Thus normal ,  free breathing : 
" is  presumab l y  maintained by hal ancing bronchocon ­
strictive effects of chol inergic (PNS) and a lpha­
adrenergic  (SNS)  s t imulation against the bronchodi­
l atory effect of  beta-adrenergic stimulation 
(Wi l l iams , 1973 , p .  1 7 ) . "  
I t  can be seen then , that any tipping of this delicate homeostatic  
balance could result  in impaired breathing . Such "tipping" could be the 
function of either a PNS or SNS mal function .  
In some asthmatic s , PNS overreactivity has been imp l icated as the 
source of difficulty (Wenger et  al . ,  1956) .  Evidence in support of this  
inc l udes : the fact that brondPspasm which normal ly occurs in react ion to 
inhal at ion of certain antigens by a l l ergic ( i . e . , extrinsic)  asthmatics 
does not occur i f  PNS innervation is  b locked . Such a PNS b lock can be 
obtained medica l ly (e . g . ,  by ingestion of a PNS b locking agent such as 
atropine) , surgica l l y  (e . g . , by severing the vagal nerve associated with 
respiratory activity) , or by cool ing either the afferent or efferent 
(or both)  fibers of the vaga l nerve (Gold ,  1980;  O lton & Noonberg , 1980) . 
In addition ,  stimulation of the PNS pharmacological l y  Ce . g . , with metha-
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cho l ine or mechol y l ) wil l resul t  in bronchoconstriction . Final ly ,  inges-
tion of atropine (a  PNS b locking agent)  in the absence of  a l l ergens wil l 
resul t  in a s light dilatory e ffec t  (Ol ton & Noonberg , 1980) . 
Within the SNS there l ie several possibilities for mal function as a 
result o f  its dual action of  constriction and dilation . For examp l e ,  a 
decrease in the sensitivity or activity of  beta-adrenergic receptors 
woul d  resul t  in constriction . Indeed ,  beta-b l ocking drugs such as pro -
prano l o l  c an cause bronchospasm . Further , Kahn ( 1973 )  has suggested 
that "deficient immobilization of  epinephrine (which acts via the beta 
receptor sites )  in response to psycho logica l  stress"  may be crucia l  
(p . 197 ) . Similarl y ,  hyperactivity or hypersensitivit y  of the alpha-
adrenergic receptors woul d  result  in bronchoconstriction . In  any case , 
it seems c l ear that , at least with regard to underlying physio logica l  
patho l ogy,  a l l asthmatics are not created equa l . 
Medical  Treatment of Bronchial Asthma 
Prior to dis�ussiag actua l  medical  s trategies which are used in the 
treatment of asthma , two point s need to be made . First ,  the type of  
treatment util ized can vary with the type of asthma which the individual 
has (e . g . , extrinsic versus intrinsic ) . The reader wil l reca l l that 
Scadding ( 1976 ) has suggested that intrinsics  and extrinsics may have a 
differentia l  response to certain bronchodilators (e . g . , isoprotereno l ) . 
Second , that medical  treatment of  asthma fo l l ows the '�rincipal of 
esca l ation (Wil l iams , 1973 , p .  38 ) . "  Thus : 
"The key to successfu l  us e of  medication in asthma 
is the principal of escal ation , adding more effect ­
ive , but more hazardous agents on l y  when simp l er 
drugs have not been effective (p . 38 ) . "  
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One of the most common c l asses  of drugs which are used in the treat­
ment of asthma are the bronchodi l ators . As a rul e ,  drugs from this c l as s  
operate via SNS innervation . Examples - of these  medications inc l ude : 
ephedrine , benzedrine inhalants/aerosol s ,  epinephrine , and isoproterenol . 
Severe , l ife-threatening attacks are often treated with inj ections of 
epinephrine (C lark & Godfrey,  1977 ; Lachman , 1 972;  Wil l iams , 1973 ) . 
Potent ial  side effects  of this c lass' of  drugs inc l ude the production of a 
rapid , irregu lar heartbeat ( Evans , 1 979) . 
Another c lass of medications are those which operate via PNS activity . 
The reader wil l reca l l  that the normal action of the PNS is towards bron­
choconstriction .  Thus , ingestion o f  anticholinergic drugs such as 
atropine which b locks  PNS innervation of the respiratory system sometimes 
produce a dilatory effec t . A problem ass ociated with the use of anti­
cholinergics , however , is that they may result  in the drying of bronchial 
secretions (Ol ton & Noonberg , 1980 ; Wil l iams , 1973) . 
For more severe cases of asthma , the corticosteroids are commonly  
used . These inc l ude : prednisone , prednisolone , and cortisone (Evans , 
1 979 ;  Wil liams , 1973) . The s ide effects of this c l ass of drugs can be 
serious and include : hindering of  growth in children ; cataracts ; hyper­
tension ; depression and even psychosis ( Baker , 1979) . Recent l y ,  s teroids 
have been empl oyed in aerosol form (e . g . , beclomethasone ; triamcinolone) 
in an attempt to limit their effects  to the bronchial area (C l ark , 1 9 7 7 ;  
Evans , 1979) . 
Another type of  medical  approach is the process known as immuno­
therapy . Basical ly ,  immunotherapy involves an innoculation procedure 
which serves to raise an individual ' s  tolerance for certain antigens . 
The process  involve s :  identifying the appropriate a l lergens (e . g . , via 
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ant igen ski n  test); inj ecting gradua l l y  increasing dosages of this sub­
stance i nto  the b l oodstream over the c ourse of  several years . Thi s  
procedure has demonstrated uti l ity , however , i ts  use is  l imited t o  asth­
mati c s  of the extrins i c  type (Evans , 1 979 ; Wil l i ams , 1 973 ) . 
In certain severe cases surgery may be needed (e . g . , severing of 
vagal nerve fibers ) , however , it i s  general ly  cons i dered to be impracti ­
cal  and the result s  often do not warrant the ri sks involved (Gold ,  1976 ; 
Wenger et a l . ,  1 956 ; Wi l l i ams , 1 973) .  
Additional treatment recommendati ons i nc l ude : remov pets , dust , 
molds , etc . from the asthmati c ' s  environment ; maintain a cool and some­
what humid room temperature (e . g . , 35-50%  humidity) to prevent the drying 
out of bronchial  passages; drink p l enty of fluids; fol l ow a p l an of pro­
grammed exercises (e . g . , swimming) ; practice  breathing exercises 
(American Lung Assoc i ation ,  1979 ; Evans , 1979 ; Wi l l iams , 1 973 ) . 
The Rol e  of Psychological  Factors 
Psychol ogical  factors have been associated with cases of bronchia l  
asthma since Hippocrat i c  times (Leigh and Marl ey ,  1967 ) . This  association 
has been a controversia l  one throughout the years and opinions have varied 
regarding the actual role and importance of these factors in the onset 
and maintenance  of asthmatic  symptoms . For examp l e ,  at the turn of the 
current century asthma was referred to as "asthma nervosa" and psycholog i ­
cal  variab l es were considered t o  b e  the primary cause o f  thi s  disorder 
( Le igh and Marley ,  1967 ) . Shortly  thereafter the connection between 
a l l ergies and bronchia l  asthma was discovered and the "nervous factor 
fe l l  out of fashion ( Leigh and Marley ,  1 96 7 ,  p .  2 ) " .  At sti l l  other 
time s psychol ogical  factors were seen as a necessary component of "psycho­
somati c  asthma" in an interactiona l rel at ionship with genetic , infective , 
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and a l l ergic factors ( e . g . , A l exander , 1950) . 
The precise re l ationship between psycho l ogical  variables  and bron­
chial asthma has yet to be c l early defined and , as such , remains the 
subj ect of investigation (Cl ark , 1977 ) . In the fo l lowing pages I wil l 
review the areas of  the psychologica l  l iterature which have made signi­
ficant contributions to this investigation . In general , these areas can 
be c l assified according to whether they view psychological factors as 
being primarily  etio logica l  or maintenance variab les . 
Etio l ogica l  Perspective 
The Psychoanalytic Approach . The Psychoanalytic position regarding 
the rel ationship between psychologi�al factors and bronchial asthma 
is best represented by the work of Franz Alexander and his col l eagues 
(e . g . , A lexander , 1 950 ; A lexander , et a l . ,  1 968 ; and French and A lexander , 
1955) . Briefly ,  they state that underlying psychol ogical conflicts inter­
act with other factors ( e . g . , a l l ergies , infection , genetic predisposi­
tion) to produce asthmatic symptoms . Thus , asthma was considered to be 
a psychosomatic or psychophysio l ogical  disorder by this group and psycho­
l ogical  factors were thought to p l ay a primary ro l e  in the etio l ogy of  
this disorder . 
The underlying conflict associated with the deve l opment of  bronchial 
asthma was fe l t  to be an "excessive unreso lved dependence upon the mother 
(Alexander , 1 95 0 ,  p .  1 33 ) . "  In this context , impaired breathing was 
thought to symbol ize a "suppressed cry for the mother ( 1 9 5 0 ,  p .  1 39 ) . "  
In addition , it was fel t  that asthmatic symptoms woul d  continue to occur 
in response to stress fu l  situations un l ess this underlying conflict was 
resolved (i. e . , via Psychoanalysis ) . 
While the Psychoanalytic position may be an interesting one , it has 
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never rea l l y  been rigorous l y  evaluated (Graham , 1972 ) . In addit ion , i t  
has been critici zed because some , but not a l l  asthmatics  have been found 
to have strong dependency needs and because persons with excessive l y  
s trong dependency needs d o  not always deve lop asthma ( B l anchard , 1 98 1 ; 
Dirks  et  a l . ,  1 9 79a) . 
Personal i ty Research . The study of personal ity variables  thought 
to be re l ated to the inception of asthmatic  symptoms has had a great deal 
of influence upon asthma research . The ini tia l  thrust behind this move­
ment was the attempt to demonstrate a connection between speci fic perso­
nal ity  styles  and specific  psychosomat ic disorders . Thus , i t  was fe l t  
that there was an "asthma persona l i ty , "  a "migraine personal i ty , "  an 
"ul cer personal i  ty" and so on . Based upon c l inical observations and 
psychometric eval uations , the "as thma personal i ty" was described as 
fol lows : "immature , insufficient l y  bal anced , pas sive-dependent , egocen­
tric , and insecure ( Bastiaan and Groen , 195 5 ,  p .  245 ) " ;  emotional ly  
l ess  stab l e ,  more sober ,  serious , tens e and frustrated than normal s  
(Agarwal and Setthi , 1978 ) ; dependent , meek , anxious , perfectionistic , 
obsessive , and over-contro l l ed (Cohen , 197 7 ;  P lutchik , 1978 ; Rees , 1 964 ) . 
Three primary assumptions of this position were : that al l asthma 
was psychophysio logical  in nature ; that psychol ogical factors p l ayed a 
ro l e  in the genes i s  of  asthma ; and that asthmat ics , as a rul e  were more 
patho logical  than so-ca l l ed norma l s .  In genera l , none o f  these assump ­
t ions has been conclus ive ly  supported by recent research (e . g . , Ai tken 
et a l . ,  1 97 2 ;  Rees , 1964) . Ne ither has the not ion o f  a uni form "as thma 
personal ity" received much support (Al exander ,  195 0 ;  Davidson and Nea l e , 
1974 ; Grinker and Aronson , 1973) . Despite the lack of support for an 
"asthma personal ity" , several authors have noted that substantial  subgroups 
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o f  asthmati cs  do s eem t o  possess the common characteristic o f  bein g  un­
assertive (e . g . ,  Cohen , 1977;  Groen , 1 979 ; Goyeche et a l . ,  1980 ; 
A lexander et a l . ,  1 968; and Jackson , 1976)  and that this inhibited inter­
personal  Styl e  may adversel y  affect the course ,  severity , and duration 
o f  asthma regardl e s s  o f  whether it contributes to the etio l ogy of asthma 
(Teiramaa , 1978a; Teiramaa , 1 978b; Teiramaa , 1 978c; ) .  Kinsman ·and his 
co l leagues (e . g . , 1 980a)  have a l so investigated the re l ationship between 
specific personal ity  characteristics and the maintenance , severity and 
i ntractability of asthma (their work wi l l  be revi ewed in some detai l in 
an upcoming section entit l ed "Psychomaintenance") . Thus , while  a uniform 
"asthma personal i ty" may not exist , the study of personality variab l e s  
and their re lationship to asthmatic symptomato logy remains a fruitful 
area of research however ,  the focus has shifted to more of  a maintenance 
perspective . 
Maint�nance Perspective 
Proponents  of this perspective do not attempt to assess the ro l e  
psychol o gica l  factors may p l ay i n  the etio logy of bronchial asthma . Rather , 
the focus is on the ways in which such factors can effect the severity 
and intractability of the disorder regardl ess  of etio l ogy . Matus ( 1 9 8 1 )  
summarized the ro l e  of  psycho l ogical  factors in asthma and suggested that 
they may act in three different ways : 
1 )  Precip itate - emotions can trigger asthmatic attacks due to the 
respiratory changes which accompany them (e . g . , hyperventilation) ; 
2) Exacerbate - once symptom ons et has occurred , strong emotional 
responses such as intense fear can result  in worsening of  
symptoms ; 
1 3  
3 )  Maintain - the response of  persons in the asthmatic ' s  environment 
can serve to reinforce the occurrence of symptoms (e . g . , i f  
attacks fo l low arguments and result  in sympathy for the asthma­
t i c ,  future attacks in response to stressfu l  situations might 
be inadvertent l y  reinforced ) .  Thi s  category is particularly  
app licab l e  to the chi ld asthmatic . 
rt shoul d  be noted that thi s  de-emphasis upon the etio logica l ro l e  of  
psychol ogical  factors in bronchial asthma is  consi stent with the DSM- I I I  
redefinition o f  what were formerly known as psychosomatic  disorders 
(which imp l ies  a psychological  rol e  in the etio logy of the disorder) into 
the category of "Psychological Factors Affecting Physical  Condition 
(1981, p .  171)." Two areas of asthma research which hest exemplify this 
maintenance perspective are described below .  
The Behavioral Approach. The primary focus of the Learning/ Behavioral 
tradition has been upon the re l ationship between environmental  stimu l i  
and onset o f  asthmatic symptoms . Thi s  re l ationship has been demonstrated 
in several ways . 
First , it has been shown that c l assical  conditioning can result  in 
an expansion of  the number of  environmental  cues which can come to e l icit 
an attack . For examp l e ,  i f  asthmatic symptoms are initia l l y  in response 
to an a l l ergic agent (e . g . , a feather p i l l ow or dust in a bedroom) , after 
repeated pairings of  neutral obj ects in the room (CS) with asthma attacks 
(UCR) , these  previous ly  neutral obj ects (e . g . ,  bed , mattress , rug )  may 
come to e l icit attacks even after a l lergenic substances (UCS ) have been removed 
(e . g . , Dekker et a l . ,  195 7; Cohen , 1977; Spevack , 1978). Second , this 
same c l ass ical  conditioning process can , over time , result  in patients '  
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reacting to the cues whi ch signa l  the initial  onset of an attack with fear! 
anxiety in anticipation of a ful l -blown attack . Thi s  fear response , 
then , may adverse l y  effect the respiratory system (e. g . , hyperventi l at ion) 
and may either trigger an attack or increase the severity of an attack 
which may have occurred in any event. As a resu l t  of the conditioning 
process , a vicious cyc l e  may ensue in which severe attacks beget fear , 
whi ch subsequently  beget more serious attacks , etc . (Cohen , 1 97 7 ;  Matus , 
1 98 1 ; Wi l l iams , 1973 ) . Behavioral interventions  such as re laxat ion 
therapy and systematic  desensiti zation are thought to be of benefit to 
certain asthmatics  because they serve to "short -circuit"  this vicious 
cyc l e  by reducing physiological  arous a l  leve l s  (Spevack , 1 978 ) . 
Operant conditioning can a l so contribute to the maintenance and 
onset of asthmati c  symptoms . It has been suggested (e . g . , Matus , 1 9 8 1 )  
that the frequency o f  asthma attacks might b e  inadvertent l y  increased 
if such attacks resul t  in extricating the asthmatic  from stressful  or 
undesirab l e  situations . This  "secondary gains " notion has been stres sed 
particularly with regard to chi l dhood asthma . I n  thi s vei n ,  such things 
as : increased parental attention ; avoidance of school ; and avoidance 
of unpl easant chores have been mentioned as potential l y  "rewarding" for 
the chi l d  asthmati c  (Evans , 1979 ; Wi l l iams , 1 973 ) . 
A final way in which environmenta l  events can effect the occurrence 
of asthmati c  symptoms is  the mode l l ing process . Several authors have 
noted that the inappropriate response of parents (e . g . , pani c ,  overprotec ­
tiveness )  to the chi l d ' s  asthmat ic symptoms might serve to :  foster 
dependency (Evans , 1979) ; promote an "unneces sary atti tude of inval idism" 
(Wi l l iams , 1 97 3 ,  p .  70) ; and in genera l present the chi ld  with a poor 
role  mode l for coping behavior . The reader wi l l  note that such a process 
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could result i n  a vicious cy�le s imi l ar t o  the one noted i n  conj unction 
with c l as s i cal condit ioning (i . e.,  attack produces anxiety which worsens 
the attack and so on) . As such , most  physicians advise  parents to remain 
reasonab ly  concerned ,  but calm ,  in response to their chi ld ' s  attacks 
(Weiss , 198 1 ) . 
Psychomaintenance . Kinsman and his  assoc iates (e . g . , Kinsman et  al . ,  
1 98Qa ;  Jones et  a l . ,  1979)  have defined Psychomaintenance as the process 
by which: 
" . . .  p sychologi c  and behavioral factors maintain and 
increase both the severi ty and medical intractab i l ity 
of the i l lness once it has already deve loped (Kinsman 
et a I . ,  1 980a ,  p .  3) . " 
They s tate further that such factors serve to impede "medical  treatment 
which i s  e ffective in most other cases (p . 3) " and that these psychomain-
tenance issues  must be addressed if the patient i s  to achieve the maxi -
mum benefit from medical l y  oriented treatment . 
Kinsman et aI . C1980a) assume "that the patient brings to  the i l lness 
a personal style that may either defeat , have no effect upon , or fac i l i -
tate medical management (p . 1 1 ) . "  In an impressive series of studies 
(e . g . , Dirks et al . ,  1978 ; Jones et al . ,  1979 ; Kinsman et al . ,  1 980a) , 
these authors have investigated one such style which they suggest  
contributes  to the  intractibi l ity of  asthmatic  symptoms . They have 
l abe l l ed this the Panic-Fear personal ity styl e .  
According to these authors , asthmatics  can b e  cat e.gori ze.d into Low , 
Moderate ,  and Hi gh level s  of panic- fear through the use of psychometric 
instruments (e . g . , the Asthma Symptom Check l i s t , and the 20 P-F). Low 
pani c- fear patients have been described as sympt om minimi zers; moderate 
panic- fear pat i ents as adapt ive and healt�y;and High oanic-fear pat ients 
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a s  symptom maximi zers ( i . e . , over- reactors ) .  Both extreme l y  Low and High 
leve l s  o f  panic -fear are vi ewed as being mal adaptive because they serve 
to interfere with medical  treatment whi ch i s  normal ly  very effective . 
Panic -fear l eve l has been cons i stently  related to such things as : non­
comp l iance with medication instruct ions ; intensity of discharge medication 
l eve l ;  l ength of hosp ita l  stay ;  and probab i l ity of  re -hospitali zat ion ; 
independent of the severity of one ' s  as thma (Dah lem et a l . ,  1 977 ; Dirks  
and Kinsman , 1 98 1 ; Dirks et a l . , 1 977a ; Dirks  et a l . ,  1 978b ; Kinsman et 
a l . ,  1 980d ; K l i eger and Dirk s , 1979) . 
Pani c - fear i s  assessed on two l eve l s : symptom vigi l ance and person­
a l i t y .  Symptom vigi l an ce i s  measured w i t h  the ASC and Low l eve l s  are 
cons idered mal adapt ive (i . e . , patient i gnores severity o f  symptoms ) .  
Pani c - fear persona l ity  i s  measured w ith the 20 P - F  and both Low and High 
l eve l s  are considered to be ma l adaptive (i . e . , Low P - F  patients under­
react to severity of symptoms ; High P - F  patients panic  and over-react ) . 
Ut i l i z ing the se two measures,  9 asthma subtypes have been identi fi ed ( i . e . , 
1 )  Low vi g i l ance - Low Persona l ity ; 2) Low-Moderate ; 3 )  Low-High ; 4) 
Moderate - Low ; 5 )  Mode rate -Moderat e ;  6 )  Hoderate High ; 7 )  High- Low ; 8 )  
High-Moderate ; 9) High-High) and each subtype carries with  i t  di fferent 
treatment needs and recommendations . For examp l e ,  categori es 5 and 8 are 
said to be comprised of "good" pat ients who do not require psycho logical 
intervention regarding psychomaintenance i ssues . Categories 1,  2, and 4 
are o f  the Low panic - fear type , and it  i s  fe l t  that a strategy which 
focuses upon their  denia l / counterdependence i s sues and educates them re­
garding the importance of attend ing to their symptoms would  be he lpful . 
Fina l l y ,  categori es 6 and 9 are of the High panic- fear type , and Kinsman 
and his  col l eagues recommend . an intervention strategy which wi l l :  
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1 )  he lp  pati ents  perceive they are not powerles s ;  2) teach them appropriate 
means of personal control  over i l l ness, (i . e . , improve coping ski l l s ) ; 
3 )  teach them to contro l thei r  reactions ( i . e . , pani c )  to their i l lness 
(Dirks  et a l . ,  1 9 79a ;  1 979b). ( Because of the inadequate number of  
patients  i nvo lved , Kinsman et  a l.  C.1 980a) were not  abl e  to offer treat ­
ment suggestions  for patients  in categories 3 and 7) . Of particular 
interes t  to the current study i s  the suggestion by Kinsman et a l . (1980b) 
that anxiety reduc ti on s trategies  such as re l axation therapy are indicated 
only for these  l at ter two panic-fear subtypes ( i . e . , 6) Moderate-High and 9) 
High-High) and that re l axation approaches may , in fact , be detrimenta l 
to as thmatics  with other pan i c - fear styles (e.g., Low-Low ; Low-Moderate ; 
Moderate- Low) . 
Summary 
Several conc l us i ons can be drawn regarding the re l ationship between 
psychological  factors and bronchia l  as thma . First , a lthough psycho logical  
factors have been imp l i cated in  the etiology of asthma , such a ro l e  has 
not received widespread support . Second , regardless  of  the eti o l ogy of 
asthmati c  symptoms , psycho logical  fac tors can serve to;  precipi tate 
exacerbat e ,  and maintain the severi ty of these symptoms. In addition , 
psycho l ogical  ( i . e . , psychomaintenance)  fac tors can interfere with nor­
mal ly effect ive medical  care i f  ignored . 
Thus , whi l e  psycho l ogical  factors may not neces sari l y  p l ay a ro l e  in 
every case of bronchial  asthma , fai l ure to evaluate their  potential  
effects  may result  in  l ess  than opt ima l control of  symptomatology . 
Indeed , several authors have stressed the importance of  a cooperati ve! 
ho l i s t i c  approach in both the assessment and treatment of  as thmatic  
patient s .  For examp l e ,  Cohen ( 1 977)  states; 
"Al l aetio l ogical  aspect s , infective , a l l ergic and 
emotional  - shoul d  as far as poss ib l e  be treated 
simu l taneous l y  and management of the patient j oint-
l y  by the p sychiatris t and the physician can be very 
rewarding . I t  is import ant  to remember that an il l ­
ness may start main l y  as a l l ergic , and l ater emotional 
or infective factors may become dominant in determin­
ing whether attacks occur (p . 1 8 3 ) ." 
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Similar views regarding a cooperative approach to treatment have been 
offered by others (e . g . , B lanchard and Ahl es ,  1979 ; Goyeche et  a l . ,  1980 ; 
Leigh & Reiser,  1 977;  Mik l ich , 1979) . In this vein , psycho l ogical inter-
ventions can be seen as attempts  to assis t ,  not rep l ace , medica l  manage-
ment of  bronchial asthma . We turn now to the discussion o f  specific 
psychological  strategies which have been emp loyed for the treatment of  
asthma . 
Psychol ogica l  Treatment o f  Bronchial Asthma 
General 
Given the degree to which psycho logica l  factors have been imp l icated 
in both the etio l ogy and maintenance of  bronchial asthma ,  it is not surpris-
ing that a variety o f  psycho l ogical ly-oriented strategies have been emp loy�d 
as primary or adj unct treatments  for this disorder . A number of  such strate-
gies have been evaluated and determined to have varying degree s of  success . 
In that A lexander ( 1950)  has been a maj or figure in the area of psycho -
somatic disorders , it is not surprising that strategies based upon his 
Psychoanalyt ic approach to the treatment of asthma can be found in the l itera-
ture . A l exander ( 1 950)  reported  the succes s ful use of Psychoanalysis 
in treating the unresolved dependency needs of the asthmatic . Similar l y ,  
Jackson (1976)  report ed success in case studies which emp loyed psycho-
drama for the treatment of asthma . He noted that this approach seemed to 
promote a cathartic effect which was beneficial to the asthmatic . Fina l ly ,  
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·Knapp ( 1 980)  has  reported that th.e free association technique can  be 
used successfu l ly with asthmatic s .  He states that the asthmatic ' s  "need 
to c l ing  and fuse" is at the core of his/her disorder and should  be the 
focus of  treatment . 
Fo l l owing the l ead o f  the Psychoanalytic approach which stres ses the 
importance of parent-child re lationships in the genesis of  asthma , 
several authors have reported success in treating child  asthmatics with a 
family  therapy orientation. Examp les  of this approach inc lude : Abramson 
and Peshkin ( 1 9 78) ; Groen and Pe I s er ( 1 960); Minuchin et a l . (1 975 ) ; 
Pinkerton (1967 ) ;  and Piazza (19 8 1 ) .  
With a somewhat s imil ar emphasis upon the ro le  which famil y  difficul ­
ties may p lay upon asthma , several authors have reported that asthmatic 
symptoms subside fo l lowing a "parentectomy" (i . e . , the removal of the 
patient from the home situation) .  Such a strategy obvious ly  is reserved 
for more severe cases ( Bastiaans & Groen , 195 5 ; Grinker & Aronson , 1973 ; 
Lewis & Lewis , 1972 ; Purce l l  et a l . ,  1969) . 
Stil l other approaches which have been reported as being he lpful  with 
asthmatics inc lude : Hypnosis (Co l l i§on ,  1968 ; Leigh & Marl ey ,  1967 ) : Rog­
erian therapy (Anderson , 1 978 ; Kleeman , 1 97 1 ) ; Yoga (Goyeche et a l . ,  1 980 ) ; 
and increasing speech activity (Mook & van der P loeg , 1980) . This last 
study is o f  particul ar interest in that it serves as at l east indirect 
support for use of assertiveness training with asthmatics . These authors 
noted that expiration improved when patients  were encouraged to verbalize 
free ly  and that it did not improve when they were forced to listen OT 
were interrupted . 
Fina l ly ,  some authors have sugge sted that the success of  psycho logi­
cal l y  oriented treatments with as thmatics may be l arge l y  based upon an 
20 
expectancy e ffect . For examp le , Aitken et a l . (1972) state : " I t  l ooks 
as i f  this contact ( i,e . , psycho logical l y  oriented) need be l i t t l e  more 
than minima l , i . e . , sufficient only to make c l inical  obser�ations (p . 375) . "  
Whi l e  the potenti a l  for p l acebo effects  certain ly  cannot be overl ooked in 
asthma-treatment research , the fact that a myriad of studies  (primari l y  
i n  the Behavior Therapy l iterature) have demonstrated active and s igni fi ­
cant treatment e ffects when compared with appropriate no-treatment control 
groups suggests  that the above authors may be overestimating the power 
of such effects ( Knapp & We l l s ,  1978 ; Spevack , 1978 ) . 
Behavioral 
Behavior therapists  have been invo lved in  the treatment of bronchial  
asthma for over 20  years (see Wal ton , 1960) . During this period a 
cons i derab l e  amount of  research has evaluated the uti l ity of  a variety of  
behavioral strategies for u se  as adjunct treatments for thi s  d isorder . 
Such strategies have inc luded: various forms of biofeedback (Danker 
et a l . ,  1 9 75 ; Kahn et a l . ,  1 9 7 3 ;  Scherr et a l . ,  1 9 75 ) ; progressive musc l e  
re l axat ion (Al exander ,  1972 ;  A lexander e t  a l . ,  1972) ; systemat i c  desensi ­
ti zation (Cooper , 1 964 ; Sergeant and Yorkston , 1 969) : and assertiveness  
training (Wa l ton , 1 960 ; Hock et  a l . ,  1978 ) . In genera l , those strategies 
whi ch inc l ude some form of re l axation training have been found to be 
effective on variab les  such as : decreased frequency ,  durat ion and 
intensity of asthma attacks ; decreased medication usage and emergency 
room vis its ; and increased respiratory functioning (the reader is refer­
red to : B l anchard & Ah l es , 1 979 ; Knapp & We l l s , 1978 ; Er'skine-Mi l l i s  
& Schonel l ,  1 98 1 ; and Spevack , 1978 for exce l lent reviews of this 
l i terature) . Stated s imp l y ,  the rational e  for the effectiveness  of such 
strategies is that s ince strong autonomic arousa l  has been shown to have 
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adverse e ffects  upon asthmati c  symptoms (e . g . , Matus , 1 98 1 ) , reduction of 
such arousal l evel s  should prove beneficial  (Kinsman et al . ,  1 980b ; 
Spevack , 1 9 78) .  
Despite substantial  evidence which supports the us e of  re l axation ­
type strategies for the treatment o f  asthma , several studies have 
questioned the b l anket app l i cahi l i  ty of these techniques . For ex.amp l e ,  
it  has been suggested that these techniques may onl y  be successful  with 
asthmati cs who : 1 )  are of the intrinsic  versus extrinsic  type (Phi l l ip 
et a l . ,  1 9 72 ) ;  2 )  are of mi ld  to moderate severity (Davis  et a l . ,  1 9 73 ) ;  
and , 3 )  have a speci fi c  p sychomaintenance style (e . g . , Moderate t o  High 
in  terms of panic - fear symptom vigi l ance , Hi gh in terms of personal ity ; 
Kinsman et a l . ,  1 980b ) . I n  addition ,  some researchers have suggested 
that onl y  "mental"  (i . e . , autogenic  training ; meditation) as opposed to 
traditional muscul ar relaxation techniques result  in any real c l inical 
improvement . Thus , i t  seems that many i ssues remain unresolved . In the 
fol lowing  di scussion I wi l l  review the evidence ,  both pro and con ,  con ­
cerning the use of arousal reduction strategies such a s  re laxation train­
ing for the treatment of bronchial asthma . 
Support ive Dat a .  Evidence which supports the effi cacy of re l axation 
techniques can be found in several areas . These inc lude studies  which 
have evaluated traditional progressive musc le  re l axation (or variants of 
this procedure such as autogenic  training and medi tation)  both in isolation 
and in conj unction with additional treatment components (e . g . , desensiti ­
zation hierarchies ; frontal is e lectromyograph (EMG) feedhack) .  
Studies in which re l axat ion training of the Jacobsonian mus c l e ­
tense-re l ax type was evaluated i n  isolation have consistent ly resulted in 
sign ificant improvement . For examp l e ,  Alexander et al . ( 1 9 7 2 )  reported 
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s igni ficant changes in  PEFR l eve l s  of treated versus non-treated 
asthmatics  after an average of  l ess than five sessions . A lexander ( 1972 ) , 
reported s imi l ar success after an average of  approximate l y  four 30-minute 
sessions of  such training . In each of  these studies moderate to  severe 
asthmati c  chi ldren were used as subj ects and improvements in PEFR 
averaged over 20  l i t ers/minute (an improvement of  approximate l y  1 1 % ) . 
Several s tudies  have empl oyed variants of "traditional "  re l axation 
and met with s imi l ar success . For examp l e ,  Wi l son et  a l . ( 1975 )  treated 
subj ects  with Trnnscendental  Medi tation and observed s ignificant  changes 
on s e lf-report ( e . g . , s e l f-rating of symptom severity) and pulmonary 
funct i on measures (e . g . , FEVl , PEFR) for treatment as compared to contro l 
sub je ct s .  Simi l ar l y ,  Schwobel  ( 1948 )  used a treatment strategy which 
emp loyed an autogenic training component (i . e . , autogeni c  training involves 
s e l f- suggestion that musc les  are heavy and warm) and "showed subj ective 
and obj ective improvement in 42 out of 50 patients (Erskine-Mi l l i s  & 
Schone 1 1  , 1980 , p .  367) . "  
A recent trend in the use of  re l axat ion strategies has been their 
emp l oyment as active coping ski l l s  as opposed to passive techniques by 
which one can reduce overal l  l eve l s  of phys io logical  arousa l . In this 
type of procedure , subj ects are taught not on l y  to practice  re l axation 
on a dai l y  basi s ,  but also  to use such ski l ls act ive l y  to maintain their 
composure when faced with the initial  cues of an oncoming attac k . Tn one 
case study , Rathus ( 1 973 )  taught a 22 -year-old  asthmatic  re l axation ski l l s 
and then encouraged her to we l come rather than fear the onset of  her 
symptoms and to view each attack as an "opportunity to prove to herse l f  
that she could  deal effective ly  with them (p . 3 1 )  . "  He reports that the 
patient remained symptom- free for two years after tre.atment . 
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Sirota and Mahoney ( 1974)  treated a 4 1 �year�old  woman with a thirty­
four year h i story of asthma us ing a relaxation as coping strategy and 
reported that , after nine sessions , she was ab le  to : reduce the frequency 
of usage of her portab le  nebu l i zer to almost  zero ; decrease the usage of  
s teroi d  medication s , and s imi l arly  reduce her  usage of addi tional asthma 
medi cations . Improvement was maintained at a two month fol low-up . 
S iche l et a l .· ( 1 973 ) , reported simi lar success in s t i l l  another study in 
which relaxation was emp l oyed as an acti ve coping ski l l  with asthmati c  
chi l dren . I t  shoul d  be noted that the success of  re l axation as a coping 
strateg y may be a function of  both the direct effect s  of  decreased 
arousal upon lung  functioning and the indirect effects  of  the patient ' s  
increased confidence in  his/her abi l ity to cope with , and have a certain 
degree of  control over , asthmatic  symptoms (as Kinsman et  a l . ,  1980a 
might suggest ) . 
Re l axation therapy has a lso  been emp l oyed with asthmatics  in  con j unc­
tion with fronta l i s  EMG biofeedback . Thi s  EMG- assi sted re laxation train­
ing invo lves teaching subj ects s ome systematic  method of  rel axing (e . g . , 
progressive mus c l e  relaxation) whi l e providing them with ongoing feedback 
whi ch purportedly demonstrates the success of their efforts (e . g . , lower 
EMG l eve ls  reflect decreased mus c l e  tens ion as a function of re l axation 
exerci ses ) .  To dat e ,  a fair number of s tudies have demonstrated the effi­
cacy of  thi s  technique . For examp l e ,  Scherr et a l . ( 1 975)  provided 
asthmatics  with fronta l i s  EMG- assisted re laxation training and ,  after 15  
sess ions , treated subj ects showed improvement on  the fo l lowing variab l es 
as compared to  a control group : reduced number of infirmary visits ; 
decrease in number of attacks ; reduced steroid usage and an almost  two­
fo ld improvement in Peak Expiratory F low Rate . I t  i s  interesting to note 
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that both treatment and contro l subj ects were chi l dren at a summer camp 
whi ch speci a l i zed in the intensive treatment of  asthmatics , thus , the 
gains rea l iz ed can be seen as above and beyond what coul d  be attributed 
to the other components of  the camp ' s  treatment regimen . Kotses et a l . 
( 1976)  and Kotses  et a l . (l 978) demons trated s imi l ar improvement , inc lud ­
ing improved PEFR,  using EMG-assisted re l axation training . 
One case s tudy (Lerro , 1980}  reported success ful  treatment of an 
asthmati c  with a mul t icomponent package whi ch inc luded EMG-ass isted 
re l axation training and finger-temperature feedback . Whi le the rat iona l e  
for inclusion o f  finger-temperature feedback was not given , the patient 
did improve . However , s ince. the treatment program a l so inc l uded a compo­
nent wi th demonstrated efficacy, there is no way one can assess the added 
bene fits  of this  package . 
Thi s  author was ab l e  to find on ly  one study which compared EMG­
as s i sted re l axation training with relaxation training al one and a no 
treatment contro l .  Davis et a l . ( 1 973)  carried out thi s study and re ­
ported s i gn i ficant improvement in the treatment groups as measured by PEF R .  
I n  addition ,  they report that EMG feedback resulted i n  sti l l  further 
gains over re l axation training a lone . I t  i s  interesting to note , however , 
that these resul t s  held  on ly  for subj ects who had been defined as non­
severe asthmatics  and not for severe patient s . In this cas e ,  severity/ 
nonseverity was determined according to the presence or absence of s teroid 
therapy (reca l l  that steroids are reserved for use only  in more severe 
cases ) .  On the bas i s  of these  findings , Davis et a l . suggested that re ­
l axat ion-type strategies might be of  l imi ted uti l ity for severe asthmatics . 
One prob l em with this conclusion , however ,  i s  that a severity/nonseverity 
distinct ion based upon medi cat ion alone does not insure that one i s  a l so 
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di fferentiating between asthma type , As s tated previous l y ,  both intrinsic  
and extrinsi c  asthma can b e  equal ly  severe and require steroid therapy , 
In  addition ,  s ince i t  has been suggested that intrinsics  and extrinsics  
may respond different i a l l y  to re l axation training (e , g "  Phi l l ip e t  aI " 
1972  suggest that intrinsics  respond more favorab l y) , conc lus ive s tate­
ment s  cannot be  drawn from these resu l t s , It  may be that the treatment 
samp l e  in thi s  case was composed of a mixed group of asthma types which 
coul d  have resulted in a "washout " effect among severe asthmat i cs , In  
addi tion , i t  i s  ent ire ly  possib l e  that a l l treatment groups did not con­
tain an equa l number of intrinsic  and extrinsic  asthmatics . As a resu l t , 
the EMG-assisted groups may have had an advantage over the re l axation 
onl y  groups due to chance assignment of intrinsics to these groups , 
One final  area of research supporting the efficacy of  re l axation­
type techniques wi th bronchial  asthmatics  is  the sys tematic  desens iti za­
tion l i t erature , Since systematic  desens iti zation (SOl , as defined by 
Wo lpe ( 1973 )  inc l udes progressive mus c l e  re l axat ion as a maj or component 
of treatment ,  it is not surpris ing that it  has been emp l oyed effective ly  
with as thmatics , Whi l e  the rational e  of  each approach can be vi ewed as 
s imi l ar ( i , e "  to he lp  the patient decrease emotional arousal  associated 
with symptom onset ) , these approaches do di ffer . The maj or di fference 
between these s trategies is that re l axation provides the patient with a 
ski l l  whi ch can resul t  in genera l i zed anxiety reduction , whereas , SO 
attempt s  to systemat ica l ly reduce arousa l  associated with speci fica l ly 
identi fi ed cues as sociated with symptom onset . This  systematic anxi ety 
reduction is achieved by having the pat ient imagine hims e l f  in a stress ­
ful s ituation whi l e  maintaining his/her body i n  a re laxed state . I t  is  
theori zed by some that this  more specific arousal reduction i s  the reason 
for the apparent superiority of  SD to relaxation alone . For examp l e ,  
Spevack ( 1 978)  states : 
"Perhaps the superiority of  desens i t i z ation over 
rel axation is due to the fact that the initia l  
asthma symptoms are invo lved in the desensiti za­
tion hierarchy (albeit in a pass ive way) , and this 
enhances the l ik e l ihood that an individual wi l l  re-
lax during the init ial  phase of an attack ( 1 978 , p .  325 ) . "  
Several s tudies  whi ch demonstrate the efficacy of this technique wi l l  
now be discussed . 
As previous ly  stated , SD invo lves the pairing o f  asthma-re lated 
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s ituat ions (in imagination) with a relaxed bodi ly  s tate . According to 
Knapp and We l l s  ( 1 978) , s tandard items of an SD  hierarchy include such 
thing s as : fighting for one ' s  breath and fearing one might die . Whi l e  
i t  is  fe l t  that many asthmatics  w i l l  experience simi l ar l eve l s  o f  an-
xiety as soc iated with i tems on the standard hierarchy , most authors 
recommend the use of  individua l i zed hi erarchy items whenever possible  
(e . g . , Knapp & We l l s ,  1 97 8 ;  Moore , 196 5 ;  Spevack , 1 978) . 
The e ffi cacy of  SD  with asthmatics is  we l l  documented . For examp l e ,  
Cooper ( 1 964)  used S D  t o  treat a 2 4-year o l d  severe asthmat i c .  After 
12 sessions , the subj ect reported experiencing only 4 attacks over a 
period of  16 months .  Cooper fe l t  that the key ingredient of change was 
the patient ' s  improved abi l i ty to remain calm in previous ly  anxi ety 
e l i c iting situat ions . In another case study , Sergeant and York ston 
( 1 969)  effected simi lar improvement with a 26 -year o l d  asthmatic ' after 
only eight ses s ions . Th i s  patient was reported as being symptom- free for 
five years fo l lowing treatment . Whi l e  such resul ts  are encouraging , 
they can be taken as only suggestive evidence of the effi cacy of  SD due 
to their l imited scope . 
In a larger study , Moorefield  ( 1 9 7 1 )  treated nine subj ec ts  with an 
SD package which subst ituted hypnosis for the relaxation component . After 
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an average o f  j ust  over 1 3  sessions , a l l  pat ients improved o n  s e l f-report 
measures and in t erms of medication usage patterns ( i . e . , medication 
usage decreased) . Unfortunate ly,  neither pulmonary function nor fo l low­
up data were reported in thi s  s tudy . 
In  s tudies whi ch have compared SO with re l axation training on l y ,  SO 
has consi stent ly  been found to be superior ( B lanchard & Ahles , 1979 ; 
Knapp & We l l s ,  1 9 78 ; Spevack , 1978 ) . For examp l e ,  Moore ( 1965)  compared 
relaxation onl y ,  re laxation p lus pos i t i ve suggestion ( i . e . , "you ' re 
hand l ing  your attacks wel l " ) , and rel axati on p lus SO on a group of 1 2  
asthmatics . Whi l e  a l l  treatments resul ted in  improvement in  terms of  
decreased frequency of attacks , on ly  the SO  p lus relaxati on group improved 
on measures of respiratory function . These di fferences were maintained 
at a 6 -month fo l low-up . 
In  a simi lar  s tudy , Yorkston et a l . ( 1974)  treated 1 4  asthmatics  
with  e i ther re l axati on training or SO  p lus re l axation training . After 
only 6 sessions , subj ects  in the SO group demonst rated s i gn ificant ly  
greater improvement in terms of  reduced medication usage and pulmonary 
function increases (e . g . , % predic ted FEVI rose from 56 to 76%) . Results  
were maintained at a two year fo l low-up .  
No studies were found whi ch compared SO wi th re laxation as coping 
(which might be viewed as a type of "in vivo" desensi t i zation procedure) , 
and Spevack ( 1978 )  has suggested that such an invest igation would  be a 
f?Uitful  undertaking . In  addition ,  no s tudies have specifi ca l ly compared 
SO to various bio feedback techniques . Knapp and We l l s  ( 1 9 78) have 
suggested , however,  that since biofeedback techniques have not been found 
to be c l ear ly  superior to rel axation training , and since SO has demon­
strated such superiority over re laxation , we might expect simi l ar resul t s  
in a study whi ch compared S O  with biofeedback . In  any event , most authors 
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attest  to  the superiority of  SD over other behavioral techniques at this  
point i n  t ime (e . g . , B l an chard & Ahl es ,  1 979 ;  Erkskine-Mi l li s  & Schone l l ,  
1 98 1 ; Knapp & We l l s ,  1 978 ; Spevack , 1 978) . 
At the present t ime , the fo l lowing  conc lusions  regarding the use . of  
rel axati on -type approaches for the  treatment of  b ronchial  asthma can be  
made : whether traditional musc l e - t ension or variants  are emp loyed ; 
whether these s trategies are used in an active or pas sive manner ; and 
whether they are used in i s o l at ion or in conj unction with SD hierarchies  
or  EMG- feedback ; the  data seems to consistent l y  support the  use of re ­
laxation-type ( i . e . , arousa l  reducing} techniques as adj unc t  treatments  
for bronchi a l  asthma . Further work i s  n�eded , however , to determine such 
things as : whether EMG-feedback i s  a s i gni ficant addit ion to systematic  
re l axation techniques ; whether active rel axation i s  superior to passive 
re laxation ; and the comparative efficacy of SD and EMG-assisted techniques . 
Restrictive Data . Despite  the overwhelming evidence which supports 
the use of arousal reduction strategies such as biofeedback , re l axation , 
and syst emati c  desens i t i zation as adj unct treatments  for bronchi a l  asthma , 
several studies  have questioned their b l anket app l i cation and have sug ­
ges ted that their uti l ity may be l imited . In  general , these s tudies  can 
be seen as attempts  to identi fy more precisely  which type of pati ents 
( i . e . , asthmati c s )  wi l l  respond favorably to what intervent ion technique ( s )  
(Kies l er ,  1 966 ; Paul , 1970 ) . 
Phi l l ip et al . ( 1 9 7 2 )  i s  the on ly  s tudy in  the asthma treatment 
l i terature which has systematica l ly examined the e ffects  of arousa l re­
duc t ion strategies such as re laxat ion therapy upon di fferent asthma sub­
types ( i . e . , intrinsic  versus extrinsi c ) . In this study , asthmati c  type 
was determined by react ion/nonreaction to an ant i gen skin test  (recal l  
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that extrinsics  respond pos i tive ly to such a test and intrinsics  do not ) . 
On the basi s  o f  t hi s  determinat i on ,  2 0  subj ects were assigned to each of  
the  fo l lowing groups : 1 )  Intrinsi c -Re l axation ; 2 )  Intrinsic -No Re l ax­
ation ; 3 )  Extrins ic - Re l axation ; 4 )  Extrins ic-No Re l axation . After five 
sess ions of re l axation training , the fo l lowing result s  were obtained : 1 )  
an overal l re l axat ion e ffect was observed a s  7 out o f  1 0  relaxation sub ­
j ects  improved o n  measure s o f  pulmonary function (e . g . , FEV1 ) ,  whereas , no 
control subj ects  showed such improvement ;  2) When the data were eva luated 
individua l ly  ( i . e . , subj ect by subj ect) , they found that the l argest  im­
provements occurred among the Intrinsic  as thmatics treated with re laxa­
t ion . As such , they suggest that re l axation may be more effective with 
intrinsic  asthmatics . 
Several points need to be made based upon these resu l t s . First , 
g iven the potenti a l  importance that an i l lness variab l e  such as asthma 
type could have upon the s e l ect ion of appropri ate treatment s trategi es 
for use wi th asthmatics , i t  seems c lear that the results  of Phi l l ip et 
a l . requi re repl ication .  Second , s ince al l of  the subj ects in this in­
vesti gation were rated as non severe asthmatics , such rep l i cation efforts 
shoul d  attempt to extend the se findings to more severe asthmatic  popula­
tions . Fina l l y ,  pending the outcome of such efforts ,  it  would  seem 
neces sary for asthma-treatment researchers to account for such a potent ial  
moderator vari ab le  when assess ing  the  efficacy of their result s . 
Davis  et a l . ( 1 973)  have a l so  sugge sted that the use of arousal 
reduction strategies  may be restricted on the bas i s  of asthma severity 
(i . e . , such strategies may only be effect ive with mi ld  to moderate 
asthmat i c s ) . However , s ince severity in thi s study was determi ned so le ly  
on the bas is  of medication needs it  i s  not a l l  c l ear whether this  
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a lso  resul ted in subj ects  being di fferent iated according to asthma type 
( i . e . ,  intrinsic  versus extrinsi c ;  recal l  that both of  these types re-
quire steroids  in severe cases ) . rf, as suggested by Phi l l ip et a l . 
( 1 9 7 2 ) , intrinsic s  and extrinsics  respond differentia l l y  to re l axation 
training (i . e . , intrinsics  respond more. favorably) , i t  i s  quite possib l e  
that the equivocal  result s  obtained i n  the Davis et  a l . (1 973)  study 
were the funct ion of a "was·h out effect" due to the presence of both 
intrinsic  and extrins ic asthmati.cs  in the severe group . I ndeed , these 
authors commented that : 
"Extreme response variab i l ity disp l ayed by members of 
the severe group accounts for the l ack of s i gnificant 
improvement in the group (p . 1 26 ) . "  
Such "extreme variab i l ity" i s  exact ly  what one woul d  expect from a group 
composed of di fferent asthma types . At this point , then , the l imitations 
suggested by Davis  et a l . ( 1 973 )  cannot be accepted as conc lus ive . Such con-
c lus ions may onl y  be drawn when these findings are rep l icated in a s tudy 
whi ch either examines both asthma type and severity s imul taneous ly or 
systemat ica l l y  contro l s  for asthma type . I t  may be that a more adequate ly 
contro l l ed study wi l l  demonstrate that re l axation strat egies can be used 
with severe asthmatics  who are of  the intrinsic type . 
Fo l l owing a rat ional e  simi l ar to Davis  et a l . ( 1973) , A l exander et 
a l . ( 1 9 79)  attempted to evaluate the usefulness of  re l axation training 
with severe asthmat ic chi l dren . In  what these authors cal led a confirma-
t ion of  the results  of  Davis  et al . ( 1973) , no signi ficant improvements 
were obtained by these subj ects in response to re l axation . These authors 
went further and suggested that since re l axation theoretical ly  operates 
via PNS innervation and that PNS innervat ion a l so can result  in broncho-
constrict ion , we shoul dn ' t  expect that re l axation would  be effect ive 
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with asthmatics , rather , we shoul d  anticipate a worsening o f  symptoms . 
The resul ts  o f  thi s s tudy can be critici zed upon severa l  
grounds . First , l ike  Davis  e t  a l . ( 1 973)  these authors fai led to 
di fferent i ate subj ects accord ing to asthma type . In fact ,  because 
the subj ects were a l l  under 15 years of  age , and the onset o f  
intrinsic asthma tends to be i n  adul t  l i fe ,  one could specu l ate that 
these subj ects were of the extrinsi c  type and as such , might not be ex­
pected to respond favorably  to rel axation training .  Further evidence of 
the probabi l ity that at least some of  these subj ects were of the extrins i c  
type can be found i n  the facts that : 1 )  A l l the subj ects showed reversi ­
b i l i ty o f  symptoms i n  response to bronchodi l ators ; 2 )  On ly  some o f  the 
subj ects were on cort i costeroids . The reader may reca l l  that intrinsi c  
asthmatics , a s  a rul e ,  d o  not respond t o  bronchodi l ators and , a s  such , 
general l y  require steroid  therapy . Another criticism of  thi s  investi gation 
is  the fact that some research has demonstrated that re l axation strate­
gies are difficu l t  to imp l ement successfu l l y  with chi ldren because of  the 
attention and concentrat ion required (e . g . , Hat zenbuehl er and Schroeder , 
1978 ) . As such , the four sessions of  re l axation given to subj ects in this 
study may not have been adequate to achieve appropriate l eve.l s of arousal  
reduction . The fina l , and perhaps most important , criticism is  that , in  
cha l l enging the  theoretical  rational e  of  re laxation therapy these authors 
have apparently  assumed that the bronchoconstrict ion associated with asthma 
is caused uni formly  by PNS activity . As was stated previous ly (in the 
Pathophys i o logy section ) , the re spiratory system does not operate in such 
a straight forward manner (i . e . , constriction may be a funct ion o f :  PNS 
overreactivi ty ; SNS - beta adrenergic hypoactivity ; SNS-a lpha adrenergic 
hyperactivity) . It i s  ent irely  possiQle  that re l axation therapies may be 
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effective with  certain asthmatics  because they s erve to minimi ze the  phy­
siological  arousal  whi ch may be adversely  effecting the SNS-adrenergic 
receptors in the first p l ace . Tn any case , i t  seems c l ear that the use 
of  re l axat i on - type strategies cannot be contraindicated on the bas i s  
of a methodological l y  flawed investigation ani an overl y  simp l istic  con­
ceptua l i zation of respiratory physiology'. 
In  addition to i l l ness  variab les  such as asthma type and severity , 
some authors have suggested that the use of arousal  reduction strategies 
may be res tricted on the basi s  of  psychological  variab l es . As Kinsman 
et a 1 . ( 1 98 0b )  s tate : "Asthmatic  pat ients simply  are not a homogeneous 
psychological  group (p . 403 ) . "  A long these l ines , Kinsman and his  
associates ( 1 980a) have identified 9 di fferent asthmatic personality 
subtypes via the use of psychometric instruments (i . e . , the ASC and the 
20 P-F) . 
According to the se authors, arousa l  reduction strategies are indica­
ted for onl y  two of  these 9 subgroups ; i . e . , Moderate-High and High-High 
(recal l  that moderate to high l eve l s  o f  symptom vi gi lance are considered 
adaptive whereas only  moderate l eve l s  of panic-fear personal i ty are adap­
tive) . These  authors a l so state that arousa l  reduct ion strategies are 
contraindicated for patients  who measure low on symptom vig i l ance (i . e . , 
Low- Low ; Low-Moderate ; Low-High) . This is based on the assumTlt ion that 
re l axati on in these cases might se.rve to decrease an a lready mal adaptive 
leve l of  symptom vigi l ance (Kinsman et a1 . ,  1980b ; Staudenmayer et a l . ,  
1979) . Whi l e  these authors present a convincing rationale  for the restriction 
of arousa l  reduction strategies to use with speci fic patient subtypes , to 
this date , no study has specifical ly evaluated their hypothes es . 
One fina l qua l i fication on the use of arousa l  reduct ion strategies 
with asthmatics concerns the method by which such arousal  reduct ion i s  
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achieve d .  Evidence to date nas, for the mos t  part , supported the use of a 
variety of approaches to re laxation training . Erskine-Mi l l i s  and Schone l l  
( 1 9 8 1 )  have cha l l enged tnis b lanket endorsement in a recent review . They 
state : 
" . . .  muscul ar rel axation � lone appears to be ineffec­
tive in  the treat�ent of asthma , however , mental  re lax­
ation techniques , sucn. as autogenic training and trans­
cendental  meditation , s eem to produce c l inica l ly  and 
stat i s t i ca l l y  s ign i ficant improvement in pulmonary func­
tion and subj ective 'measures ( 1981 , p .  368) . "  
A review of  the studies whi ch these authors based this conclusion on 
suggests  that this conclus ion i s  premature . For example , to support the 
ineffectiveness  of muscular relaxation these authors cite three studies 
which have been reviewed previous ly  in the current paper . These studies 
are : A l exander ( 1 9 72 ) ; A l exander et a l . ( 1 9 72 ) ; and Al exander et a l . ( 1979) . 
As previous l y  discussed ,  the resul t s  of  the A l exander et a l . ( 1 979) s tudy 
cannot be considered conclusive because of several shortcomings ; e . g . : 
fai l ure to di fferentiate according to asthma type ; use of  chi l dren for 
subj ect s . Both the A lexander ( 1972 )  and the Alexander et al . ( 1972 )  studies 
can be critici zed for these same snortcomings . In  addit ion , Erskine-Mi l l is  
and Schone l l  state  that whi l e  these l ater two studies did report stat i s t i -
cal ly s i gnificant results , improvements achieved on PEFR measures were 
only  1 1 %  and l ess  than 1 5 %  is considered c l inical ly ins ignificant . Whi le 
this criticism  i s  an appropriate one , these authors fai l  to report that 
in each of these s tudies  there was extreme response variab i l ity of  the 
type reported in the Davis  et a l . ( 1 973)  study ear l ier .  For examp l e ,  
Alexander ( 1 972)  reported that : the top third of his  subj ects improved 
over 35% ;  the middl e  third improved on ly 5 % ;  and some of the bottom third 
actua l ly deteriorated . Again , such resu lts  are consi stent with what one 
woul d  expect of a heterogeneous treatment popul ation made up of both in-
trinsic and extrinsic  asthmatics . 
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A second cha l l enge which can b e  l eve l ed against their conc lus ion re­
garding the effectivenes s  of "mental" techniques i s  the fact that , for 
the mos t  part , none of these s tudies  involved a direct comparison between 
mental and muscular techniques (e . g . , recal l  Schwobe l l ,  1948 and Wi l son 
et al . ,  1 9 75 ) . As such,  i t  woul d  seem difficu l t  to pronounce these tech­
niques  as superior regardl e s s  of  how effective they may be . 
Final ly ,  in the one s tudy they cite as a direct comparison between 
muscular and menta l techniques , neither technique was found to be effec­
tive (Erskine and Schone l l ,  1979) ! In addition , thi s s tudy was a l so  
pl agued by  the fo l l owing methodo logical prob l ems : First , subj ects were 
not contro l l ed in terms of asthma type . Second , in attempt ing to estab ­
l ish a neutral expectancy s e t  for these  subj ects , it  seems that these 
authors may have actua l ly estab l i shed a negative set (i . e . , subj ects were 
to ld  that the "effect s  of re l axation therapy on asthma are unknown" ) . 
In summary , wh i l e  these authors have raised a pert inent treatment 
issue which certain ly warrants investigat ion , it  seems far too premature 
to l i st mus cu lar re l axation techniques in the ob ituary co lumn . 
Conclusions and Recomm�ndations . At the present time , the fo l lowing 
conclus i ons can be drawn regarding the use of  arousa l  reduction te chniques 
such as re laxat ion therapy with bronchial asthmatics : 1 )  The blanket app li ca­
tion o f  these strategi es  has been cha l lenged on severa l grounds , however ,  
no chal l enge has been strong enough to serious ly restrict their  usage 
at thi s time ; 2) Severa l variab les have been suggested as potential  areas 
of restriction (e . g . , i l lness  type ; i l lness severity ; treatment type ; 
personal i ty type ) , however , no study to date has adequately eva luated 
even two of these variables  s imul taneous l y ;  3 )  Pending further and more 
adequately  contro l l ed research into these areas , statements concerning 
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the " b lanket indictment o f  anxiety reduct ion techniques i n  asthma" and 
the " indictment of b lanket app l icat ion" (Kinsman et al . ,  1 980b) of such 
techniques cannot be made conc lusivel y .  
Given the importance of  the i s sues and chal l enges whi ch have been 
rai sed by the above authors , such investigations must be impl emented i f  
further progress i s  t o  b e  made in this area of  the asthma-treatment 
l i terature . What appears to be cal l ed for ,  then , are a series of  mul t i ­
factorial  eva luations which  wi l l  examine the fo l lowing vari ab les  (mini ­
mal l y) in  a systematic  fashion : 1 )  Intrins i c  versus Extrinsic  asthma 
type ; 2) Nonsevere versus Severe intensity ;  3) Muscular versus Mental Re­
laxation strategi es ; 4) Panic-Fear asthma subtypes . The present study 
represent s an initial  step in this seri es . 
The Present Study 
The obj ectives  of  the current investi gat ion were twofo ld . First , 
thi s s tudy was proposed as an attempt to reconfirm the ut i l ity of  re l axa­
t ion therapy as an adj unct strategy fo r the treatment of bronchia l asthma . 
Second , i t  was intended to examine specifi c  psycho logical  and i l lness 
vari ab les  which could potent ial ly be useful in predi cting responsiveness/ 
unresponsiveness to such a treatment strategy . The spec i fi c  variab l es 
whi ch were examined in this study were asthma severity and panic- fear 
personal i ty type . It  had been intended that the asthma type variab le  
(i . e . , intrinsic  versus extrinsi c )  would  a l so be  examined , however , the 
fina l subj ect samp l e  cons i sted of either extrins ic  asthmat ics  or mixed 
asthmatics  who were primar i l y  influenced by extrinsic  factors .  As such,  
thi s study contro l l ed for ,  rather than systematical ly eva luated thi s 
important factor . Simi lar ly ,  a l l  subj ects who part i c ipated in thi s 
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program received i dent ical  treatment ( i . e . ,  re l axation therapy inc luded 
muscular , menta l , pass ive , and act ive coping components ) .  Thus , 
questions pertaining to the most effect ive form o f  re l axation (i . e . , 
menta l or muscular) were not addressed . 
Hypotheses 
Several hypotheses were made for each of  the stated obj ect -
ives of  this  i nvest igation . These hypothesi zed result s ,  as expected 
across  severa l assessment domains (i . e . , sel f-report ; pulmonary funct ion ; 
physici an rat ings) , are summari zed be low . 
Treatment E fficacy 
F i rst  and foremo s t ,  it  was predicted that a l l  subj ects who part i c i ­
pated i n  this  program would demonstrate the acqu i si t ion o f  the relaxa­
t ion ski l l  as indicated by decreased se l f-rat ings of tens ion/ re l axat ion 
fo l lowing a l l treatment sess ions . Assuming the acqui s i t ion of this  
ski l l ,  i t  was  a l so hypothesi zed that re laxation therapy would e ffect the 
fol lowing outcomes : 
1 )  Decreased frequency , durat ion , and intensity o f  asthma attacks ; 
2) Decreased med i cation usage as indi cated by phys ican ratings 
and s e lf-monitoring data ; 
3 )  Improved respi ratory funct ioning as indicated by several rul -
monary measures ; 
4 )  Decreased scores on the symptom vig i l ance or " state" measure 
of pan i c - fear (i . e . , as measure d by the ASC) ; 
5 )  Decreased fee l ing of  he lp lessness in  response to asthmat ic  
symptoms as indicated by  decreased scores on the panic - fear 
"trait" measure ( i . e . , the 20 P - F ) . 
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Vari ab les  Re l ated to Outcome 
The fo l lowing hypotheses were made regarding the predi ctive abi l ity 
o f  asthma severity ,  panic-fear persona l i ty typ e ,  and comp l iance to treat ­
ment instructions : 
1 )  Panic - fear personal ity type (i . e . , as determined by scores on 
the ASC and the 20 P-F) wi l l  be s ignificant ly  re lated to favorabl e  out­
come . Specifical l y ,  i t  i s  expected that "high" panic-fear types wi l l  
respond more favorably  to re l axation therapy than " low" or"moderate" 
types ; 
2) Asthma severity wi l l  be s i gnificant ly  rel ated to favorab le  out­
come . Specifical l y ,  i t  is  expected that nonsevere extrinsi c  asthmat ics  
wi l l  respond more favorably to re laxat ion therapy than their severe 
counterparts ;  
3 )  The degree to which subj ects co�p ly to treatment instructions 
(as indicated by the amount o f  t ime spent practi cing re l axation train­
ing) wi l l  be positive l y  rel ated to improvement in their asthmatic  
symptoms . 
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Method 
Subjects 
Source . Subj ects were vo lunteers recrui ted from one of  two 
sources : 1 )  An Adul t  A l l ergy C l inic affi l iated with the Medical  Col ­
l ege o f  Virgini a ;  2 )  The case loads o f  private physicians who treat 
asthmatics  in the Richmond Metropol i tan area . The recruitment pro ­
cedure varied s l i ght ly  according to the source o f  the subj ects . For 
examp l e ,  at the Adu l t  Al l ergy C l inic recruitment was done directly  by 
the principal investigator . As patients came for their  regularly 
schedul ed appointments , they we re asked by the staff if  they woul d  ob­
j ect to speaking with someone about a Jesearch proj ect invo l ving asthma­
t i c  pat i ent s .  The proj ect was then described to those consent ing 
pat i ents and the names and phone numbers of persons interested in part ici ­
pat ing. were recorded . By contrast , recrui tment at the physicians ' 
o ffices was genera l ly done persona l ly by the physic ian or a member of  
his/her staff . The typical  procedure invo lved the physician and/or  
staff member briefly  describing the  proj ect to  persons in  their case load 
whom they fe l t  would  ei ther be interested in or bene fit from part icipa­
t ion . After thi s ini t ia l  process was comp l eted , the names and phone 
numbers o f  interes ted individua l s  were forwarded to the writer who 
hand led a l l  further contacts . 
Regardl ess o f  the source of  subj ects , invo lvement in thi s treatment 
pro gram was a lways coordinated with the primary care physic ian of each 
indivi dua l .  At no time were subj ects asked to change the i r  medi cat ion 
regimens by the princ ipa l inves tigator . Any changes in medi cation made 
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during the period of  this study were so le ly  the resul t of  pati ent -doctor 
consu l tat ions and i t  was as sumed that such changes (e . g . ,  increases or 
decreases)  would  be indicative of the physic ian ' s  j udgement of either 
worsening or improving symptomato l ogy . 
Pretreatment Rat i ngs . Subj ects who parti cipated in  thi s investi ga­
tion were assessed on the fol lowing variables  before the first treatment 
sess ion : 
a) Asthma Type :  Subj ects were assigned to an asthma type category 
by their phys icians  according to the fo l l owing criter i a  as suggested by 
Scadding ( 1 976) . Thi s  informat ion was conveyed to the writer via  the 
comp l eted Asthma Type Form (see Appendix  L ) . 
1 )  Intrinsic -nonreact ion to an antigen skin test ; no known 
rel at ionship between externa l agents and asthmati c symptoms (wi th the 
except ion o f  aspirin sensitivity) ; 
2 )  Bxtrin s i c  - pos i tive ( i . e . , wheal and flare) react ion to an 
ant igen skin test ; in absence o f  such a reaction ,  a demonstrated re ­
lationship between externa l agents  and asthmati c  symptoms ; fami l y  h i s ­
tory o f  asthma or  other atopic  disorders such a s  hay fever ,  rhi n i t i s  
and ec zema ; 
3 )  Other - this  cat egory was to inc lude either mixed or exer­
cise- induced asthmatics . Mixed asthmatics  were defined as those who 
posses sed both intrinsic  and extrins i c  trai t s .  Exerc ise- induced as thma i s  
s e l f  explanatory . 
B) Severit y :  Subj ects  were rat ed a s  e i ther severe or nonsevere 
according to the fo l lowing criteria : 
1 )  Severe - rating of  at least l evel 4 ( i . e . , "Requi res 
steroids , mo st , not a l l  of  the t ime" ) on the Phys ic ian ' s  Severity Rat ing 
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Scal e (P lut chik e t  a l . ,  1 97 8 ;  see Appendix D) ; 
2 )  Nonsevere - Physician ' s  Severity Rat ing of  3 or l es s . 
C )  Pani c -Fear Type : As reported previous l y ,  pani c - fear type i s  
determined by two variab l es - i . e . , Symptom Vigi l ance (as measured by 
the Asthma Symptom Check l ist ; see Appendi x A) and Personal ity (as 
measured by the 20  P - F ; see Appendix B) . A l l subj ects in the curren� 
investigation were categori zed according to panic fear type based upon 
their scores on these two instruments . The reader wi l l  reca l l that 
Kinsman and h i s  associates ( 1 980a) have identified 9 panic - fear person­
a l i ty subtype s based upon various combinations o f  symptom vigi l ance and 
personal i ty scores , respective ly  (e . g . , Low-Low , Low-Moderat e ,  Low-High , 
etc . ) . The cutoff scores for the symptom vigi l ance categories are de ­
fined according to the mean score on the pani c - fear items o f  the ASC 
and are as fol lows : 
1 )  Low - mean score of less  than 2 . 4 3 ;  
2 )  Moderate - mean score o f  greater than or equa l t o  2 . 4 3 o r  l ess  
than or equal to  3 . 29 ;  
3)  High - mean score greater than 3 . 29 .  
The cutoff scores on the persona l i ty variab l e  are determined by the raw 
score achieved on the 20 P - F  and are as fo l lows : 
1 )  Low - raw score l ess than or equal to 2 ;  
2 )  Moderate - raw score between the range o f  3 and 8 ;  
3)  High - raw score equal to or greater than 9 .  
A description of and psychometric information regarding the ASC and the 
20 P - F  i s  provided in the "Dependent Measure� I section of  thi s  paper . 
Number .  Attempts  were made to recruit 40 subj ects for this  invest i ­
gat ion . An initial l i st of  over 5 0  names of potent ial part ic ipants was 
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obtained from the above sources . Of  thi s  tota l , 5 0  individual s  were 
contacted and 40 agreed to participate in this program . Of  this  4 0 ,  
on l y  28  attended t h e  pretreatment assessment s ession and further 
attrition at various points in the study resul ted in a final samp l e  o f  
1 5  parti cipants  who compl eted the entire 1 0 -week program . 
Description of Final Sampl e .  The fina l samp l e  was composed o f  1 2  
fema l es and 3 ma les  who ranged in age from 1 5  t o  6 1  years o ld �=32 . 33 ;  
5 . 0 . = 1 1 . 1 7 ) . Three of the partic ipants were B lack and the remaining 1 2  
were Whi t e  (Note : Variab les  such a s  age and sex have been investigated 
e l s ewhere and have been reported to be unrelated to treatment outcome ; 
Knapp and We l l s ,  1 978) . 
A l l the subj ects  who part ic ipated were either extrins ic  asthmat ics 
( 1 3 )  or mixed asthmatics  with extrins ic  factors being dominant (2) . 
Ten o f  the subj ects  were rated as nonsevere and five as severe according 
to pretreatment PSRS rat ings �= 3 . 33 ,  5 . 0 . = 1 . 40 ) . A l l subj ects were 
being treated with varying types of medicat ion for their asthma; 
these inc l uded : bronchodi l ators (e . g . , Theodur Provent i l ) ; ant ihistamines 
(e . g . ,  Dimetane , Fedahest) ; and corticostero ids (e . g . , Predni sone) . 
On the FEVl/ FVC pulmonary function measure (which is commonly used to 
as sess  severity in terms of pulmonary demi se ) , pretreatment performance 
ranged from a l ow of 6 1 . 3 3% to a high of 98 . 67% (�=85 . 78% , S . D . =9 . 58 ) . 
Onl y  one subject  was categori zed as be ing below normal l imits according 
to the guide l ines o f  the Intermountain Thoraci c  Society ( i . e . , be low 
69% i s  cons idered to be subnormal ;  Cooper , 1 982 ) . Given these figures 
it would seem safe to describe thi s samp l e  as epi sodic as opposed to 
chroni c  asthmatics  s ince ,  by definit ion , episodic asthmatics  may perform 
wi thin norma l l imits between asthma att acks whereas chronic asthmat ics  
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usua l l y  exh ib i t  cons istent ly subnormal performance . 
According to pani c - fear persona l i ty subtypes , the samp l e  was di vided 
as fo l lows : 1 subj ect in  the Low-Moderate category ;  7 subj ects in  the 
Moderate-Moderate category ; 2 subj ects in the Moderate-High category ; 1 
subj ect i n  the High-High category . The reader w i l l  reca l l  that Kinsman 
et a l . ( 19 80a) woul d  rec ommend rel axation therapy only  for these l atter 
3 subj ect s . 
Dependent Measures 
Se l f- Report . Three se l f-report instruments  were used in this  s tudy : 
the ASC (Appendi x  A) ; the 20 P - F  (App end ix  B) ; and the Dai ly  Asses sment 
Form (Appendix  E ) . The first two o f  these measures ( i . e . , the ASC and 
the 20 P - F) were a l so  used for the purpose  of pretreatment asses sment . 
1 )  Asthma Symptom Check l i s t  - the ASC i s  a 50  item questionnaire 
whi ch measures the fo l lowing i l lnes s - specific  factors as sociated with 
asthma : 1 )  Pan i c - Fear ; 2j Irri tab i l i t y ;  3 )  Fat i gue ; 4 )  Hypervent i l a­
tion - Hypocapn i a ;  5 )  Airway obstruct ion . Each item on the check l i st i s  
a symptom commonly  associ ated with as thma (e . g . , short of  breath , 
a fraid o f  dying) and the subj ect i s  asked to report the degree to whi ch 
each symptom affect s  him or her on a five -po int sca le  rangi ng frow 
"never ( 1 ) "  to "always ( S j . "  As mentioned previous l y ,  the ASC i s  
thought to b e  a measure o f  symptom vigi l ance ; i . e . , the degree to whi ch 
the pat ient pays attention to/ is  aware of his/her symptoms . Of the five 
factors l i sted above , the Panic -Fear factor is of primary interest in 
the current s tudy . The ASC categori zes asthmati c s  into Low , Moderate ,  
and High categories , with Low scores being considered l eas t adaptive . 
The ASC i s  a highly re l i ab le  instrument with coefficients of tes t -
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retest stabi l i ty (after a two week interval )  ranging from . 76 (Fatigue ) 
to . 95 (Panic -Fear) (Kinsman et a l . ,  197 3 ) .  I ts  val idity i s  supported 
by i t s  cons i stent  abi l ity to predict  variab l es such as : usage of  as­
needed (PRN )  medi cat ions ; intens i ty o.f d ischarge medi cat ion ; and prob­
abi l i t y  of re -hosp i ta l i zation in an exhaustive series of studies  over 
the past decade . The reader i s  referred to Kinsman et a l . ( 1 973) , 
Kinsman et a l . ( 1 974 ) , and Jones et a l . ( 1 979)  for a more comp l ete d is ­
cussion of th e  development of  the  ASC as  we l l  as  its  psychometri c prop­
erties . 
2 ) 2 0  P - F : The 2 0  P - F  i s  a twenty item ,  true- fal se sca l e  consi s t ­
ing o f  items from the �finnesota I.lu l t iphasic Personal ity Inventory (MMP I )  
designed to measure a personal ity variab l e  cal l ed PAN IC- FEAR . The scale 
was deve l oped by Dirks et a l . ( 1977b ; 1 978 ) and its  items were chosen because 
of their  abi l i ty to correc t l y  ass ign ast��at ic pati ents to Lew , Moderate ,  
and High Panic- Fear cat egori es as previous ly  measured by the Asthma 
Symptom Check l i st ( Kinsman et a l . ,  1 973) . F i fteen of  the 2 0  i tems are 
actua l l y  ut i l i zed in assess ing Panic -Fear Persona l i ty whi l e  the remain-
ing five items are fi l lers . Like the ASC , the 20 P-F a l so di fferent iates 
subj ect s in  t erms of  Lav , Moderate , and High categories  of  Par.ic -Fear 
(with L� and High considered ma l adaptive) . Un l ike the ASC , whi ch i s  
said t o  b e  a meastire o f  i l lnes s - speci fic  symptom vigi l ance , the 2 0  P - F  
measures a trait o r  more charactero logical  form of  anxiety (Dirks e t  a l . ,  
1 977c ; Jones et a l . ,  1 9 79 ; Kinsman et a l . ,  1 9 80a) . 
The 20  P - F  appeurs to be a very re l iab l e  and stab l e  measure . Dirks 
et a l . ( l 978a) reporteJ a test-retest re l i ab i l ity of . 79 after an i nter­
val o f  several months . More recent studies  ( Kinsman et a l . ,  1980)  have 
reported s imi l ar stabi l i ty fo l l owing interva ls  of up to two years . 
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In  terms of  val idity ,  the 20  P - F  has been found to correlate . 83 
with  the Taylor Manifes t  Anxiety Scale , a sca le  used to assess Trait 
Anxiety ( Kinsman et  a l . ,  1 980c) . I n  addi t ion ,  the 20  P - F , both a lone 
and in conj unction with the ASC , has cons i s ten t ly been shown to predict  
such important variabl es as : inten s i ty o f  discharge medication ; l ength 
of  hospi t a l  stay ;  and probab i l i ty  of  re-hosp i t a l i zati on in an impress ive 
ser ies of s tudi es over the past five years . For further informat ion re­
garding the development and psychometric  propert ies of the 20  P - F ,  the 
reader is referred to  Jones et a l . ( 1 9 79) , and Kinsman et a l . ( 1 980 ) . 
3) Dai l y  Asses sment Form : The DAF i s  a s e l f-report quest ionnaire 
deve l oped for use in the current inves t i gation . The DAF was uti l i zed 
to co l l ect  the fo l lowing informat ion : number of  att acks per day ; dura­
tion of each att ack ; intens i ty rating ( l : mi l d  - 1 0 : severe) of each 
attack ; amount and type of medications inges ted each day . For the pur­
pose of this  s tudy , an attack was defined minima l l y  as the initial  on­
set o f  the fo l low i ng symptoms : wheez ing , tightening of  the ches t ,  and 
dyspnea . The DAF was comp l eted by pat ients on a dai ly  bas i s  throughout 
the entire course o f  this  study . 
Pulmonary Function .  Five s eparate measures o f  pulmonary funct ion 
were used to assess the impact of treatment . Four of these measures are 
commonly  used as outcome variab l es in asthma treatment studi es . These 
measures inc luded : Peak Expiratory F l ow Rate (PEFR) ; Forced Vital  
Capacity (FVC ) ; Forced Expiratory Vo lume in one  second (FEV1 ) ;  and 
the ratio  of FEV1 / FVC . A fi fth measure , Maximal �1i d-Expiratory F low 
Rate (��EFR) was added for experimental contro l purposes . A brief 
description o f  each of these measures i s  provided be low . More 
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extens ive revi ews  can b e  found e l sewhere (Cherniac k ,  1 97 7 ; Ruppel , 1 979) . 
A) PEFR i s  a measure of  the i ndividual ' s  maximum rate of exp ira-
t ion fo l l owing a ful l inspiration . PEFR i s  recorded in l iters 
of  air per unit  of t ime (usua l ly l iters per second or minute) . 
PEFR i s  a rather crude measure o f  pulmonary function in that i t  
t ends to be variabl e  and somewhat effort-dependent . 
B) FVC i s  essent i a l ly an estimate of l ung capac ity . I t  is  a 
measure of  the maximum vo l ume of expiration fo l lowing a ful l in-
spiration . FVC onl y  est imates total lung capaci ty i n  that a 
certain  amount of  air always remains  in the lungs fol l owing 
even the most comp l ete  expirat ion .  fVC i s  a measure o f  the overal l 
flow-res i stant properties of the lungs and air pas sages and is  
general ly reported in l i ters . 
C) FEVI i s  a measure of  the amount of air ( in  l i ters ) forcibly  ex-
hal ed in  one second fo l l owing a ful l  inspiration . Whereas non-
asthmati c  ind iv idua l s  genera l l y  expire be tween 7 5 % - 8 5 %  of in-
spireu air wi thin the  first second of expirati on ,  asthmat i c s  ex-
p i re a l ower percentage as  a function of  impaired breathing 
passages . 
D) FEV _ / FVC i s  the percentage of  the FVC exp i red in  the first 1 
second of  expiration f o l l owlng a ful l  inspiration . Nonasthma-
tics  general ly  expire greater than 75% of FVC in the first 
second of  exp i rat i on . An FEV l / FVC of  l ess  than 69% i s  
general l y  considered t o  be subnormal . lfuen FEV1/ FVC drops to 
20% or below , hosp i t a l i zat ion i s  usua l l y  required . 
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E)  MMEF R  i s  a measure o f  the averag(: rate  o f  expiration during the 
"midd le-half" o f  a ful l inspiration .  1-1MEFR i s  reported in 
l iters per second or minute . This  measure i s  being added to 
the "standard battery" because it  tends to be l ess  susceptible  
to subj ective variab l es such as mot ivat ion than some of the 
other measures (e . g . , PEFR,  FEV1 ) .  
A maj or advantage o f  us ing the ent ire "battery" described above i s  
that predi ctive nomograms have been estab l i shed for each o f  these val ues 
(wi th the except ion of  PEFR) , based upon the age , height , and sex o f  the 
individual asthma pati ent (Morris ,  Koski  and Johnson , 1 97 1 ) 1 . Use of 
these nomograms enab l e s  the investigator to estimate the degree of  pulmon­
ary demi se as a function of asthma.  In  addition,  it  enab l es one to  
better estimate the c l ini cal s ignifi cance of any change whi ch results  
from treatment ( i . e . , post -treatment values which c losely  approximate 
the predicted normal values for a given as thmatic can be viewed as 
c l inical l y  s ignificant ) . 
Physic i an Ratings . Like the 20  P - F  and the ASC , the Phys ician ' s  
Severity Rating Scale (PSRS , see Appendix D) a l so served the dua l 
function o f  a pretreatment assessment device and a dependent measure . As 
a dependent measure , the PSRS was uti l i zed as an independent as sessment 
of patient functioning based upon their current l evel of medi cation re­
quirement s .  The PSRS i s  a nine po int scale ranging from 0) "Mi ld" to 
(9)  "Constant l y  disab l ed . "  I t  was devel oped by P l utchik et al . ( 1 978 )  
" to provide an overal l index of  asthma severity in terms o f  the  dependence 
of the patient on medication" (p . 426 ) . "  The PSRS was comp l eted by the 
primary care physician (or nurse)  of each patient invo lved in this in­
vest igation . 
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Additi ona l Measures 
Two addi ti onal measures were emp loyed for differing purposes in 
this inves t igation . One measure , the Asthma Survey Schedule  (AmSS ;  
Caute l a ,  1 98 1 ; s ee Appendix  C )  was inc luded for the purpos e o f  informa­
tion gathering . The AmSS i s  a 39 - item quest ionnaire which asks patients 
to provide a wide range of  information such as : age,  height , medicat ion 
(dosage and type) , a l l ergies , typical  symptoms , and particular t imes of 
year the pati ent may consider to be espec ial ly troub l esome . The AmSS 
was emp loyed primar i l y  because it provided the invest igator with infor­
mat ion which was helpfu l  in eva luat ing other assessment variabl e s  (e . g . , 
time of  year information was useful  when examining data regard ing out ­
come o n  the frequency o f  attacks variab l e) . This  form was comp l eted 
at pre- treatment onl y .  
A final measure , the 2 4  Hour History (Appendi x F)  was used to 
assess and control for variab les  which could  po tentia l l y  confound the 
above measures of pu lmonary function (e . g . , stimul ants such as caffeine 
might resul t in a temporary improvement ) .  The 24 History is an I I - item 
questionnaire adapted for use in this  investi gation . I t  asks ques tions 
such as : How many hours since your last mea l ?  Beverage? This  question­
naire was comp l eted by subj ects prior to each pulmonary asses sment 
session . 
Apparatus 
A Col l ins 1 3 . 5  l i ter water-seal spirometer was used to as sess al l 
measures of  pulmonary funct ion with the except ion o f  PEFR . The spiro ­
meter features a bel l -counterweight pul l ey system ,  recording pens and 
a vari ab l e  speed kymograph . The Co l l ins spirometer and its  features 
are des cribed more ful ly  e l sewhere . (Ruppel , 1979) . A Wright Peak F low 
Meter (Wright , 1 959 )  was used to measure this  final pulmonary function 
variab l e  ( i . e . ,  PEFR) . 
Pro cedure 
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Initial  Contact . Persons express ing an interest in  part ic ipating 
in  thi s  invest igation were contacted direct ly  by the princip le  investi ­
gator . At this  t ime the general purpose and requirements  o f  partic ipa­
t ion in  the study were exp lained (see the Informed Consent in  Appendi x  
H for the content o f  this  discuss ion) . In addition ,  any quest ions whi ch 
individual s had at this  t ime were answered . Fina l ly ,  an appointment was 
made for the pretreatment assessment . 
Pretreatment As sessment . Several events took p l ace at the pretreat­
ment sess ion . F irs t ,  subj ects were given a copy of  the Informed Consent 
Form to read . After al l questions were answered to the sat i s faction o f  
the individua l ,  he/she was asked t o  s ign the form . Next , subj ects were 
asked to comp l ete : 1 )  The Asthma Symptom Check l i s t ;  2) the 20 P - F ;  and 
3) The 24-Hour His tory . Subj ects then comp l eted the ini t i a l  pulmonary 
function sess ion at this  t ime (the pro cedures o f  this wi l l  be described 
in the "Spirometry" sect ion) . 
Upon comp letion of the above task s , an appo intment was made for 
the init i a l  re laxation training sess ion . Whenever po ss ib l e ,  this 
init ial  sess ion was arranged to be at least 7 days fol lowing the pre­
treatment assessment session . During this  7 day period , subj ects  were 
asked to begin col lecting base l ine data on the OAF (Appendix  F) . In 
addi tion ,  they were asked to  comp l ete the AmSS (Appendix  C) and bring 
it to their  first treatment sess ion .  Final ly , a copy o f  the PSRS 
(Appendix  D )  was sent to each pat ient ' s  phys ic ian for comp let ion . 
Treatment . A l l  treatment sess ions were conducted by the principal 
invest igator who had comp l eted 3 years of  graduate  training in  the 
C l inical P sychology Program at Virg inia Commonweal th University (VCU) . 
Each session was he l d  at the P sycho logical Services Center (PSC) at 
VCU . The PSC i s  an out-patient c l inic  operated by the C l inical P sych­
o lo gy Program which o ffers genera l  outpatient mental  hea lth services 
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to re s ident s  of the greater Richmond area . A l l  treatment sess ions were 
conducted in a group format with a minimum of two persons in addit ion to 
the investigator present at al l sessions . Decis ions as to which subj ects  
would attend which sessions were made so l e l y  on  the bas i s  of  convenience 
for the pati ents  (i . e . , membership was not determined according to 
asthma severi ty or  panic -fear type) . Initia l l y ,  subj ects were g iven 
the choice of s igning up for 1 of 4 c l ass  t imes . I t  was hoped that they 
would attend each c l ass  on a regular bas i s ,  however , i t  became necessary 
to a l low certain subj ects  to rotate their meeting t imes from week to 
week because of varying schedules  and commitment s .  As a resul t ,  on l y  
3 individual s out of  1 5  attended a l l  sess ions a t  the same t ime each 
week . Treatment consi sted o f  a total  o f  five weekly sess ions with each 
session l ast ing between 60 and 90 minut es . The therapist  was bl ind to 
the asthma type , severit y ,  and panic- fear type of part icipants unt i l  
the comp letion o f  the treatment period . 
Components o f  the re laxation training emp loyed in this investiga­
t ion i nc luded : Progress ive Musc le  Re laxation (Jacobson , 1 938 ; Wo lpe and 
Lazarus , 1 966 ) ; Cue -Contro l l ed Re l axat ion (Russe l l  and Sipich , 1 973) : 
and Pos i t ive Imaging (Shoemaker , 1 979) . A comp l ete descript ion of 
these procedures can be found e l sewhere (Rimm and Masters , 1 979) . 
At the init ial session , the general process o f  progressive 
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rel axat ion was des cribed to  the  subj ect s and each subj ect was provided 
with a manual which describes each component of  the training program 
(see Appendix I ) . Thi s  manual is designed to faci l it ate the acquis i t ion 
of the re l axation t ec hn iques in that it enabl ed subj ects to practice  
these  ski l l s  on their  own . A synopsis  o f  each component i s  provided be­
low . 
Progressive mus c l e  relaxation " invo lves the successive tens ing and 
rel axing o f  voluntary musc les  in an o rderl y  sequence unti l  a l l  the main 
mus c l e  groups o f  the body are re l axed (Rimm and �'laster s ,  1 97 9 ,  p .  3 5 ) . "  
Examp l es o f  musc l e  groups which are typi cal l y  focused upon inc l ude : 
hands , arms , neck ,  and lower extremi ties . Subj ects  were asked to report 
in the first session  any particular muscl e group which may prove prob l e ­
mati c  for them (e . g . ,  as  t h e  resul t  of  a previous inj ury) . I f  there 
were such probl em areas , subj ects were instructed to skip any exerci ses 
which proved aggravating . In addition , subj ects were urged to report 
any physical  discomfort whi ch they exper ienced in the course of relaxa­
t ion training . Once again , spec ific  exercises which seemed to cause 
discomfort were e l iminated from their part icu l ar program . 
Pos itive imaging (Shoemaker , 1 979)  i s  an exercise which was devised 
to aid in the re laxation of  the eyes and forehead area . I t  s imp ly  in­
vol ves hav ing each subj ect imagine a scene which he or she finds to be 
particular l y  re l axing . Exampl es o f  such p l easant image s typical l y  in­
c l ude : mountain l akes ; the seashore ; and invo lvement in relaxing activi ­
ties such as go l f  or swimming . This exerc ise was emp loyed at the com­
p l etion of the mus c l e -tense -relax sequence .  
The fina l re l axat ion component ut i l i zed in the current training 
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program was cue-control l ed relaxation (Russe l l  and Sipich ,  1 973) . Cue­
contro l l ed re l axation was employed for two reasons : 1 )  to he lp the 
individual become even more deeply  rel axed fo l l owing the comp l e t ion of  
more trad i t ional rel axation exerc ises ; 2 )  to teach the c l i ent a method 
of re laxing in a very brief period of t ime when running through an en­
t ire progres sive musc l e  rel axat ion sequence might be impract ical  (e . g . , 
at the office) . The process  invo l ves having each individual pay c lose  
attention to his/her breathing and to  recite  a word such as "calm" or 
"re l ax" to themse lves each t ime they exha l e .  I t  i s  fe l t  that the com­
bination of rhythmic  breathing with sel f- instruct ion to relax or be calm 
contributes s igni fi cant ly  to the overal l abi l ity of  the individual to 
rerax . 
Once subj ects were taught al l the steps o f  this procedure , they 
were instructed to emp loy the ir relaxation sk i l l s ,  part icularly cue ­
control l ed re laxation , as act ive coping mechani sms in the face of day 
to day stres sfu l  s i tuat ions . Part icular emphasis  was made on the 
ut i l i zation of  relaxat ion ski l l s  when faced with the initial  cues of 
an oncoming asthma attack (e . g . , chest t i ghtening , dyspnea ; s l ight 
whee ze)  ( c f .  Sirota and Mahoney , 1 974) . 
As a check on the degree to which subj ects in each group acquired 
the re l axation skil l ,  subj ects were asked to rate themse lves on a " re­
l axation thermometer" (Al exander et  al . ,  1 972 )  at  the  beginning and 
end o f  each sess ion . The "re laxat ion thermometer" (see Appendix J)  
i s  a 1 0  po int rating sca le  ranging from 1 (very relaxed) to 1 0  (extreme ly 
tense) . I t  was expected that acqui sition of  the relaxat ion ski l l  wou ld 
result in decreased ratings at po st- session as compared to pre-sess ion . 
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I n  an effort to fac i l i tate the acquisition of the rel axat ion tech­
niques , subj ects were instructed to practice their rel axation ski l l s  
o n  a dai l y  bas i s  for approximately 3 0  minutes . As a partial  check on 
the degree to whi ch subj ects in eac� group comp l i ed with thes e instruc­
tions , they were asked to  keep a dai l y  l og of their practice time (see 
Appendix K) . 
Fo l l owing the fi fth and final training sess ion , an appointment was 
made with each subj ect for a po st-treatment assessment ses s ion . In al l 
case s ,  this appointment was scheduled within one week of  the final 
treatment session . In addition ,  subj ects were asked to : 1 )  continue 
comp l eting the DAF dai l y ;  2 )  continue practicing re laxation ski l l s  
dai l y  as we l l  a s  k eep an ongoing l og o f  their practice . Final l y ,  a 
copy o f  the PSRS was sent to each pat ient ' s  phys ician for comp l etion . 
Post -treatment/ Fo l low-up As sessments . Except for comp l eting the 
Informed Consent Form and the Asthma Survey Schedule , the procedures 
at these two sessions fol lowed exact ly the same format as those de­
scribed in the "Pretreatment Assessment" section . As stated , al l post ­
treatment sessions were arranged within one-week of the final relaxa­
tion therapy session . Al l fol low-up sessions , with one except ion , were 
scheduled at l east 4 weeks after the po st-treatment sess ions . The one 
exception invo lved a subj ect who was to be out of town for two weeks be­
ginning in what i-/oul d have been her fourth week fol lOlving post-treat­
ment . Rather than lose thes e data,  an appointment was made for this 
individual three weeks fo l lowing post- treatment . After the fo l l ow-up 
session , subj ects were thanked for their participation in the proj ect 
and encouraged to cont inue us ing their relaxation training as they 
deemed appropriat e .  
Spirometry . With the except ion of one ses s ion at the pretreatment 
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assessment , pulmonary function sess ions for al l subj ects were conducted 
by a second-year graduate s tudent in  the C l inical  Psycho logy Program 
at Virginia  Commonwea lth  Univers ity . The procedure was designed in  
this manner i n  order that  the  principal investigator would  remain b l ind 
to the outcomes o f  these asses sments . Thi s  condition was met in al l 
but the one case noted ( i . e . , the principal  i nves tigator had to fi l l  in 
due to a s chedu l i ng prob l em) . The second-year s tudent and the principal 
investigator ( i . e . , for back-up purposes)  were trained and supervised 
in  the conduct ing of pulmonary assessments  by an As sistant Professor in 
the Department of Heal th and Physical  Education at the same univers ity . 
The seco nd-year s tudent was b l ind to t he hypotheses of  thi s invest iga­
t ion in an attempt to minimi ze the potential  for experiment er bias . 
A l l sessions were conducted in the Psychophys io logy Labora�ory of  
the C l inical  Psychology Program . Al l assessments for any g iven subj ect 
were to be performed at the same t ime of  day (p lus or minus a n  hour) in  
an  attempt to ho ld  any potentia l  circadian cyc l e  effects cons tant . 
Thi s  condi t ion was met in  most cases , however , three p�st - treatment 
sess ions were he ld  approximately  1 1 / 2  hours earl ier than the respect ive 
pretreatment t ime . 
Prior to each assessment session , the second -year s tudent comp l et ­
ed the fo l l owing tasks : Firs t ,  the spirometer was checked in order to 
ensure that i t  was working properl y .  Next , the t ime , temperature of  
th e  spirometer,  and the  barometric pres sure were recorded . The tempera­
ture and barometri c pressure were needed to convert obtained results  
from Amb ient Temperature Pres sure Saturated (ATPS) to  Body Temperature 
Pressure Saturated (BTPS) ( i . e . , these conversions are necessary in  
order to approximate "true" lung vo lumes ; Gaens ler and Wright , 1 966) . 
Final l y ,  the peak - f low meter was c l eaned { i . e . , with a germic idal product )  
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and prepared for usage . 
Subj ects were asked to refrain from ingesting the fo l l owing items 
for at l east 3 hours prior to  each assessment : foods , l iquids (with 
the exception of water and j uices ) ; c i garettes . A 24-Hour History 
(Appendix  F )  was compl eted before each sess ion in order to moni tor such 
intake . With  a few minor except ions this  post-absorp tion requirement 
was met sat i s factori l y .  E fforts were made t o  schedule  assessment t imes 
so that this  pos t - absorp t ion requi rement would not present a maj or in­
convenience to the subj ects . 
Subj ect s  were asked to s it  quiet ly  and compl ete the 24-Hour His tory 
whi l e  the pulmonary examiner was preparing the equipment . Thi s  pro cedure 
genera l l y requi red 1 0- 1 5 minutes and was intended to a l l ow subj ects t ime 
to adapt to the surroundings of the Psychophys iology Laboratory before the 
actua l  asses sment . Prior to the initial  sess ion , the pulmonary funct ion 
maneuver was exp lained to each subj ect and each was provi ded with a 
wri tten descri ption o f  the - procedure (see Appendix  G) . The pulmonary 
funct ion maneuver is a s imp l e  procedure which requi res the indiv idua l to 
exhale  as much air as po ssib l e  from h is/her lungs , as  rap i d l y  as pos si b l e ,  
fo l l Ol"i ng a deep insp irat ion o f  a i r .  Four o f  the pu lmonary func t ion 
measures ( i . e . , FEV I ; FVC ; r:EV l/ FVC ; MMEFR) I"ere based upon th i s  one 
maneuver , whereas , the fi fth measure ( PEFR) required a s imi l ar rapid 
exha l at ion on the Peak- flow meter . Prior to the pretreatm�nt assessment , 
subj ects were a l l owed to practi ce the procedure unt i l  (in the j udgement 
of the exami ner)  they were fami l i ar w i th the process . Th is  was done 
primari ly to e l iminate learn i ng effects ( i . e  . .  persons perform at hi g h -
er leve ls once they are fami l iar with the maneuver) . At  the po st -
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t reatment and fol l ow-up s ess ion , subj ects were given on ly  one  such 
practice trial . During each sess ion , three maneuvers on both the spiro ­
meter and t h e  peak - fl ow meter were performed and the resu lts  of  t hes e 
tri a l s  were averaged . Subj ects were encouraged to g ive maximum effort 
on al l tri al s .  The ent i re process , inc luding the 15 minut e adaptation 
period,  required approximately  30 minutes . 
Each subj ect was required to  part icipate in  3 separate pulmonary 
assessment sessions in the current inves tigation . As indicated pre­
vious l y :  the pretreatment sess ion was s chedu l ed approximately one week 
prior to the first  re l axation sess ion ; t he pos t -treatment sess ion was 
schedu l ed wi thin one week of the fina l  relaxat ion session ; and the fo l low­
up sess ion was schedul ed at l east 4 weeks  (with the one except ion noted 
ear l i er)  fo l lowing the post-treatment assessment . 
Data Col l ection . In order to minimize the effects of  experimenter 
bias , the principal invest i gator remained b l ind to the performance of  
spec ific  individua l s  on a l l  t he dependent measures throughout the in­
ves t igat ion . Thi s  was accomp l ished in two ways . Firs t ,  as indicated , 
a l l  pu lmonary funct ion sess ions (wi th one exception) were performed by 
a res earch assistant who was b l ind to the hypotheses of the investiga­
t ion . Data co l l ec ted by this  individual were ident i fied by code num­
bers before being given to the principa l invest igator . Simi lar l y ,  any 
ques tionnaire/ s e l f- report data co l l ected by the principal investigator 
was ident i fied by code number and s tored unt i l  it was to be evaluated . 
Thi.s coding served the dual purpose o f  protecting the confidentia l i ty 
o f  part i c ipants as we l l  as encouraging more accurate ( i . e . , l es s  
social l y  des irab l e) comp l et ion o f  data forms . The reader i s  referred 
to Figure I for a pictora l summary of the asses sment schedule  fo l lowed 
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for this entire inves t igation . 
Tabl e 1 
Summary o f  Assessment Schedu l e  
Pretreatment/ 
Bas e l ine 
Measures Week 1 
Asthma Survey Schedule* X 
As thma Symptom Check l i st * X 
20 P - F  (Panic-Fear Persona l ity) X 
Physician ' s  Severity Rating X 
Dai ly Asses sment Form .. X 
Pulmonary Funct ion Bat tery X 
Rel axat ion Thermometer -
24 Hour History 0 X 
Practice Log 6 -
Notes  
* 
CD 
Used only in Subj ect Se l ect ion Process 
Used prior to each Pulmonary Funct ion 
Battery for control purposes 
• Gi ven on a dai ly  basis throughout the 
entire course of the invest igation 
• Comp l eted on a da i ly  bas is after treatment 
Re l axat ion Po st -Treatment 
Training 
2 3 4 5 6 7 
- - - - - -
- - - - - X 
- - - - - X 
- - - - - X 
X X X X X 
- - - - - X 
X X X X X -
- - - - - X 
X X X X X X 
begins 
FO l low -Up 
1 0  
-
X 
X 
X I 
X 
X 
-
X 
X 
Symbo l s  
X As sessment Compl eted 
As ses sment Omitted 
U1 
--J 
Result s  
O f  the 1 5  subj ects who parti cipated in the entire 10  week treatment 
and eva l uat ion process ,  comp l et e  data on a l l  measures were avai l abe for 
only 1 3  subj ect s . One subj ect apparently  did not ful ly understand the 
assignment to record the number attacks she experienced in a given day . 
Thi s  probl em was not detected and rec t i fied unti l  the second' week of 
s e l f-monitoring and as a resul t  the base l ine information regarding number 
of asthma attacks per week was los t .  A second subj ect was t o  have com­
pleted and mai l ed her final se l f-report forms during the fol low-up period . 
Unfortunat e ly this information was never received by the investigator . 
As a result  o f  the above di fficul t i es ,  the number of  subj ects invo lved in 
each statistica l  analys is  varied from 13 to 15  depending upon the variable 
under study . 
Treatment Efficacy 
The ana lyses in this sect ion were conducted to determine whether 
re laxati on training resul ted in a s igni ficant improvement for al l subj ects 
regardless  o f  asthma typ e ,  severity,  duration of the i l lness , or Pani c ­
Fear personal i ty type . Change in s·tatus was evaluated from pretreatment 
to posttreatment and pos t - treatment to fo l low-up for a l l  dependent measures .  
The primary stat is t ical  analys i s  emp loyed in this section was a P lanned 
Comparison T-Test . The results  of these 'analyses are summarized in Tabl e  2 .  
Acquis i t ion of  the Relaxation Ski l l . Before and after each of  the 5 
re l axation sessions , subj ects rated themselves on the Re laxat ion Thermo ­
meter (RT ; see Appendix  J )  which i s  a scale ranging from 1 (very re laxed) 
to 1 0  (extremely  tense ) . Comparison of pr� and pos t -sess ion ratings ind i ­
cated that sel f-rat ings of  tension decreased s ign i ficantly  i n  al l 5 treat-
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Tab l e  2 
Summa ry o f  � leans and P l anned Compa r i sons for a l l  Dependent �1e asures 
Var i ab le  
Re l axat i on Therometer 
S e s s i on 1 
Ses s i on 2 
Se s s i on 3 
Ses s i on 4 
Ses s i on 5 
Frequency o f  A t tack s 
Phys i c i an Rat ings ( PS RS ) 
Peak F l ow 
Forced E xp i ra t ory 
Vo l ume ( FEV l ) 
Forced V i t a l  Capac i ty 
( FVC)  
FEV  1 / F VC 
�la X l ma 1 � l i dexpi ra tory 
F l ow Ra t e  (�II\'IEFR )  
Symptom V i g i l ance (ASC ) 
Pa n i c - Fea r P ers ona l i ty 
(20 P - F )  
I No t e .  One-Ta i l ed t - t es t s  
* p <. . 05 
* *p <. . 0 1 
* * *]1 <.. . 00 1 
* * * *]5 -<.... • 0001  
n d f  
1 5  1 4  
1 5  1 4  
1 5  1 4  
1 5  1 4  
1 5  1 4  
1 3  1 2  
1 5  1 4  
1 5  1 4  
1 5  1 4  
1 5  1 4  
1 5  1 4  
1 5  1 4  
1 4  1 3 
1 4  1 3  
Pre t reatment Pos t t reatment Fo l l ow-uE 
Mean �. �1ean �. Mean � .  
6 . 07 2 . 0 2 3 . 00 1 . 4 1  
5 . 8 7 2 . 0 7  2 . 60 1 .  5 0  
6 . 4 7  1 .  8 1  2 . 80 1 .  4 7  
5 . 4 0 2 . 03 2 . 6 0  1 .  8 4  
6 . 5 3  1 .  68  3 . 07 1 .  90  
5 . 4 6  4 . 3 1 3 . 1 5  3 . 80 4 . 84 3 . 89 
3 . 33 1 . 4 0  2 . 4 7 1 .  30 2 . 33 1 . 1 8 
4 2 9 . 5 1  1 1 0 . 8 7 4 4 0 . 7 8 9 2 . 5 7 4 5 3 . 97  85 . 6 7  
2 . 66 1 .  04 2 . 69 . 94 2 . 7 7 . 90 
3 . 1 3  1 .  2 3  3 . 1 2  1 . 1 5 3 . 35 1 . 1 8 
8 5 . 7 8 9 . 5 8 8 7 . 24 7 . 77 8 3 . 9 3 9 . 1 9  
3 . 6 4  2 . 38 3 . 6 7  2 . 3 3 3 . 2 1 1 .  32  
3 . 29 . 75 2 . 7 2 . 93 2 . 64 . 84 
6 . 7 9 2 . 75 6 . 50 2 . 90 6 . 2 1 2 . 4 5 
P l anned ComEari s on s  
1 
Pre to Po s t  
J; - va 1 ue 
- 6 . 95 * * * *  
- 5 . 70 * * * *  
- 8 . 07 * * * *  
- 6 . 92 * * * *  
- 6 . 6 1 * * * *  
- 2 . 0 1 * 
- 2 . 8 3* *  
. 66 
. 29 
- . 09 
. 76 
. 1 4 
- 2 . 6 7 * *  
- . 6 7  
Post  t o  Fa ! .  Up 
!,-v a 1 ue 
2 . 1 9  
- 1 . 00 
1 . 1 5  
. 96 
2 . 5 1 * 
- 4 . 8 7 
- 1 . 33 
- . 47 
- . 6 7  
Vl 
<D 
60 
ment sess ions (£( 1 4) = -6 . 95 ,  £ < . OOUl ; £(14 ) = -5 . 70 ,  p <.  . 0001 ; £(14 ) = -8 . 70 , 
£ < . 00 0 1 ; £(1 4 ) = - 6 . 92 ,  £< . 0001 ; £(1 4 } = - 6 . 6 l ,  £< . 0001 ; respectively) . 
These  resu l t s  suggest that the subj ects invo lved in this investigation 
acquired the re laxation ski l l  suffi cient ly within the treatment sessions 
themselves . 
Frequency of  Attacks . Throughout the study subj ects recorded the 
number of  attacks they. experienced on a dai ly bas is  and the frequency of 
these  attacks during pretreatment , post-treatment , and fo l low-up periods 
was analyzed for change in response to treatment . Pretreatment basel ine 
consist ed of the number of attacks experi enced by each subj ect the week 
prior to  their first rel axat ion session . In most cases , this invo lved a 
7-day period ; however , because of  schedul ing di fficulties , in some cases 
a ful l seven days did not transpire between the pretreatment assessment 
session and the first relaxat ion session (e . g . , in 4 cases on ly 6 days 
transpired ;  in 1 case , 4 days transpired) . For these subj ects , the number 
of attacks recorded prior to treatment was prorated for seven days . The 
post - treatment period consi sted of the 7 days immedi ately fo l lowing the 
final treatment sess ion for each subj ect . The fol low-up period invo lved 
the 7 day period immediately  preceding the final pulmonary asses sment 
sess ion . Prorat ing was not necessary for either the post-treatment or 
fo l l ow-up periods . 
Comparisons of  the mean number of  attacks per week indicated a s i gn i ­
ficant decrease for the int e rval between pr�reatment and pos t -treatment 
(!.c.12 ) = - 2 . 0l ,  £<' . 05 ) . Contrary to expectations , a two-tai l ed T-Test 
revealed  a s i gn i ficant increase in the number of  attacks experienced 
between the post - treatment and fo l low-up periods (£(1 2 ) =2 . 1 9 ,  £<. . 05 ) . 
These resul t s  suggest that whi l e  improvements on this variable  were 
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achieved a s  a resu l t  of  treatment , they were not maintained through the 
fol low-up period . It is important to note that al though subj ects "rel apsed" 
during the fo l low-up period , they apparent ly were no worse o ff then when 
treatment began (i . e . , pretreatment �=S . 46 ,  S . D . =4 . 3 l ;  fo l low-up �=4 . 8S ,  
S . D . = 3 . 89 ) . These results  are shown in Figure 1 .  
Phys ician Rat ings/Medication Usage . A l l  subj ects were rated by their 
physician at the pretreatment , posttreatment and fo l low-up periods . These 
rat ings were based upon the type and l evel o f �edication which the subj ect 
was currently  using and determined the severity of  each individua l ' s  asthma . 
Ratings of  1 (Mi l d }  to 9 (�onstantly Disabl ed) were ass i gned using the 
PSRS with l ower numbers be ing associated with less  intens ive medicat ion 
requirements for the contro l of asthmat ic symptoms . 
A P l anned Compari son T-Test was used to assess whether invo lvement 
in the treatment program resulted in decreased severity rat ings . A 
sign i ficant decreas e in these rat ings was found when the pos t -treatment 
rat ings were compared with the pre -treatment ratings (�( l4 ) = - 2 . 83 ,  � � 
. 0 1 ) . A further decrease was observed between post -treatment and fo l l ow­
up , however ,  this decrease was not statistical ly significant . Thes e 
resul ts (shown in F i gure 2 )  suggest that in the opinion of  their respec­
tive phys ician ' s ,  subj ects required less intens ive doses and types of  
medicat ions for control of  asthmatic symptoms at  post-treatment and 
fo l low-up than at pretreatment . In addi tion ,  their asthma was seen as 
being less  severe at the conc lus ion -of thi s treatment program than at 
the outset at least according to this cri terion . 
In addit ion to the phys ician rat ings , subj ects were required to 
moni tor their medicat ion intake on a dai ly bas is throughout the course 
of  this inves t i gat ion . Unl ike the physician ratings , these data were 
not analyzed as a dependent variable  because the wide variety of medi -
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F i gure 1 .  Frequency of asthma attacks experienced during pretreatment , 
posttreatment , and fo l low-up periods . 
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Figure 2 .  Phys ician ' s  Severity Rat ings (PSRS) at pretreatment , posttreatment , 
and fo l l ow-up assessment . 
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cation types and dosages used by subj ects made stati stical analysis 
impractical . Instead, they were used to determine whether subj ects 
increased , decreas ed , or maintained simi lar medicat ion patterns 
throughout the study . The primary focus was upon whether or not medi­
cation use increased during pretreatment , post -treatment and fol low-up 
periods . I t  was reasoned that improvements made on other dependent 
measures could be more unambiguously attributab le  to the re laxation 
therapy i f  medication l evel s  either decreased or stayed the same during 
these comparison periods . Such an inference could not be made i f  improve ­
ment was associated with increased l evel s  of  medication . 
Dec i sions as to whether a given subj ect ' s  medication l evel had 
changed were made in the fo l l owing manner .  Medications inges ted by each 
subj ect during week one were recorded and were used as a pretreatment 
bas e l ine l evel . This  basel ine l evel was then compared with the leve ls  
recorded in week 6 (pos t - treatment)  and week 1 0  (fo l low-up)  respectively 
and an overal l  rating was assigned to each patient according to the 
fol l owing cri teria : A rating of  "increase"  was assigned i f :  a )  a part i ­
cul ar dosage was increased ; b)  a new medication was added without discon­
tinuation or decreas ing other medications ; c )  usage of inhalers (i . e . , 
number of  sprays per day) increased . A "decrease" rating was assigned 
i f :  a) dosage level decreased ; b) a medicat ion was discontinued ; c)  use 
of inhal ers decreased . A rating of  "same" was given when medication 
usage patterns remained ident ical  for each of the comparison weeks . 
On the bas is of  this procedure the fo l lowing resu l ts were obtained . 
At week 6 :  2 subj ects had increased medication intake ; 3 had decreased ; 
9 had remained the same . At week 1 0 ;  2 subj ects were rated as increas ed , 
7 decreased , and 5 remained the same . These results are consistent with 
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the findings for the phys ician ' s  ratings . It i s  also  worth noting that 
during the course of the study : I subj ect d i scontinued medication us age 
altogether (week 6 ) ; I subj ect discontinued use of predni sone (week 7 ) ; 
and 2 subj ects decreased prednisone usage s igni ficant ly ( e . g " one sub­
j ect  was abl e  to  cut dosage in  pal f over a 6 week period) ; onl y  I subj ect 
increased prednisone usage and that was on ly for a 4 day period during 
week number 9 .  
These findings ,  taken together with the PSRS results  suggest that 
medi cation us age decreased as a function of participation in the treat ­
ment program . Whi l e  these findings seem worthwhile  in and of  themse lves 
the intended pu�ose of being able to evaluate addit ional dependent measures 
without the potent ial  confound of medication increases clearly appears to 
have been met . 
Pul monary Funct ion . Several measures of pulmonary function were 
emp loyed to evaluate change over the course of this investigat ion . For 
each measure use d ,  improvement was indicated by increased values for 
that parti cular measure . A Planned Compari son T-Test was used for ana­
lys i s  in a l l  cases (see Tab le 2 ) . 
Three measures of flow-rate were used in thi s study . On the measure 
of Peak Expiratory F low Rate (PEFR) , resul ts  at pos t -treatment were not 
significantly  greater than pre-treatment . Increased PEFR values were 
observed between pos t -treatment and fOl low-up , however , thi s increase 
did not reach s i gnifi cance . On the measure of  Forced Expiratory Vo lume 
in one -second (FEVI ) ,  no s i gni ficant di fferences were observed at either 
post - treatment or fo l l ow-up . Simi lar to the PEFR , an increase was ob­
served between post - treatment and fo l low-up , however , it  fai led to reach 
signi ficance . Fina l l y ,  on the measure of Maximal Mid - Expiratory Flow 
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Rate (MMEFR) , no s i gnifi cant di fferences were observed in either the 
pretreatment/posttreatment or posttreatment/fo l l ow-up comparisons . The 
above results  indicate that flow-rate of  breathing was not sign i ficantly 
e ffected by rel axation training . 
One measure of  lung vo lume was used in this investigation (Forced 
Vital Capacity ;  FVC ) . On this measure no significant di fference was 
found between the pretreatment and post-treatment assessments , however ,  
a s i gnificant increas e was observed between the post -treatment and 
fQl low-.up periods (,£( 1 4 ) = 2 . 5 1 ,  £,<' . 05 ) . This resu l t  (see Fi gure 3) 
suggests that re l axation training may be s igni ficantly re lated to improve ­
ment in usabl e  l ung capacity and efficiency (i . e . , due to improved e las ­
t icity) . It  appears , however ,  that this effect did not occur unt i l  after 
the formal treatment sessions had terminated which suggests that this 
benefit of relaxation therapy may be achieved on a de l ayed basis . 
FEV1/FVC was used to eval uate the percentage of air exhaled within 
the first second of  a forced exp irat ion . As noted previous ly , FEV1/FVC 
is commonly  emp loyed to assess pulmonary demi se/ improvement in asthmatics . 
A nons ign i ficant increase on this measure . was observed between pretreat ­
ment and posttreatme
.nt . Contrary to expectat ions , a two -tai led T-Test 
revealed a signifi cant decreas e between post-treatment and fo l l ow-up 
(,£( 1 4 ) = -4 . 87 ,  £,<. . 00 1 ) . As indicated in Figure 4 ,  it appears that sub ­
j ects received some initial bene fit from the treatment strategy before 
returning to essential ly pre- treatment performance leve ls  (pretreatment 
�=85 . 78% ,  S . 0 . = 9 . 5 8 ;  pos t - treatment M=87 . 24 % ,  S . 0 . = 7 . 7 7 ;  Fo l l ow-up 
�= 8 3 . 93% ,  S . 0 . = 9 . 1 9 ) . 
PeTcent -predicted va lues  for 4 of the above measures (i . e . , FEVl ; 
FVC ; FEV1 /FVC ; MMEFR)  were calculated to assess the degree to which 
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Figure 3 .  Forced Vital Capac ity (FVC ) performance at pretreatment , 
post treatment , and fo l l ow-up asses sment . 
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Figure 4 .  FEV l/ FVC performance at pretreatment , pos ttreatment , and 
fo l l ow-up assessment . 
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subj ects· changed as a resul t of  treatment when compared to normative 
standards establ ished for persons of simi l ar age , height , and sex .  The 
use o f  such comparisons is helpful  in determining the c l inical signifi ­
cance of  improvements on these pulmonary measures . The means and stan ­
dard deviations o f  these percent -predicted values are summari zed in 
Tab l e  3 .  
On the two measures o f  flow-rate (i . e . , FEV1 ; MMEFR) , on ly minimal 
improvements were made . For examp l e ,  the mean performance on the FEV 
1 
measure increased only  1 %  between pretreatment and post - treatment and 
an addit ional 2 . 8% between post -treatment and fo l low-up (pretreatment 
�= 8 3 . l 0 ,  S . 0 . = 1 9 . 84 ;  post- treatment �= 84 . l 2 ,  S . 0 . = 1 7 . 32 ;  fo l l ow-up 
�=86 . 9 l ,  S . 0 . = 1 3 . 89 ) . Simi larly ,  the mean performance on the MMEFR 
measure increased 2 . 3% between pre -treatment and post -treatment and de ­
creased over 1 3% between pos t -treatment and fo l low-up (pretreatment M 
= 1 0 1 . 4S ,  S . 0 . =6l . 96 ;  pos t -treatment �= 103 . 77 ,  S . 0 . =62 . S8 ;  fOl low-up M 
=90 . 29 ,  S . 0 . = 34 . SS ) . It  should be noted that al though performance on 
the MMEFR variable  at fo l low-up was lower than at pre -treatment , it was 
neverthe less  within normal l imi ts . On the FVC measure , on ly s l ight ly 
greater improvement was observed in that an overa l l  increase of 5 . 4% 
was achieved (pretreatment �= 7S . S6 ,  S . 0 . = 1 8 . 93 ;  post -treatment �: 75 . 60 ,  
S . 0 . = 1 6 . S6 ;  fo l low-up �= 80 . 98 ,  S . 0 . = lS . 4 l ) . Final ly , on the FEV1 /FVC 
measure , resul ts were mi xed as a 1 . 9% improvement at pos t -treatment was 
fol lowed by a 7 . 6% decrease at fo l low-up (pretreatment �= 109 . 99 ,  
S . 0 . = 1 3 . l l ;  pos t - treatment �= 1 1 1 . 87 ,  S . 0 . = l l . 04 ;  fo l low-up �= 104 . 2 7 ,  
S . 0 . = 20 . 4 7 ) . Simi lar to the MMEFR measure , i t  should be noted that 
al though subj ects appear "worse off" at fo l l ow-up they were s t i l l  per­
forming within normal l imits . Given that a 15% improvement is genera l ly 
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Tab le  3 
Mean Va lues for Percent-Predicted Pulmonary Funct ion Measures 
Assessment Period 
Variable  Pretreatment Posttreatment Fo l lOW-Up 
FEV1 
M 83 . 1 0 84 . 1 2 86 . 91 
SO 1 9 . 84 1 7 . 3 2 1 3 . 89 
FVC 
M 75 . 56 75 . 6 0  80 . 98 
SO 1 8 . 93 16 . 56 1 5 . 4 1 
FEV1/ FVC 
M 1 09 . 99 1 1 1 . 8 7 1 04 . 27 
SO 1 3 . 1 1  1 1 . 04 90 . 29 
l-1HEFR 
M 1 0 1 . 45 1 03 . 77 90 . 29 
SO 6 1 . 96 62 . 5 8 34 . 55 
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considered to be  a minima l l y  acceptab l e  l evel of  cl inical s i gni fi cance 
(c . f . ,  Erskine-Mi l l i s  and Schone l l , 198 1 ) , these findings indicate that 
relaxati on therapy resulted in only l imited improvement in respiratory 
functioning . 
Panic-Fear Variables . Two measures of  pan i c - fear associated with 
asthma were eval uated .  The As thma Symptom Checkl ist (ASC) is  a measure 
of symptom vig i l ance with low scores being associated wi th a mal adapt ive 
t endency to downpl ay the severity of  symptoms and high scores associated 
with  adap tive vigi l ance . The 20 P-F is a measure o f  panic- fear person ­
a l i ty for whi ch both low and h i gh scores are cons idered to  be mal adap ­
t ive . A Paired Comparison T-Test was used to  eval uate the sus cept i ­
bil ity o f  each o f  these variabl es t o  change i n  response t o  rel axation 
trainin g .  
On the measure of  symptom vigi lance a s i gn i ficant decrease was 
observed from pretreatment to pos t - treatment (.!.( 1 3 )  = - 2 . 6 7 ,  P <... . 0 1 )  . 
A further nons i gn i ficant decrease was observed between post- treatment 
and fo l low-up . These resul ts  (see Fi gure 5 )  suggest that symptom 
vi g i l anc e ,  as measured by the ASC ,  is suscept ible to change in response 
to rel axat ion training and are consis tent with the description of  
symptom vigi l ance as a "state" measure of anxiety (Dirks et al . ,  1 977) . 
Whether such change should  be cons idered adaptive is a point of discus ­
s ion which wi l l  be addres sed l ater . 
On the measure of  panic - fear personal i t y ,  nons ign i ficant decreases 
occurred at both the pos t - treatment and fo l low-up assessments .  These 
findings are cons i s tent with the suggestion that panic -fear personal ity 
i s  a trait variable which i s  not readi ly susceptible to change (Dirks 
et al . ,  o1 9 7 7c ) . They are not , however , consi stent with the hypothes is 
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F i gure S .  Symptom V i g i l ance CASC) scores at pretreatment , postt reatment , 
and fa l l aw-up asses sment . 
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that rel axati on therapy should result in  a decreased fee l ing of  helpless­
ness  in response to  asthmat ic symptoms . 
Variab l es Re lated to Outcome 
Whi l e  the analyses in the previous section attempted to assess the 
effi cacy of relaxati on with asthmat ics regardless of variables  such as 
severity and pan i c - fear personal ity type , the ana lyses in this section 
were conducted to determine i f  these variables were associated with 
succes sful /unsucces s ful response to re l axation training . 
The primary statist ical analysis emp l oyed for this purpose  was a 
Hierarchi cal  Multiple  Regression analys i s . Three dependent measures ( i . e . , 
frequency of attacks ; phys ician ratings ; FEVI /FVC) were uti l i zed in 
these evaluations . These measures were chosen because they were j udged 
to be the mos t  rel evant from their respective c l asses of dependent 
measures ( i . e . , FEV I/ FVC was chosen over other pulmonary funct ion measures 
because it is more frequently  uti l i zed than these other measures in 
the as thma- treatment research literature) . In a l l  cases , two analyses 
were computed for each dependent measure . The first analysis  examined 
whether pretreatment values on the independent variabl es predicted pos t ­
treatment values o n  the dependent variables after pretreatment values on 
the dependent measures were part ial  led out . The second analysi s  examined 
the abi l ity of pretreatment values of the independent variables  to pre­
dict fol low-up values on the dependent variables after post -treatment 
values of the dependent measures were part ial l ed out . Simi l ar to an 
Analys i s  of  Covariance (ANACOVA) , these ana lyses were emp loyed to evaluate 
whether the addition of  predictor variab les signi fican t ly increased the 
percentage of  predictab l e  criterion varianc e .  
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Panic-Fear . In a previous section it was demonstrated that at 
l east one of the panic - fear variables (i . e . , symptom vigi l ance) is  
susceptib l e  to change in  response to relaxation therapy . In the current 
section , the rel at ionship between panic -fear style (as determined by 
symptom vigi l ance and panic - fear personality scores)  at pretreatment 
and responsiveness to re l axation training was examined . Since Kinsman 
et al . Ce o g . , 1 980)  have recommended that onl y  speci fic panic-fear 
types be "prescribed" rel axation therapy, it was reasonable to predict 
a s i gn i fi cant relationship between these variables and response to 
treatment . A Hierarchical  Mul tiple Regression analysis was used to 
examine this hypothes is on the three dependent measures noted above . 
The results  of  these ana lyses are summarized in Tab le 4 .  
Niether symptom vigi l ance nor panic-fear personal ity type were 
found to be signi ficantly re l ated to reduced as thma severity (as measured 
by the PSRS) at either the pos t -treatment or fo l low-up periods . Simi l arly , 
no relationship was found between these  variables and changes in the fre ­
quency of  as thma attacks a t  either post- treatment o r  fo l l ow-up . Fina l l y ,  
o n  the pulmonary function measure (FEV1/FVC) , symptom vigilance was not 
signi ficantly  associated with improvement at either pos t - treatment or 
fo l low-up , however panic - fear personal i ty was found to be signi ficantly 
rel ated to improvement on this variable at post - treatment (f( 1 , 1 0 ) = S . 96 ,  
£ < . 05) . The combined R2 for pretest val ues on FEV1 /FVC , symptom vigi ­
l ance , and panic - fear persona l i ty was . 74 with the lat ter variable  
accounting for 16%  of  the total  variance .  With the exception of this 
latter finding ,  the above results  do not seem to support the hypothes is  
panic- fear personal ity style  is a pertinent variable  associated with re ­
sponsiveness/unrespons iveness to re laxat ion therapy . 
Tab l e  4 
Rel at ionships Between Symptom Vigi l ance (ASC)  , Panic-Fear Persona l ity ( 2 0  P - F) 
and : Asthma Severi ty (PSRS) ; Frequency of  Attacks ; and Forced 
Exp iratory Vo l ume l / Forced Vi t a l  Capac ity  (FEVl /FVC) 
Pretreatment - Posttreatment Posttreatment- Fo l low-uE 
Increment Increment 
SteE Variab l e  Added n R
2 R F R2 R F 
PSRS 
1 PSRS 1 4  . 39 7 . 8 1 * , . 84 6 3 . 89* *  
2 ASC . 39 0 . 00 0 . 00 . 84 0 . 00 0 . 1 0 
3 2 0  P -F  . 4 0 0 . 01 0 . 07 . 85 0 . 0 1 0 . 1 9  
Frequency of  Attack s 
1 Frequency of  Attacks 1 3  . 24 3 . 39 . 55 - 1 3 . 25 * *  
2 ASC . 25 0 . 0 1 0 . 2 3 . 6 6  . 1 1 3 . 1 7  
3 20 P - F  . 26 0 . 01 0 . 07 . 7 1 . 05 1 . 6 2  
FEVl / FVC 
1 FEVl / FVC 1 4  . 5 2 1 2 . 8 7 * *  . 92 1 4 3 . 35 * *  
2 ASC . 5 8 . 06 1 . 6 1  . 93 0 . 00 0 . 54 
3 20 P -F  . 7 3 . 1 5  5 . 96 * . 94 0 . 02 2 . 87 
*E- <. . 05 
* *E- <" . 0 1 
'-I 
U1 
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Severity. It has been suggested (e . g . , Al exander et al . ,  1979)  
that s everi ty o f  asthma may determine one ' s  responsiveness to a treat ­
ment such as rel axati on therapy . Speci fical ly ,  that such treatments 
wi l l  be beneficial  to on ly nonsevere asthmatic patients . In the 
present study it was hypothes i zed that severity of asthma may indeed 
be rel ated to favorable/unfavorable  response to rel axation therapy , 
howeve r ,  only among asthmatics of  the extrins ic  type . It has been demon­
strated that intrinsics respond more favorably to re laxation therapy 
than extrinsics  (e . g . ,  Phi l l ip et al . ,  1 972 ) , and has been hypothesi zed 
that no such di fferent ial  response according to severity would  be found 
among intrins ics . A Hierarchical  Mul tiple Regression a.nalysis was 
emp l oyed to examine whether the severity of i l lness at pretreatment was 
indeed rel at ed to favorab l e  outcome as measured by decreased frequency 
o f  attacks and improved pulmonary performance (i . e . , FEVl/ FVC ) . The 
results o f  these analyses are summari zed in Table  S .  
On the frequency of  attacks measure , no signi ficant re lationship 
was found between asthma severity and improvement at either the pos t ­
treatment or fo l low-up period . Simi l ar nonsigni ficant findings were 
observed on the FEVl / FVC variable . These resul ts do not support hypo ­
thesis  conc erning the re lationship between severi ty and respons iveness 
to rel axat ion therapy among extrinsic asthmatics . 
In add i t ion to these regress ion analyses , compari sons were made 
between severe/nonsevere subj ects via visual  inspect ion of outcome on 
the frequency of attack and FEVl / FVC variables . For the purpose of  
these comparisons , subj ects were divided into severe and nonsevere groups 
based upon their score on the PSRS (i . e . , a score of 4 or greater was 
defined as severe ) . This resulted in groups of  1 0  nonsevere and 5 
Tab l e  5 
Re lat i onship Between Asthma Severi ty (PSRS) and : Frequency of Attacks ; and 
Fo rced Expi ratory Vo l ume l ! Forced Vita l  Capaci ty (FEVl ! FVC) 
Pretreatment -Posttreatment Post treatment - Fo l low uE 
R2 
Increment 
R2 
Increment 
Step Variah l e Added n R F R F 
-
Frequency of  At tacks 
1 Frequency of At tacks 1 3  . 24 3 . 39 . 55 1 3 . 25 * *  
2 PSRS . 24 0 . 00 0 . 02 . 58 0 . 03 . 75 
FEVl ! FVC 
1 FEVl! FVC 1 5  . 5 2 1 2 . 87 * *  . 92 1 4 3 . 35 * *  
2 PSRS . 6 1  . 09 2 . 5 3 . 92 0 . 00 0 . 2 2 
*E. � . 05 
* *E. <. . 0 1 
--J 
--J 
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severe pat i ents on the pulmonary function variabl e ,  and 8 nonsevere and 
5 severe on the frequency of attacks variable  (due to miss ing data) . 
The mean number of attacks per week were cal cul ated for the severe 
and nonsevere subj ects . On ly the firs t 9 weeks of  the comparison period 
were uti l i zed s ince the number of days this information was recorded in 
week 1 0  varied from 1 to 7 and it was fe l t  that prorating woul d not be 
appropriat e .  The weekl y  means for the severe and nonsevere groups on 
this variabl e  are summari zed in Tabl e  6 and were p l otted for compari son 
(see Figure 6 ) . 
A review o f  Fi gure 6 reveals  several points . First , the nonsevere 
group of asthmatics actua l l y  averaged a greater number of attacks per 
week than the severe as thmatics during each week of the compari son 
period . Secon d ,  with the except ion of  week 5 ,  the nonsevere group 
showed a cons is tent downward trend in the frequency of attacks whereas 
the severe group remained at a fairly cons istent leve l . It should be 
noted that in week 5 ,  two of the nonsevere subj ects experienced 1 7  and 
2 1  attacks , respective l y ,  and together accounted for 38 out of  the 56 
total attacks for this group . Whi le the results of  this inspection 
suggest that the nons evere subj ects may have been more respons ive to 
rel axat ion therapy than the ir severe counterparts ,  this conc lus ion is 
comp l i cated by the fact that the severe subj ects were at a consi stent ly 
l ower frequency of attacks throughout the compari son period and may not 
have had any room for further improvement on this particular vari ab le .  
We wi l l  return to this issue in the Discussion sect ion . 
The performance of the nonsevere and severe groups was a l so com­
pared on the FEVl /FVC variab le . The mean performance for the 1 0  non­
severe and 5 severe subj ects was cal cul ated at the pretreatment , pos t -
Group 
Nons evere 
M 
SD 
Severe 
M 
SD 
Tab l e  6 
Mean Week ly  Frequency of  Asthma Attacks for Severe and Nonsevere Subj ects 
Week 
n 1 2 3 4 5 6 7 8 
8 
6 . 6 3 I) . 1 3  . .  S :  1 3  5 . 1 3 7 . 00 3 . 8 8 4 . 25 4 . 25 
4 . 24 4 . 4 2 4 . 64 4 . 29 7 . 96 4 . 09 6 . 5 2 3 . 9 2 
5 
3 . 00 3 . 00 2 . 4 0 3 . 2 0 2 . 00 2 . 00 2 . 4 0  3 . 00 
3 . 04 3 . 56 3 . 46 3 . 66 2 . 55 3 . 54 2 . 83 3 . 76 
9 
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treatment and fo l l ow-up periods . These. values are summari zed in Tabl e  7 
and p lotted in F i gure 7 .  
A revi ew o f  these results reveal s  several facts . First , al though 
the severe group performs at a cons i s tent ly lower l eve l than the non ­
severe group at each comparison point , performance by these subj ects 
is wel l  within normal l imits  ( i . e . , FEVI /FVC for non-asthmatics is  gene­
ral ly between 75%-85%) . Second , neither group appears to have improved 
dramat i ca l ly on this variable  over the cours e of treatment . In fact , 
the severe group actua l l y  appears to worsen s l i ght ly at the fo l low-up 
period and the nonsevere group seems to relapse after achieving some 
minimal gains . These resul ts do not appear to support the hypothesis 
that severe and nonsevere asthmatic patients respond di fferentia l l y  to 
relaxat ion therapy on this variab l e .  As  was the case with the frequency 
of attacks variable , thi s conclusion is comp l i cated by factors whi ch 
warrant further discussion . For examp l e ,  it may be that members of the 
nons evere gr9up have reached optimal  performance and may not have had 
room for additional improvement (and thus , a di fferential response on 
this variabl e  would be impos s ib l e ) . 
Compl i ance . Common sense would suggest that the degree to whi ch 
one adheres to a spec i fi c  treatment program should be rel ated to pos it ive 
outcome i f  in fact the treatment is  effect ive . In the current investi ­
gati on , subj ects were requested to practice their rel axation ski l l s  for 
one -ha l f  hour dai ly  throughout the treatment and fo l l ow-up phases and 
to record the actual  amount of time they practiced . Total practice time 
was used as a measure of  comp l i ance to treatment instructions and it was 
hypothes i zed that greater comp l iance would resul t  in more favorab le out ­
comes . A Hierarchical Mul t ip l e  Regress ion analysis was used to examine 
the re l at ionship between this measure of comp l i ance and favorable out -
Tab 1e 7 
11ean Performance of Severe and Nonsevere Subj ects on the 
Forced Expiratory Vo 1ume 1 /Forced Vital 
Group 
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come as measured by the PSRS , FEV1!FVC , and frequency of  asthma attacks . 
The resul ts o f  these ana lyses are summarized in Table  8 .  
On the Phys ician ' s  Severity Rating Scale  practice time was sign i - . 
ficant ly rel ated to improvement at the post-treatment asses sment 
CE:.C l , 1 l ) = 1 0 . 49 , 1'.- . 01 ) . The. combined B2 for pretreatment severity 
ratings and practice t ime was . 69 with practice time accounting for 30% 
of  the total  variance . Results  o f  analyses of  the fo l low-up period did 
not demons trate a s i gni ficant re lationship between comp liance and 
severity rat ings . Th is is not surprising , however , since subj ects did 
not improve s i gn i ficant ly  on thi s  variable  between the pos t -treatment 
and fol l ow-up assessments . These resu l t s  suggest that the amount of 
t ime one practices re l axat ion training can s i gnificant ly reduce the 
amount of medication required to contro l as thmat ic symptomato logy . No 
such re lat ionship was found between pract ice time and frequency of attacks 
or performance on FEV1 ! FVC at ei ther the post - treatment or fo l l ow-UD 
periods suggesting that the regular practice of rel axation ski l l s is  
not re lated to improvements on these measures . 
Tab le  8 
Rel at ionship Be tween Comp l iance (i . e . , Total Practice Time) and : Frequency o f  Attacks ;  Asthma 
Severity (PSRS ) ; and Forced Expiratory Vo 1ume l/ Forced Vital  Capacity (FEV1/ FVC) 
Pretreatment - Posttreatment Postt reatment - Fo l low-uE 
R2 
Increment 
R2 
Increment 
Step Variab l e  Added n R F R F -
Frequency o f  Attacks 
1 Frequency of Attack s 1 3  . 24 3 . 39 . 55 1 3 . 25 * *  
2 Comp l iance . 30 . 06 . 94 . 6 1 . 06 1 .  74 
PSRS 
1 PSRS 14 . 39 7 . 8 1 * . 84 6 3 . 89* *  
2 Comp li ance . 69 . 30 1 0 . 49* *  . 84 0 . 00 0 . 02 
FEV1/ FVC 
1 FEV 1/ FVC 14  . 5 2 1 2 . 8 7* *  . 9 2 14 3 . 35 * *  
2 Comp l i ance . 56 . 04 1 . 1 07 . 92 0 . 00 0 . 1 0 
*r. "- . 05 
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Discussion 
The current investigation proposed and examined several hypotheses 
regarding: 1) the efficacy of relaxation therapy as an adjunct treat­
ment for asthma; and 2) specific psychological _and illness variables 
which should be considered before employing such a treatment strategy. 
In general, the results of this investigation were inconsistent and 
somewhat less than robust. Several factors may have contributed to 
this inconsistency and include: 1) the fact that the study was run 
during the peak pollen months and at a particularly humid time of year 
(both factors which affect extrinsic asthmatics);2) all the subjects in 
this investigation were of the extrinsic or mixed type and as such 
might not be expected to respond as favorably to relaxation therapy 
(i.e., as compared to intrinsics); 3) pretreatment performance on one 
of the more important dependent variables (i.e., FEV1/FVC) was high 
enough so that additional gains might not have been possible; 4) base­
line levels for severe asthmatics on the frequency of attacks variable 
were low enough that, again, further gains would be unlikely. Each of 
these factors will be considered when discussing specific outcomes. 
The discussion of these specific outcomes will focus upon the following 
areas: 1) Treatment Implications; 2) Pertinent Psychological and Ill­
ness Variables (related to favorable outcome); and 3) Research Implica-
tions. 
Treatment Implications 
While the overall results of this investigation do not unequivocally 
support the efficacy of relaxation therapy as an adjunct treatment for 
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bronchial asthma , certain findings d o  strongly support its  uti l ity for 
this purpos e .  At the very leas t ,  i t  should  become evident that the 
findings of this study in no way damage the current status of this 
treatment strategy . In addition to discuss ing these results ,  comments 
can als o · be o ffered regarding the importance of comp l i ance and the 
manner in which the relaxation ski l l  is imp lemented . 
Medication Usage/ Physi cian Ratings . The primary reason for in­
c luding the p,hysician ' s  Severity Rating Scale (i . e . , severity rating 
based upon type and l evel of  medicat ion taken to control asthma symptoms ) 
and the s e l f-monitoring of  medication intake throughout this study was 
to el iminate medication us age as a confound when di scus s ing other out ­
come variab les . The resu l ts of  the analyses of these data rule  out 
medication changes as being responsible for any improvement on the other 
dependent measures . The results also  indicate that medication usage and 
severity ratings decreased as a funct ion of participation in this treat ­
ment program. 
Whi l e  the stated purpose for inc luding these variab les in the in­
ves tigation was not necessari ly to effect s i gnificant change upon them , 
these results  were the most cons is tent and perhaps most  important find­
ings of this proj ect . I f  one recal l s  the fact that physic ians fo l low 
the princ ip l e  of "escalation"  in the treatment of asthma (i . e . , "adding 
more effective , but more hazardous agents only when simp l er drugs have 
not been effective " ;  Wi l l iams , 1973 ; p .  38 )  and the fact that more 
effect ive drugs (e . g . , predni sone) carry with their usage more severe 
side effects , the goa l of managing asthmat ic symptoms on minima l  leve l s  
of  medication can c learly b e  seen a s  a worthwhile  one . Given that the 
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physician severity ratings employed in this study were based solely 
upon medication criteria, the significant decrease on this rating 
after treatment (and maintained at follow-up) can be viewed as strong 
support for the utility of relaxation therapy for the treatment of 
asthmatic symptoms. 
Frequency of Attacks. Participation in the relaxation program 
resulted in a significant decrease in the frequency of asthma attacks 
when the post-treatment period was compared with the pre-treatment 
baseline period. This improvement,however,was not maintained at a one­
month follow-up period. Subjects were, however, no worse off at this 
time than at pre-treatment. Such a "relapse" might cause one to question: 
1) the long term efficacy of relaxation therapy; 2) the efficacy of re­
laxation therapy beyond its effects as a placebo. While these are 
reasonable questions, the data does not sufficiently support these 
positions. 
First, one must consider the fact that the current investigation 
was conducted during the period between early May and mid-July. This 
period represents the peak of the pollen season in this geographic 
region (Williams, 1973; Owens, 1983) and, in addition, it was particu­
larly humid during this time. Of the 13 subjects who completed the 
Asthma Survey Schedule (AmSS; see Appendix C), 11 reported that their 
asthma was effected adversely by pollen and/or humidity. In addition, 
11 subjects also reported that Spring and/or Summer were more likely times 
for symptoms to occur than Fall or Winter. This is not surprising when 
one recalls that all the subjects in this investigation were of the 
extrinsic or mixed type and ;i,re. thus adversely affected by external agents 
such as pollen. In addition to the historical confound of pollen and 
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humidity , one must also  consider the suggestion ( i . e . , by Phi l l ip et al . ,  
1 9 7 2 )  that extrinsi c  asthmatics may not be as responsive as intrins ic  
asthmatics  to treatments such as rel axation therapy . Fina l l y ,  it  was 
stated previous ly  that comparisons of relaxation therapy with appropriate 
control groups have resulted in active and s i gni ficant treatment effects 
whi ch speaks directly  to the placebo issue (see Knapp and We l l s , 1 978 ; 
Spevack , 1 9 78) . 
There are several other facts which one must consider when j udging 
the overal l  effectiveness of rel axation therapy for reducing frequency 
o f  as thma attacks . Firs t ,  it is important to remember that the fre ­
quency of attacks d i d ,  i n  fac t ,  decreas e during the post-treatment period 
even though the po l l en season was at hand . Second , whi l e  subj ects did 
"re l apse "  by fo l l ow-up ,  they were no worse off than they were at pre­
treatment . I t  is  reasonable to speculate that participation in this 
program may have served to keep attack frequency at a l ower l eve l than 
previous years for this group of asthmat ics . Unfortunately,  data are 
not avai l ab l e  to test this speculation . Fina l l y ,  one must consider the 
fact that the number of attacks experienced by this group did not in ­
crease even though , on the average , the amount of medication subj ects 
were using to contro l as thmatic symptoms decreas ed .  The fact  that medi ­
cat ion l eve l s  could be decreased , without subsequent worsening of 
symptoms l ends support to the ro le of re laxation therapy in the management 
o f  asthmatic  symptoms . 
Pulmonary Function . Simi l ar to the results  concerning the frequency 
of attacks variab l e ,  evidence from the various pulmonary function tests 
does not c l ear ly support any direct benefits to lung funct ioning as a 
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result  of  l earning how to systemati cal ly rel ax . The only s i gnificant 
finding in the expected direction was on the Forced Vital  Capacity (FVC) 
variabl e  at fo l low-up .  In addition ,  although non s i gnifi cant , trends in 
the expected direction were observed on the measures of Peak Expiratory 
F low Rate (PEFR) and Forced Expi ratory Vo l ume in one-second (FEVl ) by 
the fo l low-up assessment . Fina l ly ,  results  on the Forced Expiratory 
Vol ume in one second/Forced Vital Capaci ty rati o  (FEV l/FVC) were in the 
expected directi on at pos t -treatment , however , they s i gnificant ly de ­
creased by the fol low-up assessment . Several comments can be offered 
regarding the above findings . 
Firs t ,  on those variab l es whi ch were s i gnificant in the pos it ive 
direct ion it appears that the benefits of re laxat ion therapy occurred on 
a del ayed bas i s . I t  is quite  pos sible  that direct benefits from rel ax­
ati on therapy on l ung functioning may take l onger to occur than benefits 
upon other variab l es . I t  may be that rel axat ion therapy s l ows down the 
physi ol ogical process in a gradual fashion and hence immediate bene fits 
shoul d  not be expected . The obs erved trends on the PEFR and FEVl 
measures lend some credence to this "de layed effect " hypothesis . 
Second , on the measure upon whi ch pos itive results  were found , one 
would  have to ques t ion whether such benefits were of c l inical or mere ly 
stat i s t ical  s i gnificance . For examp l e ,  on the measure o f  FVC the mean 
l evel at pos t -treatment
" 
was 3 . 1 1  l iters and at fo l low-up was 3 . 35 l i ters . 
Thi s  represents an improvement of  on ly 5%  whereas , as has been previous ly 
noted , improvements of  less  than 1 5%  are not genera l ly cons idered to be 
c l inica l l y  s i gni ficant . A s imi lar 5 %  improvement was noted on the 
Percent- Predicted FVC variabl e  (st i l l  smal ler increases were found on 
the remaining pul monary funct ion measures ) .  I f  one accepts the premise 
that rel axat ion therapy results in delayed pulmonary benefits , perhaps 
9 1  
more c l inical l y  rel evant results wou l d  be . observed over time .  Unfor­
tunat e l y ,  l onger term fol l ow-up data were not avai lable to investigate 
this question . 
A final point concerns whether one should expect s i gnificant pul ­
monary changes from a subj e ct populat ion composed of extrinsic asthma­
t ics . Phi l l ips et al . ( 1 9 7 2 )  have suggested that intrinsic asthmat ics 
respond more favorabl y  to relaxat ion therapy than extrins ic asthmatics 
on measures of  pulmonary function . Due to the comp l ex physiology in ­
vo lved in the respiratory system, bronchocons trict ion may be the result 
of  parasympathetic  nervous system (PNS) or sympathetic nervous system 
(SNS) mal funct ions (j . e . , 1 )  PNS hyperactivity; 2) SNS alpha-adrener­
gic hyperactivi ty ; 3) SNS beta-adrenergic hypoactivity) and it may be 
that the responsiveness of l ung funct ioning to relaxation therapy is  a 
function of  where an individua l ' s  particular respiratory di fficul ty is  
l ocated . For examp l e ,  i f  one. c l ass of  asthmatics suffered symptoms as 
a result of  PNS hyp eract ivity , re laxat ion therapy would be contraind i ­
cated s ince one of i t s  effects is  t o  increase PNS dominance . On the 
other hand , i f  the intense phys iological arousal  assoc iated with stress 
interferes wi th the SNS adrenergic receptors in some mal adaptive way 
with another subset of  as thmatics , then rel axation therapy mi ght be 
indicated becaus e  it would serve to decrease such arousal . One could  
specul at e  further that intrins ic and extrins ic as thmatics may di ffer 
in their respons ivene ss to re l axation therapy because of a di fferential 
phys i o l ogica l cause of  their respective symptomatology .  This is  clearly 
specul ation and would warrant further study . 
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The on l y  c le ar s t at ement which can be made about the resu l t s  ob­
t a i ned o n  the pulmonary funct i on var i ab l es is  t hat t hey are incon c l u ­
s ive and i ncon s i s t ent . I t  s hould  be noted , though , t hat t he incon­
c lus iven e s s  o f  the resul t s  of t h i s  s tudy doe s not prec l ude the poten t i a l  
o f  r e l axation therapy hav i n g  bene f i c i a l  e ffec t s  o n  t h e  respiratory 
funct ioning o f  certain a s t hmati cs s ince o n l y  extrins i c  and mi xed 
asthma t i c  typ e s  part i c ipat ed . 
Pani c -F e ar Vari ab l es .  The sus cept i b i l i ty to change in respons e  
t o  r e l axat i on t herapy o f  two separat e measures o f  pan i c - fe ar were e x ­
amined i n  t h i s  inve s t i gat ion . I t  was hypothes i zed t hat the mea sure o f  
symptom v i g i l an c e  ( i . e . , a s  measured by the A s t hma Symptom Check l i s t )  
wou l d  decrease i n  r espons e  t o  rel axat ion t herapy s ince i t  has been de­
s cribed as  a " state"  measure of pan i c - fear by its  deve l opers ( e . g . , 
D i rk s  et a l . ,  1 9 7 7 c ) . I t  was a l so hypo thes i z ed that pan i c - fear per­
sonal i ty s c o res  (as  measured by t he 2 0  P - F )  wou l d  decrease in respons e  
to r e l axa t i on t herapy even t hough i t  h a s  been descri bed as  a " t ra i t "  
measure b y  i ts deve lop ers  ( e . g . , D i rks e t  a l . ,  1 9 7 7c ) . The reason i ng 
beh i nd t he l at ter hypo thes i s  was that l earn ing a s k i l l  such as r e l axa­
t ion therapy wou l d  result  i n  an increas ed s en s e  of mast ery over one ' s  
symptoms and a sub s eq uent decrease in the fee l ing o f  hel p l essness  
assoc i ated with  h i gh pani c - fear pers o na l i ty . The former hypothes i s  
was con firmed whi l e  the l atter was not . 
Sever a l  po ints  can be made regardi n g  the decrease in symp t om 
v i g i l ance s cores . F ir s t , the descrip t i on o f  symptom v i g i l ance as a 
"state " measure has been suppo rted i n  this  cas e .  Second , even though 
thi s  has been con f i rmed , some woul d  que s t ion whether it ' C an b� vi el'!ed 
as improvement .  For examp l e ,  Kin sman et a l . ( 1 980a)  have sugge s t ed t;  � -:: 
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high symptom vigi l ance is  adapt ive and that rel axation therapy may be 
detrimental  if it reduces such vigilance . The pos itive results obtain­
ed on other outcome variables (e . g . , Phys ician Severi ty Rating Scale ; 
frequency of attacks ; Forced Vital Capacity) , however , do not support 
such an argument . It could  be argued , however, that if symptom vigi ­
l ance s cores had remained unchanged the results  of  the current investi ­
gation would  have been more c l early and consi stently supportive of  the 
efficacy of relaxation therapy . I t  would appear , however , that other 
factors ( e . g . , the historical confound of pol l en season ; no intrins ic 
asthmatic subj ects)  more read i ly accounted for this incons istency . 
The re l at ionship between sys tematic increases or decreases in symptom 
vig i l ance scores as a funct ion o f  treatment to favorab le/unfavorable 
outcome does seem to warrant further study , however . 
Regarding the panic-fear personal ity variabl e  (i . e . , as measured 
by the 20  P - F ) , the fol lowing can be stated . First , the status of  
this  variabl e  as a "trait"  variabl e  has been supported since scores did 
not decrease signi fican t l y .  Interestingly ,  several subj ects did 
"anecdotal ly" report an increased fee l ing of  control in previous ly 
stressful si tuat ions which they attributed to the re laxat ion therapy . 
It  was their feel ing that the decreased stress response was he lpful in 
contro l l ing their asthma on these occas ions . Whi l e  such anecdotal evi ­
dence is encouraging ,  it  certainly does not obj ectively address the 
ut i l ity of rel axat ion therapy for effect ing change on this variable . 
One could speculate that , simi lar to the pulmonary function variables , 
changes in panic- fear persona l ity may occur on ly on a gradua l basis . 
Such gradual change would be entirely cons is tent with the not ion of  
this  variab le as a trait characteristic . At  this point , however , such 
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speculation remains gri st  for the research mi l l .  
Comp l i ance . I f  one presupposes the efficacy of  a given treatment 
program , it fol lows that the degree to which one adheres to the instruc ­
tions o f  that program wi l l  be re l ated to improvement of  the probl em it  
was des i gned to  address .  In the current investigation , subj ects were 
required to comp lete 5 sessi ons of rel axation training in addition to 
practicing this ski l l  on a dai l y  basi s .  Comp l iance as the amount of 
time subj ects practiced on their own throughout this study was hypothe ­
si zed to predict improvement on several dependent measures , however , 
this hypothesis  was only c l early supported by the s i gn i ficant rel at ion ­
ship between pract i ce t ime and physican severity rat ings (i . e . , the 
re lationship between comp l iance and frequency of attacks ; FEVl/ FVC ; 
was nonsigni ficant� Whi l e  these results did not consistent ly support 
the importance o f  adherence to treatment instructions , the finding 
that such adherence was related to decreased dosages of as thma medica­
t ion without subsequent worsening of  symptoms does lend some support 
to its  ut i l ity . 
Pertinent Psycho l ogical and I l lness Variab les 
In add i t ion to attempting to reconfirm the efficacy of  re l axat ion 
therapy for the treatment o f  bronchial as thma , a second purpose of  this 
investigation was to i denti fy and examine those variab les hypothesi zed 
to different iate between favorabl e  and unfavorable  response  to this 
treatment . Unfortunate l y ,  this l atter obj ect ive was on ly partially  
achieved . 
A primary reason for this less than successful  outcome was that 
the group of subj ects who ul timately comp l eted the entire treatment 
program was far smal ler than antic ipated . Despite attempts to recruit 
a substantial  number of asthmatics ( i . e . , an original l i st of over 
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50  potenti a l  part i cipants was comp i l ed ;  and thi s does not include those 
who were contacted but said  they were not at a l l  interested) of varying 
asthma typ e ,  severity ,  and panic- fear typ e ,  the s i ze of  the final 
s amp l e  l imited the s cope of thi s  endeavor somewhat . A maj or probl em 
associ ated wi th the relat ive l y  smal l number of  subj ects i s  that i t  i s  
very poss i b l e  that real di fferences went undetected due t o  the reduced 
power o f  the stat i s t i ca l  ana lys is  emp loyed . Be that as i t  may , this  
porti on o f  the  investi gati on did at l east reveal  some points  whi ch 
warrant speculat ion and further inves t i gat ion . 
Pan i c - Fear Variables . Kinsman et a l . (e . g . , 1 980a)  have cautioned 
that anxiety reduct i on strategies such as re l axat ion therapy may be 
appropriate for onl y  2 of  9 panic - fear subtypes and may indeed be con ­
t raindicated for certain other subtypes . Based on thi s  recommendat ion , 
i t  was predicted that pan i c - fear type at pretrea tment would be s i gn i ­
ficant ly  related t o  outcome at e ither pos t -treatment , fo l l ow -up , or 
both . With except i on of  the s i gn i ficant re lationship found between 
scores on the pan i c - fear "trait"  measure C i . e . , the 20 P - F )  and FEVl / 
FVC at post-treatment , the predicted re lat ionship between these vari ab l es 
( i . e . , symptom v ig i l ance and persona l i ty) and outcome was not supported . 
Several  comment s are in order regarding these results . Desp i te 
the general l ack o f  s i gni fi canc e ,  the one s i gn i f i cant relat ionship found 
was precise ly  in the d i recti on predicted by Kinsman and h i s  assoc i ates . 
That i S , the fact that pan i c - fear trait sco res at pretreatment were pos i -
t ive l y  re l ated to improvement on FEV l / FVC at pos t - t reatment i s  cons is tent 
with the recommendation by these  authors that re l axation therapy is on l y  
appropriate for asthmatics  who are categori zed a s  h igh pan i c - fear per­
sonal ity  types . Thi s  finding lends at least part ial suppo rt to the i r  
recommendat ions . Thi rd , i t  is  interest ing to note that of the three sub -
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j ects  who scored h i gher than 9 on the 20 P - F  (i . e . , and hence were 
categori zed as high on panic - fear persona l ity) , two had scores wi thin 
the moderate range at post-treatment and the remaining subj ect de­
creased to wi thin one point of the moderate range . Fina l ly ,  anecdotal  
reports noted previous l y  lend some credence to the not ion that re l axat ion 
may result  i n  an increased sense of mastery over one ' s  i l l ness (whereas 
h i gh pani c - fear scores at pre-treatment are associated with fee l ings of 
hel p l es sness and l ack of contro l over one ' s  symptoms ) .  
G iven the , s ignificant resul t whi ch was observed in addit ion to 
the l ess  ri gorous , yet neverthe l ess , interest ing observat ions , further 
inve st igat ion into the use of panic - fear type as a se lect ion cri teria 
for re l axat i on-type s trategles is warrant ed . S ince no study 
(wi th the excep t ion of the present one) of thi s type has been imp l emen­
ted , and , s ince the sma l l  N of the current study prec ludes the drawing 
o f  any firm conc lu s ions pro or con , such further invest i gat ion i s  
c l early ca l l ed for .  
Severity . I t  has been suggested that re laxation therapy i s  effect-
ive on l y  with nonsevere as thmatic  pat i ents and , even then , may be bene­
fic i a l  on ly  becaus e of p lacebo effec ts (e . g . , A lexander et a l . ,  1 9 7 9 ) . 
In the present study i t  was a l so hypothes i zed that as thma severity may 
indeed be an important variab l e  to cons ider wren e l ecting  to emp l oy an 
anxiety reduc ing strategy . I t  was specu l ated that severe asthmat ics  
of the  intrins ic  type might be  appropri ate candi dates for th i s  treat ­
ment and that the conc l u s ions drawn by A l exander et a 1 .  ( 1 979 )  were 
premature because they fa i l ed to cons i der the asthma type of the i r  
pat ients . Wh i l e the current invest i gat ion I"as unab l e  to examine th i s  
l atter hypothes i s  ( i . e . , because no  i ntrinsics  part i c i�ated ) , it  was 
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sti l l  reasonab l e  to predict  a s ignificant  re l at ionship between asthma 
severi ty and outcome based upon the rational e  that extrins i c  asthmat ics  
shou l d  respond d ifferentia l l y according to this  variab l e . 
Th e reader wi l l  recal l that none of  the ana lyses used co examine 
this  i s sue reveal ed such a rel ationship . For examp l e . when severity 
at pre - tre atment was used to predict  outcome on the frequency o f  attacks 
and FEVI / FVC vari ab l e s ,  no s ign i fi cant re l at ionships were found . Simi l ar­
l y ,  the vi sua l  i nspe c t ion data which examined outcome on these same two 
var i ab l es were inconc lus ive and fai l ed to suppo rt the importance of 
asthma severity as  a pre -treatment s e l ect ion criteri a . 
Despite  the apparent l ack of support , several factors prec lude the 
d i smi s sa l  of asthma severity as a pert inent i l l ness variab l e  vis -a-vis  
re l axat ion therapy . F i rst , severity of  asthma in this  case (and in mo st 
cases )  was not determined by the number of attacks a given indi vidua l ex­
perienced but rather by the type and l eve l of  medicat ion requi red to 
contro l these attacks . Thus , it  may be that the severe subj ects in 
th i s  compari son were on high enough l eve l s  of medicat ion that the fre ­
quency o f  attacks they experienced had "bottomed out" and hence it  wou ld 
have been d i fficu l t  to demonstrate further improvement on thi s variab l e .  
I n  contras t ,  the nonsevere subj ect s experi enced a cons istent ly greater 
number of  attacks throughout this invest igation and hence did have the 
"oppo rtun i ty" to  ach ieve some improvement ( i . e . , reca l l that a downward 
trend in frequency of attacks was noted among nonsevere asthmat ics  
Ivhereas no  s uch  trend was ev ident among the severe subj ect s )  . r n  a 
s imi l ar vein , i t  shou ld  be noted that not on ly  was the re l at ionship 
between severity and frequency of attacks nonsign i fic ant using the re­
gress ion ana l ys is , neither was it  in the  expected direct ion ( i . e . , 
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severity was negative l y  associated with frequency of attacks ) . It may 
be that frequency of attacks i s  not an appropriate measure to use for 
this  parti cu l ar purpose un l es s  severe and nonsevere subj ects do not 
si gni fi cant l y  di ffer on this  variab l e  at pretreatment . Such was 
obvious l y  not the case in thi s investigat ion . 
Whi l e  severe and nonsevere subj ects did di ffer substantial l y  in  
terms o f  frequency o f  attacks at  pre -treatment , such a di fference d id  
not exist  on the  measure of FEVl / FVC which p6sed additional di fficul t i es . 
The reader wi l l  reca l l  that neither severe or non severe subj ects improved 
dramat i ca l l y on th i s  variab le  as indi cated in Fi gure 10 . Since both 
groups performed within norma l l imi ts throughout the invest igat ion , it 
is  quite po ss ib le  that further improvements were not l ikel y  due to a 
"topp ing out" phenomeno n .  I n  a re l ated matter , i t  appears that the 
parti c ipants in th i s  study were of the epi sodi c versus the chronic type 
g iven that none of the subj ects could be categori zed as severe according 
to accepted pulmonary standards (e . g . , The I ntermountain Thorac ic Soc iety  
defi nes  severe as an  FEV  1 / FVC 0 f less  than 45% ; Cooper , 1 982 ) . One 
would not expect dramat i c  improvements on this  va riab l e  from epi sod i c  
asthmatics  s ince , b y  definit ion .  they us ua l l y  perform within norma l 
l imits  except when experienc ing attacks . In spite of  the above factors , 
a nons i gni fi cant re lat ionship in the expected direct ion was observed 
between 5everity at pretreatment and FEVl / FVC performance at both post ­
treatment and fo l l ow-up . Thus , i t  may be that a rea l re lat ionship does 
exist  between these  vari ab les but went undetected as a resu l t  of the 
re lat ive ly smal l number of subj ects invo lved . 
In  conc lud ing this sect ion the fo l lowing can be stated : 1 )  the 
re lationship  between asthma sever ity and respons iveness to rel axation 
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therapy has not been adequately  tested ;  2 )  the crucial  study o f  the 
re l ationship between asthma type , severi ty and responsiveness to re­
l axation therapy was not adequately  addressed and shoul d  be in future 
studies ; 3 )  It i s  c lear that the j ury is sti l l  out (and wi l l  remain 
01 \t )  re ?�rn i n �  these re l at ionships pending further investigation . 
Research Impl i cat ions 
Future Directi ons . As indicated previous l y ,  the results of  the 
current investi gation are somewhat inconsistent and l ess than c lear- cut . 
A maj or factor associ ated with this status is  the relatively sma l l  
number o f  pat i ents who comp l eted the ent ire program . In  addition , the 
samp l e  examined was l imi ted in terms of vari ety (i . e . , no intrinsic 
asthmati cs , not a wide range of  pan i c - fear types ) . As  a result  of  
these l imitat ions . further in"est i a� t i on seems warranted and necessary 
for progress to be made in this area . A summary of these sal ient 
areas for future research is  presented be low . 
One cruci a l  area for investi gat ion concerns the further identi f i ­
cat ion and del ineation of variables wh ich predi ct response t o  re l axation 
therapy . The current study attempted an initial  examination of the 
re lationship between : pan i c - fear persona l ity type ; as thma severity ; and 
responsiveness  to treatment . Howe ver , whi l e  the findings of  this study 
are suggest ive , they are a lso l imited and unc l ear and warrant further 
inves t i gation on a l arger scal e .  For examp l e ,  to adequately  examine the 
predictive abi l i ty of the pani c - fear vari ab les of favorab le response to 
treatment ,  a l arger and more representat ive samp l e  of the 9 pani c - fear 
subtypes is needed . Simi larly , the investigation of the severi ty 
variab l e  would  be improved if both phys ic ian ratings and pulmonary mea ­
sures of severity were used a s  pred ic tors . 
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Another cruci a l  question which requires further examination i s  
the rel ationship between asthma type and succes s ful  response to relaxa­
t ion therapy . Given the potential degree to whi ch a
-
variable  such as 
asthma type could  influence findings in other investigations , it  seems 
crucial  that its  rol e  be c lari fied . In a s imi l ar vein , speculation 
concerning a different ial  physiological bas i s  for the intrinsic  and 
extrins i c  asthmati c ,  and the possibi l ity that this di fferential cause 
cou l d  be re l ated respons ivenes s to rel axation therapy , certainly cal l s 
for further investigation . 
Another area whi ch requires further cl ari fi cation concerns whi ch 
type o f  rel axation strategy results in the most  favorabl e  outcome . For 
examp l e ,  this writer has serious ly ques tioned the conclusions of  
Erskine-�1 i l l i s  and Schone l l  ( 1 98 1 )  regarding the superior uti l ity of 
"menta l "  versus "muscular" relaxation techniques . In addit ion , it  seems 
worthwh i l e  to investigate the re l at ive contribut ions of "active" and 
"pass ive" us es o f  the re l axation ski l l .  Since the current study employed 
a s trategy whi ch inc l uded each of the above components , neither of thes e 
issues could be addres sed . It  may be that certain subtypes of  asthmatics 
respond to  one form or another of  rel axation therapy to the exc lusion of 
other types or components . Also , it  is pos sible that strategies whi ch 
inc l ude s everal components  ( i .  e . , l ike the current study) are redundant 
and would  be more efficient if streaml ined . Addit ional topics which 
warrant examinat ion inc l ude : 1 )  whether EMG- feedback ass isted re laxa­
tion is superior to systemat ic rel axat ion alone ; and 2 )  the comparative 
efficacy of  EMG -ass isted techniques and systematic desens iti zat ion . In 
any cas e ,  it  seems c l ear that the final word has not been spoken in this 
area . 
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Sti l l  another area which cal ls  for further consideration invo lves 
the re l a t i onship between vari ab l es such as assert iveness , asthma type/ 
sever i t y ,  pani c -fear type and intractab i l i ty of symptoms . Whi l e  
severa l authors have pos ited that a substant ia l  number of  asthmatics  
are , by and l arge , unassert ive (e . g . , Cohen , 1977 ; Groen , 1 9 79) , no 
study to thi s  date  has att empted to asses s the re lative assert iveness 
(or l ack thereo f) o f  as thmatic  pat i ents as compared to the genera l 
popu l at ion . I t  may be that asthmat i c s  are no more unassert ive than 
nonasthmati cs , however ,  those asthmatics  who do possess such an inter­
personal style  may have greater di fficu l ty cop ing with stress than 
the i r  more as s ert ive counterparts .  Th i s  di ffi cu l ty cop ing w i th stress 
may in turn comp l i cate their symptom p icture . In support of  thi s pos s i ­
b i l i ty are the findings b y  Tei ramaa ( 1 978a ; 1 978b ; 1 9 78c ; 1 9 79a )  that 
introvers ive tendenc ies  are associated w i t h :  unfavorab l e  prognos i s  of  
asthma ; severity  o f  symptoms ; longer duration of  symptoms ; and intrins i c  
as opposed to extrins i c  asthma type . Thus , i t  i s  poss ib l e  that an 
introvers ive ( i . e . , pass ive ) persona l i ty style over laps with variab l es 
such as asthma type , asthma sever ity ,  and panic - fear pers ona l i ty to 
predict  respons iveness/unrespons iveness to re l axat ion- type strategi es . 
Such an inter- r e l at i onship of potent i a l  pred i ctor var i ab l es certa inly  
warrants  further study . 
Whi l e the above d i s cuss ion of  necessary research endeavors in the 
area o f  asthma treatment is not a l l  i nc l us i ve , it does serve to ca l l  
attent ion to the fact that res earch pos s ib i l i t i es in th is  area are 
abudant . Pe rhaps the idea l manner in which the above i ssues cou ld 
be addressed wou ld  be in a l arge sca l e  "grid mode l "  type fashion which 
wou ld  enab l e  one to exami ne seve ra l facto rs/ i s sues s imu l taneous l y  (e . g . ,  
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Kies l er ,  1 969) . Whi l e  su..:.h all endeavor would  b e  worthwhi l e ,  it  has 
its obvious pract ical  l imitat ions . Short of  such an effort , severa l 
s tudi es o f  the type imp l emented by thi s writer (on a l arger scale )  
would prove benefici a l  providing the variab les  identi fied by  this  
wri ter are contro l led for adequate l y .  
Methodol ogy. The s e lf-monitoring form ut i l i zed in this study 
(i . e . , the DAF) was des igned for the co l lection of  several pieces of 
potentia l l y  re l evant dat a .  These inc luded : frequency , durat ion , and 
se l f-ratings o f  intensity of asthma attack� ; and , the amount and type 
of asthma medication ingested on a dai ly basis . Unfortunate l y ,  the 
duration and intens i ty of attacks data were unava i lab l e  for ana lysis 
due to forget fulness and/or imprecise record keep ing on the part of 
certain subj ects . Such informat ion would have been us eful in that it  
woul d  have made the  analysis  o f  outcome on  the asthma at tack variab le  
more complete  (i . e . , decreases in  intens ity and duration would  have 
refl ected improvement even had the actual  number of attacks remained 
unchanged) .  
Given the loss of  this important information due to its  ques t ionab le 
re l iab i l i ty ,  va l idity ,  and accuracy , comments concerning ways to im­
prove the recording of  these data seem in order . First , regard ing the 
recording of duration data ,  perhaps it  woul d  have been he lpful if the 
data col lection form had a space for "t ime attack began" and "t ime attack 
ended" ins tead of the current "how long did the att ack las t " .  Such 
structure may have improved the accuracy of this information . Second , 
it  may have been he lpful if subj ects were given more spec ific  guide l i nes 
as to what cons t i tuted the beginning and end of an attack . It appeared 
that some pat i ents fo l l owed the instruct ions precise ly  and reported 
attack onset at the first s i gn of symptoms (e . g . , mi l d  wheezing , whereas 
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others d id  not begin coun t ing attacks unti l  symptoms became more pro ­
nounced . Al though subj ects  were told  that an attack was defined as "the 
ini ti a l  ons et"  of even very mi ld  symptoms , perhaps some pre -treatment self­
rater training  woul d  have been he lpful towards achieving greater con­
s i s tency . Final l y ,  s imi lar pre-treatment rater training woul d  have help­
ed subj ects  assess  the inten s i ty of attacks i n  a more re l iab l e  fashion 
The use of s e l f-monitoring data in treatment outcome s tudies is  
a lways l es s  t han i deal in terms of accuracy , re l iabi l ity ,  and obj ect ivi ty . 
Unfo rtunate l y ,  when examining a di sorder such as asthma there i s  no way 
these data can be exc luded in  favor of more "obj ective" pulmonary 
measures or phys i c ian rati ngs . The mo st comp lete s tudy should inc lude 
informat ion from each of these domains and attempts  should be made to 
make thi s data as useful and usab le  as poss ibl e .  
Conc l us ion 
The current invest igat ion had two primary obj ect ives . F irst , 
this  study was propo sed as an attempt to reconfirm the ut i l i ty of  re­
laxation therapy as an adj unct strategy for the treatment of bronchial  
asthma . Second , it  was also hoped to examine spec i fic psycho logical  
and i l lness variab l es which coul d potent ia l ly  predict  respons iveness/ 
unrespons iveness to such a treatment techni que . The resu l ts  of  th i s  
invest i gat ion were incons i s tent and , as  such , the former obj ect ive has 
been only part i a l ly  accomp l i shed whereas the latter obj ect ive was 
mere ly addressed . 
The s t rongest  and pe rhaps mo st important finding of  this invest i ga-
t i on was  that  the  mean severity rati ng of subj ects who partic ipated in 
th is  program decreased as a funct ion of th i s  part i c ipat ion . S i nce 
th is  s ever i ty rat ing was based upon medicat ion usage and a lower rat ing 
refl ects  decreased dependence upon medicat ion to manage symptoms , this  
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i s  i ndeed an important outcome . Further , when one cons iders the poten­
t i a l l y  extreme s ide effects  associated with certain asthma medications , 
this  resul t takes on addi tional s i gni ficance . In add i t ion to this out ­
come , re l axat i on therapy apparent ly  had some benefic i a l  effec ts upon 
decreas ing the frequency o f  attacks and improving l ung funct ioning as 
assessed by some , but no t a l l , of the pulmonary assessments  ut i l i zed . 
Thus , the ut i l i ty o f  re l axat ion therapy was at l east  part ia l l y  supported 
by the current study . 
Regarding the attempt to assess potent i a l  pred ictors o f  responsive ­
ness/un respons iveness t o  relaxation therapy , the current att empt was 
l ess than success ful . At best , the data l ent  some minimal credence 
to previous specu l at ions that variab les  such as asthma type , asthma 
severity and pan i c - fear type  shou l d  be considered before"prescribing" 
re l axation s tudy . At worst , the pres ent study demonstrated that the 
further inves t igation of these and other variables  is certa inly  warranted . 
rn conc lus ion , i t  seems that the most importan t is sues which re ­
main inadequate ly  add res sed are tho se which attempt to de l ineate which 
subj ects wi l l  respond favorab ly to whi ch treatment s under what cond i t ions 
(c . f . ,  Kies l er ,  1 966 ; Paul , 1 970) . Unt i l  such variables have been ade ­
quatel y  asses sed ,  statements  concern ing the "b l anket indictment o f  
anxiety reduc t i on techniques in  asthma" and the "indictment of b lanket 
app l icat ion" ( Kinsman et a l . ,  1 980a)  of  such techniques can not be made 
conc lusive l y .  I n  addi t i on , c l inic ians and researchers would do we l l  to 
pay more heed to the comp l ex and heterogeneous nature of the asthmatic  
populat ion pending the  outcome of such inves t i gations . 
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Footnote 
1 Morris  et a l . ,  1 97 1  have developed a technique by which one 
can determine normal or expected respiratory values based upon a 
patient ' s  age , sex and height . I f  obtained , or actual values are 
l e s s  than expected l eve l s ,  pulmonary demise has occured . 
APPENDIX A 
Asthma Symptom Check l i st  
(from Kinsman et a l . ,  1 973 )  
ASTHMA SYMPTOM CHECKL I ST 
NAME. __________ _ DATE ___________ _ 
AG E. ______ SEX ___ _ PAT I E NT N UMBER. _______ _ 
The fol l owi ng  i s  a l i s t  of thi ngs  s ome t i mes assoc i a ted wi th  a s t hma 
attacks . For each i tem , p l ease c i rcl e the numbe r wh i ch i ndi cates 
whether i t  Neve r ( 1 ) , A l mo s t  Never ( 2 ) , Some t i mes ( 3 ) , A l mo s t  
Al ways ( 4 ) , or Al ways ( 5 )  app l i es to you r  asthma . REMEMBER : 
Respond to each i tem of th i s l i s t i n  regard to i ts a bi l i ty to 
descri be how you feel duri ng  an  a s t hma a t tack . 
1 .  CRAMP S . I . • . . . . .  I • • • •  " " , , · , 
2 .  PANT I NG , I I I I • • • • •  I I I • •  I I • •  I 
3 .  NUMB I • I • • •  I • I • I I • • •  I • •  t • • •  I 
4 .  Mucous CONG E S T I ON . . . . . . . . .  . 
5 .  CRAN KY . .  t • •  I • •  1 . 1  • •  I • • • • •  I I  
6 .  I R R I TABLE . . . . . . . . . . . . . . . . .  . 
7 .  HARD TO BREATHE . . . . . . . . . . .  . 
8 .  HEADACH E . I • • . • . . . • . • • . . • • . .  
g .  EDGY . . .  I I I • •  I I I • •  I • I I I • • • •  I 
10 . FR I G HTENED . . . . . . . . . . . . . . . .  . 
11 . UNCOMFORTABLE . . . . . . . . . . . . . . 
12 . SHORT OF  BREATH . . . . . . . . . . .  . 
13 . CHEST  CONG EST I ON . . . . . . . . . .  . 
14 . AFRA I D  OF BE I N G LE F T  ALON E .  
15 . AFRA I D  OF  DY I NG . . . . . . . . . . .  . 
16 . FRUSTRATED W I TH TH I NGS  . . . .  . 
17 . H EART POUND I NG . . . . . . . . . . . .  . 
18 I D I ZZY . .  I I I t  • • • •  I I I • • • •  I I I I I 
19 . RAP I D  BREATH I NG . . . . . . . . . . .  . 
Never Al mo s t  
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
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1 
Never 
2 
2 
2 
2 
2 
2 
2 
2 
2 
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2 
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2 
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2 
2 
2 
2 
Some t i me s  
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
3 
A l mo s t  
Al ways 
4 
4 
4 
4 
4 
4 
4 
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4 
4 
4 
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4 
4 
4 
4 
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4 
5 
5 
5 
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5 
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-2-
Never A l most Some t i mes A l most Al ways 
Never Al ways 
20 . WORN OUT . I I • , • I , I 1 ' 1  I I • I I I • 1 2 3 4 5 
21 . PAN I C KY . I • , I I I • I , • I • I I • I • •  I 1 2 3 4 5 
22 . WEAK . I I • •  I I .  I I I • •  I I I I I • •  I • •  1 2 3 4 5 
23 . P I NS AND N E EDLES FEELI  NGS . .  1 2 3 4 5 
24 . DON ' T  CARE  ABOUT T H I NGS . . . .  1 2 3 4 5 
25 . FEEL I SOLATED . . . . . . . . . . • . . .  1 2 3 4 5 
26 . HHE EZY I I I , • I I I • I I I • I I • • • • • •  1 2 3 4 5 
27 . ��ORR I ED ABOUT THE ATTACK . . .  1 2 3 4 5 
28 . ANGRY . I I • •  I • I • • •  I I • •  I • •  I • I • 1 2 3 4 5 
29 . T I  NGLY I N  SPOTS I • •  I • •  I , I • I I 1 2 3 4 5 
3� . CHEST T I GHTEN I NG . . . . . . . . • . .  1 2 3 4 5 
31 . T I RED I I I I I I • I I I I • I • I • I I • •  I • 1 2 3 4 5 
32 . SCARED . I • • • •  I • • • •  I I • • • •  I • •  I 1 2 3 4 5 
33 . FUR I OUS . I I I I • I . '  I • •  I . "  I .  I '  1 2 3 4 5 
34 . N ERVOUS I • I I I I I • •  I I • I • I • • • • •  2 3 4 5 
3 5 .  FAT I G UED I .  I • • •  I I I • •  I I I I • • •  I 1 2 3 4 5 
36 . FEEL  H E LP LE  S S . . . . • . . . . . . . • . 1 2 3 4 5 
37 . CHEST FI  L L I  NG UP  . . . . . . .  I • •  I 1 2 3 4 5 
38 . SHORT T EMP ERED . . . . . . . . . . . . .  1 2 3 4 5 
39 . LON E LY I I I • •  I I • •  I I • •  I I I I I • • •  1 2 3 4 5 
40 . WORR I ED . I • I • I I I I I I I • • • • • •  I I 1 2 3 4 5 
41 . CHEST PA I N  . . . . . . . . . • • . . . . . .  1 2 3 4 5 
42 . EXHAUSTED . . . . . . . . • . . . . . . . . .  1 2 3 4 5 
43 . MAD AT THE WORLD . . . . . . . . . . .  1 2 3 4 5 
44 . COUGH I NG • •  , . I I I I I I I I I I I I • I I 1 2 3 4 5 
45 , 
46 , 
47 , 
48 , 
49 , 
50 , 
No EN ERGy " " " " " " ,  , " , , , , 
UNHAPPY • • •  I • • • • • • • •  I • • •  I • • •  
WORR I ED ABOUT MyS ELF " " , , '  
CONCERNED ABOUT ASTHMA " " ,  
CONCERNED I N  GEN ERAL " " ' " 
FE E L  I G NO R ED " " , , " " I , , , , 
Never 
1 
1 
1 
1 
1 
1 
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Al most 
Never 
2 
2 
2 
2 
2 
2 
Someti mes Al most Al ways 
Al ways 
3 4 5 
3 4 5 
3 4 5 
3 4 5 
3 4 5 
3 4 5 
APPENDIX B 
20  P - F  (Pani c -Fear Scale)  
( from Dirks et al . ,  1 978)  
NA}fE : 
SEX : 
20 P-F 
I f  a s tatement is TRUE or MOSTLY TRU E ,  as a pp l ied to you , c i r c l e  the T b e fo r e 
the s ta tcne n t .  If a s ta teClent is FALSE or NOT US UALLY TRUE , as a p p l i e d  to you , cir c l e  
the F b e f ore the s t a t ement .  
T F 
T F 
T F 
T F 
1 .  At t imes I have f i t s  of la ughing and crying that I canno t contro l .  
2 . ' N o  o n e  s e ems to unders tand me . 
3 .  I hav'e never been in troub l e  because of my sex behavior. 
4 ;  My f e e l ings are no t eas i ly hur t .  
· . T F ,  · 5 . I wou l d  l ike to . b e  a s inger . 
T F 6 .  The s ight of b lood nei the.� fr ightens me nor makes me s i ck .  
T F 7 .  Of ten I c an ' t unders tand why I have been so cross and grouchy . 
T F 8 .  I do �ot a lways t e l l  the truth. 
T F 9 .  I frequently have to f igh t agains t showing that I am bashfu l .  
T F lO . I am worr i e d  about s ex ma t ters . 
T F 1 1 .  My han d s  have not b ecome c l umsy o r  awkwar d .  
T F 1 2 .  I a m  a n  important person .  
T F 1 3 .  I frequently f ind mys e lf worrying about s omething . 
T .  F 14 . I am more s ens i t ive than mos t o ther peop l e .  
T . F  1 5 .  I a m  n o t  afraid of f ir e . 
· T . F 16 . I am n o t  unusua l ly s e lf - cons c i ou s .  
T F '17 .  I wou l d  l ik e  t o  b e  a s o l d i e r . 
T F 18 . I have had no d iff i c u l ty s ta r t ing or ho l d ing my urine . 
T F 19 . I f e e l  l ike g iving up quickly when things go wrong . 
T F 2 0 .  I s om e t imes f e e l  tha t I a m  about t o  g o  to p i e ce s .  
2Q P-F Answer Key 
Bel ow are the answers to the 20. P-F items whi ch are scored to 
obtain a panic -fear personality score , 
I .  True I I .  False 
2 .  F i l ler 1 2 . F i l ler 
3 .  False  1 3 .  True 
4 .  False  14 . True 
S .  F i l ler 1 5 . False 
6 .  Fal se  1 6 .  False 
7 .  True 1 7 .  Fi l ler 
8 .  F i l ler 18 . False 
9 .  True 1 9 .  True 
1 0 .  True 20 . True 
APPENDIX  C 
Asthma Survey Schedul e (AmSS ) 
( from Caute l a ,  1 9 8 1 )  
Title of s urvey sc hed ule  
____
____
___
_____
__ 
_ 
N a m e  ________
________
__
__
__
__
__
____
______
____
____
__ __ 
Address _________________________
__
____
______
________ 
___ 
Phone ___________________________
______
__________
__
__ __ 
Age ______ __ 
Sex 
__
____ __ 
G rade ( if student)  
Occ upation ( i f  e m ployed) ___________________ _ 
M a rita l  sta t u s  _____ __ 
l .  
Date ________ __ 
r 
r 
r 
I 
f 
f 
r 
r 
r 
r 
[ 
I 
[ 
[ 
[ 
r 
r 
r 
I 
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AST H M A  S U R V EY S C H E D U LE (AmSS)  
Purpose: To help the therapist determ i ne physiological and psychological a ntecedents and conseq uences 
that may affect a sthmat ic  episodes. The schedu l e  has been useful in p inpoint ing the behavior d ur i ng the 
episodes that can be modified by behavioral procedures, a s  wel l  a s  the a ntecedents a nd consequences that 
can be m a n ip u l ated to reduce asth ma behavior.  I t  a lso has helped cl ients to recog nize the m a ny factors that 
influence a sthmatic episodes. 
Number of questions: 39 
Question s  
3-5 
6 
7- 1 1  
1 2, 1 3  
1 4  
1 5  
1 6  
1 7  
1 8  
1 9- 2 1  
22-34 
35 
36, 3 7  
38, 39 
Topic 
Med i cat ion 
N on med ica l i ntervention 
Related i l l nesses 
History of the i l lness 
F a m i ly h i story 
Frequency of episodes 
Wa r n i ng sig ns of episodes 
Symptoms d u r i ng episodes 
D u rat ion of episodes 
Cl ient  behaviors d u r i ng a nd after episodes 
Etiological  factors 
Reactions of others to epi sodes 
How the i l l ness i nterferes with the cl ient 's  l ife 
Cl ient react ions to the physic ia n 
1 .  Physic i a n ·s name 
Address 
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ASTHMA S U R V E Y  S C H E D U LE (AmSS ) 
Phone ____________________________________________________________________ __ 
2 .  What is you r  he ight?  ______ __ you r  we ight? ______ __ 
3 . Wha t medicat ion have you previously taken for your asthma? 
Medication Dosage Effectiveness 
4. What med icat ion a re you c u rrent ly t a k i ng for your asth m a ?  
Medication Dosage Effectiveness 
5 .  What other  medicat ion a re you c u rre,ntly tak ing?  
Medication Dosage Effectiveness 
6. What  d o  you do to reduce the f req ue ncy of yo u r  asthmat ic  ep isodes besides tak ing medica t i o n ?  
W h a t  a re t h e  effects? ________________________________________________________________ __ 
7. What other a l le rg ies do you have? 
8.  Check which of t h e  fol lowing medica l  prob lems you have had:  
a .  Urtica r ia ____ __ e. Cardiac problems ____ __ 
b. High blood pressu re ____ __ f. S i n u s  problems ____ __ 
c. Pne umonia ____ __ g. Eczema ____ __ 
d. Bronc h i t i s  ____ __ 
9. What other  i l lnesses do you presently have? 
1 0. How m uch of the time do you have colds? 
Not at all  __ _ A l i tt le ____ __ A fa i r  a mount  ____ __ Much ____ __ Very much ____ __ 
1 1 .  How m uc h  of the t i me do you have headaches? 
Not a t  al l  __ _ A l i tt le ____ __ A fa i r  a mount ____ __ Much ____ __ Very m uch ____ __ 
I n  what part of your head is your ache usual ly  located? -------------------------------------
f 
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11l. When d id you have you r  l a st com plete physical exa m i nat ion? 
What were the results? -----
-
_______________________ _ 
lt3! When did you have your f i rst a sthmatic episode? 
1'4; Does anyone in your f a m i l y  have asthm a ?  Y a s  _. __ No __
___ If so. identify whom. _______ _ 
15. How frequent a re your asthmatic episodes? Per day _____ Per week ______ Per month ____ _ 
1 '6: Do you have a ny wa rning s i g n s  before your asth matic episodes? Yes _____ No _____ If so, what 
are they?--
------------------------------------
117. Check the degree to w h ic h  each of the fol lowing symptoms occurs dur ing a n  asthmatic episode: 
a. Tightness in the chest 
Not at a l l  ___ A l itt le ___ A fa ir  amount ______ M uch ___ Very much _____ 
b. Wheezing 
Not at all ___ A l itt le ___ A fa i r  a mount _____ M uch ___ Very m uch ____ 
c. Feel i ng faint 
Not at al l  ___ A l i t t le ___ A fa i r  a mount ______ M uch _____ Very much _____ 
d. Coughing 
Not at  a l l  ___ A l ittle ___ A fa i r  amount _____ M uch ______ Very much ______ 
e. Coughi ng up or spitt i ng m ucous 
Not at al l  _____ A l itt le _____ A fa i r  a mount _____ M uch ------ Very much -----
f. Sweating 
Not at a l l  ___ A l i t t le _____ A fa i r  amount ____ M uch ___ Very much _____ 
g. Pa in 
Not at a l l  ___ A l itt le ___ A fa ir  amount ----- M uch ___ Very much _____ 
h. Fear 
Not at a l l  ___ A l i ttle ___ A fa ir  a mount ------ M uch _____ Very m uch _____ 
i. Itch ing 
Not at a l l  ___ A l itt le ___ A fa i r  amount ---- M uch ____ Very much _____ 
j .  Rash or h ives 
Not at a l l  ___ A l itt le ___ A fa i r  amount ---- M uc h  __ - Very much _____ 
k. Loss of consc iousness 
Not at al l  ___ A l itt le ___ A fa i r  amount ----- M uch _____ Very much _____ 
I .  Rapid breath i ng 
Not at a l l  _____ A l itt le ____ A fair  amount ---- M uch ____ Very much ______ 
1 8. How long does an asth mat ic  epi sode usual ly  last? 
1 9. While you a re h avi ng an asthmatic episode, do you try to stop it or reduce its severity? 
Yes ______ No _____ If so, please descr ibe what you do. 
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20. What do you do d u r ing a n  a sthmat ic  episode] ______________________ _ 
2 1 . What do you do after a n  asthma tic episode? 
22. Check the degree to which each of the following factors a ppears to tr igger a sthma tic episodes: 
a. Changes in temperatu re 
Not at a l l  ___ A l itt le ___ A fa i r  amount ___ M uch ___ Very much ___ 
b. Amount of h u m id ity 
Not at a l l  ___ A l itt le ___ A fair  amount ___ M uch ___ Very much ___ 
c. Pollen 
Not a t  al l  ___ A l itt le ___ A fair  amount  ___ M uch ___ Very much ___ 
d. A n i m a l s  
N o t  a t  a l l  ___ A l itt le ___ A f a i r  amount ___ M uc h  ___ Very m uch ___ 
e. Dust  
Not at a l l  ___ A l i t t le  ___ A fa i r  amount ___ M uch ___ Very much ___ 
f .  I nsectic ide 
Not at al l  ___ A little ___ A fa i r  amount  ___ M uc h  ___ Very m uch ___ 
g. S moke 
Not at a l l  ___ A l itt le ___ A fa ir  amount  ___ M uch ___ Very much ___ 
h .  Paints 
Not at al l  ___ A l itt le ___ A fa i r  amount  ___ M uch ___ Very much ___ 
i .  Anger 
Not at a l l  ___ A l itt le ___ A fair  amount ___ M uch ___ Very much ___ 
j Tension 
N ot a t  al l  ___ A litt le ___ A fa i r  amount ___ M uch ___ Very m uch ___ 
k. Fa t igue 
N ot at a l l  ___ A l itt le ___ A fair  amount ___ M uch ___ Very m uch ___ 
I .  Stress 
N ot at a l l  ___ A l itt le __ - A fa i r  amount ___ M uch ___ Very much ___ 
m .  Fear 
Not at al l  ___ A l itt le ___ A fair  amount  ___ M uch ___ Very much ___ 
n. Overact ivity 
Not a t  all ___ A l itt le ___ A fa i r  amount ___ M uc h  ___ Very much ___ 
23. I ndicate h ow l ikely it is that  a n  asthmatic episode wi l l  occ ur d u r i ng each of the following seasons: 
a. S u m m e r  
N o t  at a l l  ___ A l itt le __ - A fa i r  amount ___ M uch ___ Very much ___ 
b. Winter 
Not at al l  _ ___ A l itt le ___ A fa i r  amount ___ M uch ___ Very much ___ 
c. Spring 
N ot at a l l  ___ A l itt le ___ A f a i r  amount _-_ M uch ___ Very much ___ 
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d. Fall 
Not at a l l  --- A litt le --- A f a i r  amount ____ M h uc ___ Very m uch __ _ 
24. Check the degree to w h ic h  you have asthmatic episodes in the following places: 
a. Home 
Not at a l l -_- A l i tt le ___ A fair  amount ___ M uch ___ Very m uch ___ 
b. Work , 
Not at a l l  ___ A l i t t le  ___ A fa i r  amount ___ M uch ___ Very much ___ 
c. School 
Not at a l l  __ - A l itt le ___ A fair  amount ___ M uch ___ Very much ___ 
d. In a car 
Not at all ___ A l i t t le  ___ A fair  amount ___ M uch ___ Very much ___ 
e. In the city 
Not at a l l  ___ A l i t t le  ___ A fair  amount ___ M uch ___ Very much ___ 
f. In the country 
Not at all ___ A l itt le ___ A fa i r  a mount ___ M uch ___ Very m uch ___ 
g. Other (specify) 
Not at a l l  ___ A l inle  ___ A fa i r  a mount ___ M uch ___ Very m uch ___ 
25 Check how often you r  a sth mat ic  epi sodes occur at each of these t i mes: 
a. Morni ng 
Not at a l l  ___ A l itt le ___ A fa ir  amount ___ M uch ___ Very much ___ 
b. Afternoon 
Not at a l l  ___ A l i t t le  ___ A fa i r  a mount ___ M uch ___ Very much ___ 
c. Evening 
Not at a l l  ___ A litt le ___ A fa i r  amount ___ M uch ___ Very much ___ 
d. Night 
Not at all ___ A litt le ___ A fa i r  amount ___ M uch ___ Very much ___ 
e. Whi le sleepi ng 
Not at all ___ A l itt le ___ A fa ir  amount ___ M uch ___ Very m uch ___ 
26. Do you have a n y  pets? Yes ___ No ___ If so, what a n imals do you have a nd where do you 
keep them? __________________________________ _ 
f7. Describe you r  work environment.  
28 .  How much of the t ime do yo u take a spi r i n ?  
Not at  a l l  ___ A l i tt le ___ A fa i r  a mount __ _ Much __ _ Very m uch __ _ 
29. Does aspi r i n  seem to make you r  asthma worse? Yes ___ No ___ If so, please expla in .  __ 
30. Do you smoke? Yes ___ N o  ___ I f so,  what do you smoke a nd how m uch per day? 
___ _ 
How long have you smoked ? 
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3 1 . Did you ever smoke? Yes -__ No ___ If so, what d id you smoke, how much per day, and when 
did you stop? 
32. Indicate t h e  a m o unt of a nxiety you feel in each of the following situations: 
a .  Being i nt roduced to a stra nger 
Not a t  al l  --- A l i tt le ___ A fa i r  a mount ___ M uch ___ Very m uch __ _ 
b. Giv ing yo u r  opinion in front of a g roup 
Not a t  al l  --- A l itt le ___ A fa i r  a mount ___ M uch ___ Very m uch __ _ 
c. Speak ing up to loved ones when a n  i njustice is done 
Not a t  all --- A l i tt le ___ A fa i r  a mount ___ Much ___ Very much __ _ 
d. Speaking up to f r iends when an i njustice is done 
Not at all ___ A l i tt le ___ A fa i r  a mount ___ Much ___ Very m uch __ _ 
e. Speaking up to strangers when a n  i nj ustice is done 
Not a t  all ___ A l i tt le ___ A fa i r  a mount ___ Much ___ Very much __ _ 
f. Speaking up to relat ives when a n  i nj ustice is done 
Not a t  al l  ___ A l i tt le ___ A fa i r  a mount ___ Much ___ Very m uch __ _ 
g .  Speak i ng up to service people, such as store clerks, whe n  an i njustice is done 
Not a t  a l l  ___ A l i tt le ___ A fa i r  a mount ___ M uch ___ Very m uch __ _ 
h .  S oc i a l i z i ng at a pa rty 
Not a t  all ___ A l i tt le ___ A fair a mount ___ Much ___ Very m uch __ _ 
i. In i t ia t ing conversat ion with a stra nger 
Not a t  al l  ___ A l i ttle ___ A fa i r  a mount ___ Much ___ Very much __ _ 
j .  R eceiving a compl iment 
Not a t  al l  ___ A l i tt le �__ A fa i r  a mount ___ Much ___ Very much _ _  _ 
k. Being cr i t ic ized 
Not at a l l  ___ A l i tt le ___ A fa i r  a mount ___ Much ___ Very m uch ---
3 3 .  Check t h e  degree to which you would describe yourself in each of the fol lowing ways: 
a. Very rela xed 
Not a t  a l l  ___ A l i tt le  ___ A fa i r  a mount ___ Much -__ Very much ---
b. Relaxed 
Not a t  all ___ A l i tt le ___ A fa i r  a mount ___ Much ___ Very m uch ___ 
c. Fa i rly relaxed 
Not a t  al l  ___ A l i ttle ___ A fa i r  a mount ___ M uch ___ Very m uch ___ 
d. A l i tt le nervous 
Not at all  ___ A l i tt le ___ A fa i r  a mount ___ Much ___ Very m uch ___ 
e. Nervous 
Not a t  a l l  ___ A l i ttle ___ A fair  a mount ___ Much ___ Very much ___ 
f. Very nervous 
Not at all ___ A l i tt le  ___ A fa i r  a mount ___ M uch ___ Very m uch ___ 
, - <.) -
34 Rate how m uc h  you pa rt i c i pa te i n  each of these activit ies:  
a .  Wa lking 
Not a t a l l  ___ A l i tt le ___ A f a i r  a mount ___ M u c h  ___ Very much ___ 
b. Jogging or r u n-n ing 
Not a t  a l l  ___ A l i tt le ___ A f a i r  a mount  ___ M u c h  ___ Very m uc h  ___ 
c. Cal isthenics 
Not a t  a l l  ___ A litt l e  ___ A fa i r  a mount ___ M u c h  ___ Very m uch ___ 
d. Lifting 
Not at all  ___ A l i tt l e  ___ A f a i r  a mo u nt ___ M uch ___ Very m uc h  ___ 
e. Pul l ing 
Not a t  a l l  ___ A li t t le  ___ A f a i r  a mo u nt ___ M u c h  ___ Very m u c h  ___ 
f. Pushing 
Not a t  a l l  ___ A l i tt l e  ___ A f a i r  a mount  ___ M uch ___ Very m u c h  ___ 
g.  Bicyc l i ng 
Not a t  a l l  ___ A litt le ___ A fair  a mount  ___ M u c h  ___ Very m uc h  ___ 
h.  Wa l k i ng u p  a n d  down sta irs  
Not  a t  a l l  ___ A l i tt le ___ A fa i r  a mount  ___ M u c h  ___ Very m uc h  ___ 
35 . Rate how often t h e  m e m b e r s  of your f a m i l y  d i splay each of the fol lowing reactions to your  i l l ness: 
a . ShOWing sympathy 
Not a t  a l l  ___ A l i t t le  ___ A f a i r  a mount  ___ M u c h  ___ Very m u c h  ___ 
b. Wa nting to be with you m ore 
Not at a l l  ___ A l i tt l e  ___ A f a i r  a mount  ___ M u c h  ___ Very m uch ___ 
c . Wa nting to be with you less 
Not a t  al l  ___ A l i tt l e  ___ A f a i r  a mount  ___ M u c h  ___ Very m uc h  ___ 
d.  Seeing you a s  less worthwhi le  
Not  a t  a l l  ___ A l i tt le ___ A f a i r  a mount  ___ M uch ___ Very m uc h  ___ 
e. Finding you a b u r d e n  
Not a t  a l l  ___ A l i tt l e  ___ A fa ir a mo u nt ___ M u c h  ___ Very much ___ 
f. Adm i r i ng your courage 
Not  a t  a l l  ___ A l i t t le  ___ A fa i r a mount  ___ M u c h  ___ Very m uc h  ___ 
9 Find i ng you a n noying 
Not a t  al l  ___ A l i tt le ___ A fa ir  a mount  ___ M u c h  ___ Very much ___ 
h. G i ving yo u m ore a tte nt ion t h a n  before your I l lness 
Not a t  al l  ___ A l i tt l e  ___ A fa ir a mount  ___ M u c h  ___ Very m u c h  ___ 
i .  G iv ing yo u less atte n t i o n  t h a n  before yo ur i l l ness 
Not a t  a l l  ___ A l i t t l e  ___ A fa ir  a mo u n t  ___ M uc h  ___ Very m uc h  ___ 
j .  f:lese n l l n g  y o u  
N o t  at a l l  ___ A l i tt l e  ___ A fa i r  a mount ___ Much ___ Very m uc h  ___ 
k. Appreci a t i n g  you m ore 
Not at a l l  ___ A l i tt le ___ A f a i r  a mo u nt --- M uch ____ Very m uch ____ 
- 9 -
36. How does your asth ma i n terfere with you r  l ife? 
37. If you no longer had asth m a ,  how would your l ife cha nge? _________________ _ 
38.  Check the deg ree to which your physic ian acts in each of t hese ways: 
a. Treats you with respect 
Not at a l l  ___ A l itt le ___ A fa i r  a mount ___ M uch ___ Very m uch ---
b. Answers your q uestions read i ly 
Not a t  a l l  ___ A l i tt le  ___ A fa i r  a mo u nt ___ M uch ___ Very m uch ---
c. G i ve s  you adequate i nformation in a c lear  manner 
Not a t  a l l  ___ A l i tt le ___ A fa i r  a mount ___ M uch ___ Very m uc h  ---
d. Makes h i m se lf or herself avai lable when you need h i m  or her (by phone or i n  person) 
Not a t  all ___ A l itt le ___ A fa i r  a mount ___ M uch ___ Very m uch ---
e .  8ehaves i n  a fr iendly ma nne r toward you 
Not at a l l  ___ A l i tt le  ___ A fa i r  a mount ___ M uch ___ Very m uch ---
f. Considers you r  emot ional  needs 
Not a t  a l l  ___ A l i ttle ___ A fa i r  a mount ___ M uch ___ Very m uch ---
g. S pe nd s  enough t i m e  with you d uring office visits 
Not a t  al l  ___ A l i ttle ___ A fair  a mount ___ M uch ___ Very much ---
h. G ives you the best medica l t reatment avai lable 
Not a t  al l  ___ A l i tt l e  ___ A fa i r  a mount ___ M uch --- Very m uch ---
39. How closely do you fol low you r  physic ian's  i nstructions for tak i ng medication? 
Not a t  al l  ___ A l itt le ___ A fa i r  amount ___ M uch --- Very m uch __ _ 
APPENDIX  D 
Physician ' s  Severity Rat ing 
( from P 1 utchik et a 1 . ,  1978)  
Phys ician ' s  Severity Rat ing 
P l ease make an overa l l  rating of the degree of severity of 
------
��������-_ asthma based upon the medication (s )  you are current­
-(patient'S name) 
ly prescribing _ P l ace a check ( next to the appropriate rating . 
1 .  Mi l d ,  epi sodic asthma , No need for steroids . 
May take oral bronchodi l ator , occasional  use o f  
spray . 
2 .  Requires continuous therapy with bronchodi l ator , 
no steroids . 
3 .  Requires steroids intermittently  for short periods . 
4 .  Requires steroids , most , not a l l o f  the time . 
S .  Needs steroids al l the t ime but we l l  contro l l ed .  
6 .  Desp ite steroids gets asthma requiring more inten­
s ive therapy - higher doses , ER vi sit s ,  hospital . 
7 .  On ful l doses o f  a l l  medication ,  s t i l l has severe 
asthma much of the t ime . 
8 .  Same as above but disab led most of  the t ime . 
9 .  Constantly  disab led by asthma despite al l therapy . 
APPEND IX  E 
Dai ly  Asses sment Form CDAF) 
Dai l y  Assessment Form (OAF) 
Instructions : Each time you experience an asthma attack (from mi ld onset 
symptoms to severe ly impaired breathing) , p l ease record the fo l low­
ing informati on at the earl iest opportunity . F i l l  out one OAF each 
day, even i f  you have no attacks . 
Attack Number 1 
1 )  How long did  the attack l ast 
2) How severe was i t  ( l : Mi ld ;  l O
-
:�S
-
e
-
v
-
e
-
r
-
e')
-----------
Attack Number 2 
1 )  How long did  the attack l ast  
.��---------------2 )  How severe was it  ( l : Mi l d ;  l O : Severe) 
Attack Number 3 
1 )  How long di d the attack last 
2 )  How severe was it  ( l : Mi ld ;  l O : Severe) 
P l ease provide the above informat ion for each attack you experience . In 
addition ,  p l ease provide the fol lowing informat ion : 
Dat e :  
Total  Number of  attacks  today : 
Types of  Medication t aken today : 
Amount of  each medication : 
APPENDIX  F 
24 -Hour History 
2 4-Hour H i s t o r¥. 
D a t e : 
Sub . No : 
C on d : 
Age : ___ He igh t :  ___ We igh t : 
One ' s  p e r f o rman c e  on the spirometer on any one given day 
m i gh t  vary as a f un c t i on o f  many f a c t o r s . In o rder to in t e r p r e t  your 
te s t  s c o r e s  a c c u ra t e l y , we wou l d  l ike t o  have s ome i n f orma t ion regard ing 
your b e h av i o r  and a c t iv i t i e s  d ur ing the p a s t 24 hour p e r i o d . P le a s e  
an swe r t h e  fo l l ow ing q ue s t i o n s  a s  a c cu r a te l y  a s  po s s ib le b y  p l a c ing a 
c i rc l e  around the a p p r o p r i a t e  numb e r  o f  t e rm . Th i s  i n f o rma t i on w i l l  
b e  ke p t  c on f i d en t i a l . 
1 .  How many h o u r s  o f  s l e e p  d id you h ave l a s t  n i gh t ?  ( c i rc le )  
1 2 3 4 5 6 7 8 9 ] 0  1 1  1 2  1 3  1 4  15 
2 .  H av e  you e xe r c i s e d  w i th i n  the p a s t  4 h ou r s ?  YES NO 
I f  t h e  an s w e r  is YES , p l e a s e  p l ace a c i r c le a round one o f  
t h e  fo l l ow in g  
LIGHT MODERATE V IGOROUS E XTREHELY V IG O ROUS 
3. H av e  you e x e r c i s e d  w i t h in the p a s t 24 hour s ?  Y E �  NO 
4 .  
S .  
6 .  
7 .  
I f  the an s w e r  i s  Y E S , p l e a s e  p l a c e  a c i r c l e a r o und one o f  the 
f o l l owing : 
LI GHT MODERATE V I GOROUS EXTREMELY V IGbROUS 
How many h ou r s  s in ce your l a s  t mea l o r  s n a c k ?  
1 2 3 4 5 6 7 8 9 1 0  1 1  1 2  1 3  1 4  I S  
1 6  1 7  1 8  1 9  2 0  2 1  2 2  2 3 2 4  
I f  you h ave e a t e n  w i th in the p a s t 4 hou r s , p l e a s e  c i r c le the 
amoun t o f  f o o d  c on s ume d : 
SMALL MED I UM LARGE 
I f  you smoke , h ow l ong h a s  i t  b e en s i n c e  y o u  l a s t  smok e d ?  ( i n  hours ) 
1 2 3 4 5 6 7 8 9 1 0  1 1  1 2  1 3  1 4  1 5  
1 6 1 7  1 8  1 9  2 0  2 1  2 2  2 3  2 4  
H ow many t im e s  pe r d a y  do y o u  smoke ? 
- 2 -
8 .  H av e  y o u  t ak e n  any medicat ions wi thin the past 24 hours? YES NO 
I f  YES , wh a t  medications ? 
9 .  H av e  you done a ny th ing unu s u a l  w i th in t h e  p a s t  2 4  hour pe r i od 
wh i ch you f e e l  migh t a f f e c t  your performance on the spiro-
10 . 
meter? YES NO 
If Y E S , p le a s e  e x p l a in in the space be l ow 
Have you c o n s umed any 
hour s ?  YES NO The p a s t 
I f  Y E S , w h a t  and how much 
beve r a g e s  w i t h in the l a s t  2 4  
1 2  h our s ?  'YES NO 
d i d  you consume ? 
1 1 .  Re l a t iv e  t o  y o ur norm a l  s t a t e  ( N o  4 ) , p l e a s e  mark a p o i n t  on the 
s even p o i n t s c a le b e l ow to i n d i c a t e  how you f ee l .  
1 
D e p re s s e d  
s i ck 
2 3 4 
NORMAL 
5 6 7 
. A l e r t  
h e a l thy 
APPENDIX  G 
Exp l anati on of Pulmonary Asses sment Procedure 
Explanation of  Pulmonary Assessment Procedure 
Examiner Statement : Thi s  assessment we are about to do i s  a very simp l e  
one . A l l  you are required t o  do i s  t o  inhal e  a s  deep ly  a s  possib le  
and to exhale  this  breath as  rapidly as  you can into  this  tube . We 
wi l l  be  repeating thi s  three t imes . P l ease try your hardest on each 
attempt . 
1 .  Adj us t  the tube so  that i t  i s  at the same l evel as your mouth .  
2 .  Inhal e  as deep ly  as you can . 
3 .  As soon as you reach the end of this inhal at ion , exhal e  this 
breath as rapidly  and as  ful ly as you can into the tube . 
4 .  Rest  for a coup l e  of  minutes . 
s .  Now l et ' s  repeat the same steps . 
APPENDIX  H 
Informed Consent 
Informed Consent 
I --r=������------�------- agree to participate in this re-
(parti cipant ' s  name) 
s earch program i nvol ving a treatment s trategy which may prove helpfu l  
to mys e l f ,  and o thers , in  attempting to control our asthma . No guaran­
tees regarding potenti a l  improvement have been g iven to me , however . 
The fol lowing information invo l ved in  this program has been pro­
vided to me and has been exp l ained to my sat i s faction . Al l my questions 
have a l so  been answered sat i s factori l y :  
1 )  Time Invo l ved : Approximately 1 8  weeks . 
i n  the fol lowing manner :  
This i s  broken down 
A) Pretreatment Assessments : one appointment which should  take 
l es·s than one hour . 
B )  Treatment sess ions : one sess ion per week for five weeks . 
Each sess ion wi l l  be one hour to one hour and a hal f  in l ength . 
C) F o l l ow-up Assessments : One appointment approximately  one 
month aft er the comp let ion of the treatment program . An 
add i ti onal  appointment three months after the comp l et ion of  
the  program ( i . e . , two months after the  initial fo l low-up) . 
Each appointment should be approximately  one hour in  l ength . 
(Note : The above services wi l l  be provided at no cost to part icipant s ) . 
2 )  Treatment Program - Re l axation Training : Thi s  training i s  de­
s i gned to teach me to  rel ax in s ituat ions which have previous ly  
caused me  to get  upset or nervous . One port ion of  this  training 
wi l l  invo l ve l earning to relax my musc l es with a series o f  exer­
cises . Any spec i fi c  exercise  which causes me d iscomfort wi l l  be 
e l iminated . These exerc i ses s imp ly invo lve tens ing and relaxing 
vari ous musc l e  groups throughout the body . Another segment of 
this training i nvo lves l earning to focus on some scene which I 
find to be p l easant (e . g . , the seashore) . A fina l segment in­
vo lves l earning to breath in an even/rhythmic  fashion and te l l ­
ing mys e l f  to "rel ax" each t ime I exha l e .  I understand that I 
wi l l  be taught these  t echniques in a group of  6 to 1 0  other 
individua l s .  In add i tion ,  I understand that I wi l l  be required 
to prac t i ce my relaxation exercises one-ha l f  hour per day at 
home . 
3 )  Assessment Devices 
�)  Questionnaires - there wi l l  be a variety of questionnaires , 
some requesting personal informat ion , which I wi l l  be required 
to comp l ete . I a l so understand that there are some forms 
which I wi l l  have to comp l ete on a dai ly bas is  throughout 
this 18 week proj ect . 
b )  Pulmonary Functi on - this  procedure wi l l  invol ve taking as 
deep an inhal at ion as possib le  and exhal ing i t  as rapid ly and 
ful ly as poss ib le  into a tube . The steps of this  procedure 
have been out l ined to me and I have been given a copy of these 
step s  in wri t ing (Appendix G ) .  I understand that I wi l l  be 
asked not to eat anything or drink any fluids except water or 
j ui ces for three hours before each assessment . In addition ,  
the procedure itse l f may cause some s li ght dis comfort , but I 
understand that the examiner i s  we l l - trained and supervi sed . 
c )  Physi c i an Ratings - on four occasions throughout the course 
of this proj ect the phys ician who is treating me for my 
asthma w i l l  be required to  fi l l  out a bri ef questionnaire . 
I understand that i f  there i s  any cost for his  comp l eting 
this form I w i l l have to  pay for i t .  I a l so understand that 
by my s ignature below I am granting Mr. Marce l lo and my 
physi c i an the privi l ege o f  discuss ing my cas e ,  either through 
the mai l  or by personal/tel ephone contacts ,  as it pertains to 
my i nvo l vement in this  proj ect only .  
I understand that my partic ipation in  this program poses n o  risks t o  
my hea l th and we l l -being . At no t ime w i l l  I be asked not to take my 
as thma medi cation by these i nvestigators . Such dec i s ions wi l l  be made 
by my physi c i an based s o l e ly upon my medica l  condition .  I a l so under­
s tand that I wi l l  remain  under the primary care of my phys i c ian during 
this  program and tha t  I w i l l  be free to vis it  with h im/her as often as 
deemed necessary by mys e l f  and my physician .  
I a l so understand that my confidenti a l i ty wi l l  b e  guarded at al l 
t imes during and after my part ic ipation in this  program . I understand 
that a l l ques tionnaires and other data wi l l  be identi fi ed by code numbers . 
My name wi l l  not be uti l i zed in any verbal  or wri tten account o f  thi s pro­
gram . 
I understand that i t  i s  my right to withdraw my consent for part ici­
pat i on in  this program at  any t ime . I w i l l  be free to exercise  this  
right as I see  fit .  
I have read the above and I understand its  contents and agree to its  
condi t i ons . 
Part ic ipant ' s  Si gnature 
Witness 
Date 
Guardian ' s  Signature i f  
parti c ipant i s  a minor 
APPENDI X  I 
RELAXATION TRAINING MANUAL 
(Adapted from : Russe l l  and Sipich ,  1 9 7 3 ;  Shoemaker, 1979 ; 
Sirota and Mahoney , 1 9 74 ; Wo lpe and Lazarus , 1 966)  
Relaxation Training 
Manual 
Part I 
MUSCLE RELAXATION EXERCI SES 
Introduction 
The basi c  i dea of  these exercises i s  to teach you how to re lax ful ly 
and comp l et e l y .  I t  has been found that an effect ive method o f  achieving 
rel axat io� is to tense the various musc les  and musc le  groups of your 
body as t lght l y  as you can ,  ho lding and studying the tension for a few 
moments ,  and then re l easing the tension and noticing the difference .  The 
i dea i s  to methodica l ly concentrate on the di fference between tension 
and rel axation . Whi l e tensing any specified area of your body, the 
rest of your body should  remain as rel axed as possib l e . As you progress 
through thes e exercises , you wi l l  l earn to enj oy the rel axation more 
and more as i t  becomes deeper and more comp l ete . Throughout thes e ex­
erci ses , you w i l l  notice  a seri es of three dots C . . .  ) . These dots indi­
cate  periods where you are to pause for five or  ten  seconds and concen­
trate on the sens at i ons you are fee l ing at that moment . 
General Loosening Up 
Thes e exerci ses are des i gned to  l oosen up your maj or mus c l es , and 
wi l l  take about two or  three minutes . Begin by standing up and stretch­
ing your hands over your head as high as you can ,  s tretching al l of the 
mus c l es from your finger t ip s  down to your toes . Ho l d  this tens ion for 
a few moment s  . . .  then relax . . .  Repeat this exercise  several t imes . 
Now s tretch your arms out sideways as far as you can and tens e them . 
Ho ld  this tens ion for a few moments . . .  then relax . . .  Repeat this ex­
erci se  several t imes . Now bend forward tensing the mus c l es along your 
back and l egs . . .  s tudy the t ens ion for a few moments . . .  then re lax 
and not ice  the di fference . . .  Repeat this exercise  several t imes . Next 
l ight l y  s hake your hands and arms for a few seconds , re laxing al l the 
mus c l e s  that you can . Then be seated , preferab ly in a comfortab l e ,  re­
c l ined loung e  chair , and carry out the fol lowing exercises : 
Deve lopment of Re laxation in the 
Hands , Arms , and Shoulders 
These  exerci s es wi l l  be directed toward re l axing the mus c l es in 
your hands , arms , and shoulders . They wi l l  take approximately  four to 
six  minutes to comp l ete . 
You shoul d  at . this point already be seated with both feet comfort � ably extended ?ut In front of you , your arms and hands resting along the 
arm of �h e  ch�Ir ,  and your head and neck in a relaxed , resting position . 
R7l ax l �ke thIS  for a few moments . . .  Now , make your right hand into a 
tIght fI:t ,  �l ench your fi st  t i ght , as t ight ly as you can and bui l d  up 
the t ensIon In your hand and forearm . . .  study this  tension for a few 
moment� . . .  �ow rela� and notice  the d ifference . . .  Once more , c l ench 
your rIght fIst as t I gh t ly as you can , bui ld  up the tension , s tudy it  . . .  
now relax and notice the d ifference . . .  Now c l ench your l eft hand and 
make i t  �nto a t i ght f� st . Make the fi st t ighter and t ighter , bui ld up 
the t ens Ion and study It for a few moments . . .  Now rel ax and notice the 
difference  : . .  ?nc e  more , make your left hand ir.to a tight fis t ,  bui ld  
up the  t ensIon In your hand and forearm tighter and t ighter , s tudy this 
thi s t ens ion for a few moments . . .  and now re lax and notice the di ffer­
ence . . .  Not ice how relaxed your hands are and how much more p l easant 
the re l axat i on is compared to t ension . Concentrate on relaxing a l l over 
for a few moment s  . . .  Next , bend your right e lbow , making your right 
hand into a fist  and tens ing your forearm and upper arm as t i ght as you 
can , bui l d  up this  t ension t i ghter and t ighter , s tudy it for a few mo� 
ment s  . . .  Now . relax . . .  straighten your arm and let the tens ion flow out . . .  
Not i ce the d i fference between the tension and rel axation . . .  Enj oy the 
rel axat i on for a few moments . . .  Now , once more , bend your right elbow , 
making your right hand into a fi st  and bui lding up the tens ion in your 
hand , forearm , and upper arm . Bui ld  up this tens ion and study it  for a 
few moments . . .  Now relax . . .  straighten out your arm and hand and let a l l  
the tens i on flow out . Concentrate on studying the di fference between re ­
l axation and t ens ion . . .  Now , breathe normal ly and rest for a few moment s 
. . .  Next , bend your l e ft e lbow making your left hand into a fist and · 
t i ght l y  t ense  your forearm and upper arm , bui l d  up the tension in your 
upper arm , study i t  . . .  now relax and not ice the d i fference . . .  Notice how 
good the absence o f  tens ion fee l s  . . .  Enj oy this relaxation for a few mo­
ments  . . .  Now once again , bend your l eft elbow very hard making your left 
hand into a t i ght fi st  and your upper arm mus c l e  into a t ight bal l ,  bui l d  
up the tension a s  much a s  you can . . .  study the tens ion . . .  now relax and 
noti ce the d i fference . . .  Let al l the tension flow out of your mus c l es and 
concentrate on becoming as re l axed as you can . . .  Just concentrate on re­
l axing as comp letely as you can , and remain in this pos it ion as the in­
s tructions for the next rel axat ion exercises begin . 
Rel axation o f  Upper Back , 
Ches t , Stomach , and Lower Back 
These exercises  wi l l  l ast  four to s ix minutes . Keeping the rest of  
your body relaxed , t ense the  musc l es in  your upper back are� by  rai �ing 
your shoulders and shrugging them back and up ; tense them tIght , bUI ld 
up the tens ion . . .  study i t  . . .  Now relax . Let your s houlders fal l  down 
and relax as comp l ete ly as you can . . .  Notice  a l l  the tension flowing 
out of your upper back area . . .  Let yourse l f  become . more and more re­laxed as the rel axation spreads throughout your entIre body . . .  Now 
once again t ense  the muscles  in your uPP7r back area b� shrugging your 
shoulders up and back , build up the tens Ion . . .  Study It . : . Now relax . Let your shoulders fal l ,  and , as they do , l et a l l  the tens Ion flow out 
of your body . . .  Let yourself  become more and more rel axed . . .  Concentrate 
on reducing even the s lighest bit  of  t ension . . .  Continue to relax and 
enj oy this fee l ing for a few moments .  
Now , as  you are rel axing , breathe in deep l y ,  fi l l ing your lungs as 
ful l y  as you can and hol d  it for a moment . . .  Now , breathe out s lowly ' 
and notic e  the increasing relaxation . . .  Breathe normal ly for a few s�c­
onds whi l e  concentrating on re l axing more . .. . Breathe in deep ly and again 
comp l etely  fi l l  your l ung s ;  then ho ld  your breath for a few moment s  . . .  
Now exhal e  and s l ow ling permit  the air t o  l eave your lung s ,  concentrate 
on experi encing the increasing relaxat ion as you s lowly exhal e  . . .  Breathe 
normal l y  for a whi l e ,  l etting yourse l f  become more and more relaxed . . .  
Enj oy this spreading rel axation as you breathe in and out . . .  Now once 
again breathe in deep l y ,  fi l l  your lungs , and hold  'your breath for a few 
moments . Study the sensation . . .  Now exhale  s l owly , and concentrate on 
the p l easant  experi ences as you do . . .  Breathe normal ly again for a whi l e ,  
each t ime l etting yourse l f  becomre more and more relaxed . . .  Once more 
breathe in deep l y  and fi l l  your lungs to capacity ;  ho ld your breath for 
a few moments . Study the tension . . .  Now exhal e  s lowl y ,  concentrating on 
becoming more and more rel axed . . .  Let this rel axation spread throughout 
your ent ire body . . .  Your upper and lower back , shoulders , neck ,  fac e ,  
ches t , and arms are a l l  becoming more and more relaxed a s  you breathe . . .  
As you continue breathing , concentrate on becoming more and more re­
laxed . . .  
As the re laxation goes deeper and deeper , center your att ention on 
your stomach and abdominal area .  Pul l  in your stomach and make it and 
your entire abdominal area as t ight as you can , bui ld up this tension , 
and study i t  . . .  Now rel ax and let  al l the tension flow out of  these 
mus c l es . . .  Notice  how relaxed and l oose  your mus c l es are . . .  Let your­
s e l f  become more and more re l axed . . .  Once again pul l  in your stomach 
and make your abdominal musc l es as t ight as you can ,  bui ld  up this t en­
s ion , study i t  . . .  Now release the tension and noti ce the di fference . . .  
once more pul l in your stomach and make your abdominal muscles  as t ight 
as you can . Study this tension for a few moments . . .  Now rel ax , releas ­
ing a l l  o f  the tension in your stomach and abdominal musc les . . .  Cont inue 
re l axing for a few moments . .  , Next inha l e  deep ly and , pushing your dia­
phragm down , extend your s tomach and tense your abdominal mus c l es as 
t ight as you can . Study this tension . . .  Now exha le  and relax , rel eas ing 
a l l the tension from your stomach and abdominal musc les . . .  Enj oy this 
re l axation for a few moment s  . . .  Once more , inhale  deep ly and pushing 
your diaphragm down , extend your s tomach and tense your abdominal musc les 
as t ight l y  as you can , s tudy this tension . . .  Now exhal e and relax , re­
l easing a l l  the tension from your stomach and abdominal mus c l es . . .  
Enj oy the ever-decreasing t ension . . .  Continue breathing in and out for 
a whi l e ,  concentrating on becoming more and more rel axed . . .  Let a l l  the 
tension flow out of the musc l es in your abdominal area as we l l  as in the 
rest of your body . . .  As your musc les become more and more relaxed , you 
feel warm and somewhat s l eepy . . .  Your eyel ids are becoming heavier and 
it is hard to keep them open . 
Rel axat ion Exercises for the Lower Back ,  
Hips , Thighs , and Ca lves 
These '  exercises' wi l l  last approximately  four to six minutes . As 
your r e laxation conti nues , pay attention to your lower back . F irst arch 
your l ower back , and t ense the musc l es there as t ight ly  as you can ,  
bui l d  up the tension , study i t  . ' , ' Now , relax and notice the d ifference 
. . .  Concentrate on rel axing your l ower back as comp l etely  as you can . . .  
Make your enti re body more and more rel axed . . .  De�per and deeper . . .  
Onc e  agai n ,  arch up your lower back and tense the musc l es there as 
t ight l y  as you can , study this t ension for a few moments . . .  Now rel ax 
and notice  the d ifference . . .  Next tense the mus c l es in  your buttocks , 
thigh s , hips , legs , and calves by flexing your buttocks as t ight ly  as 
you can whi l e  at the same t ime pressing down on the hee l s  of  your feet , 
exert ing as much p ressure  as you can . . .  Bui l d  up this tension . . .  Study 
i t  . . .  Now , re l ax and not ice the d i fference . . .  Concentrate on relaxing 
a l l of your mus c l es , deeper and deeper . . .  Once  again flex your buttocks 
and pres s  down hard on your hee l s ,  bui l d  up the tension . . .  Study it . , . 
Now , rel ax and notice  the d ifference . . .  Enj oy this relaxat ion for a few 
moments  . . .  Next whi l e  resting the heel s  of your feet , point your toes 
towards your head and tense al l the mus c l es in your feet , ank l es , and 
lower l egs , bui l d  up this tension . . .  Study i t  . . .  Now relax and once 
more noti ce the di fference , notice how good the relaxation fee l s  . . .  
Once more point your toes towards your head and tense a l l of  the mus c l es 
in your feet , ank les ,  and lower l egs , bui ld up this tension . Study i t  . . .  
now re l ax and notice the di fference . . .  Not i ce how soothing the relaxa­
t ion is . . .  Let this  re l axat ion spread throughout your body . Enj oy thi s 
rel axat ion for a whi l e .  
Breathing Instruct ions 
Continue to rest and relax as you go through thi s set of instructions . 
These i ns tructions are intended to  enhance and intensify the general over­
a l l state of deep mus c l e  rel axat ion already achieved . They wi l l  l ast  
approximat e l y  two to  s ix  minutes . By now al l of  your musc l es should  be 
fairly  wel l  relaxed . Your eye l ids fee l heavy , your arms feel heavy , and 
you fee l a warm sensation in a l l  parts of your body a long with a desi re 
to  fal l  a s l eep . . .  Now enhance your rel axati on even more by again taking 
a deep breath fi l l ing your lungs comp l etely and ho lding this tension for 
a few moments
' 
. . .  Then relax and s l owly  exhal e  . . .  Notice  how relaxing 
it is as you exhal e  . . .  Breathe normal ly for a whi l e  and . concentrat� on going i nto  a deeper state of re l axation . . .  Now once agaln breathe ln 
deep ly ,  fi l l  your lungs to maximum capac i ty ,  and ho l d  your brea�h for a 
few moments . . .  Study the tension . . .  Now exhal e  s lowly and not lce the 
i ncreased re l axation as you do so . . .  Breathe norma l ly for a whi le , and 
concentrate on e l iminating any t ension anywhere in your body . . .  As you 
breathe in and out , you wi l l  become more and more relaxed . . .  The relax­
ation wi l l  go deep er and deeper . . .  Now once again breathe in deep ly and 
fi l l  your l ungs to  capacity . .  , Ho ld  yo�r breat� for a few momen�s and 
study the tension . , .  Now relax and notlce  the lncreased re l axatlon . . .  
Continue breathing norma l ly for a whi l e  and , as you do , you become even 
more and more relaxed . . .  Deeper and deeper . . .  You shoul d  now be in a 
state o f  comp l et� rel axati�n . . .  Enj oy and apprec iate this state of  
compl ete  relaxatlon . . .  EnJ oy .and appreciate the  very warm , pl easant , 
and comfort ab l e  experience of comp l ete rel axat ion 
Part I I  
Positive Imaging 
Now that you are fee l ing very rel axed , I want you to choose a 
s cene which you find to be very p l easant and re l axing . This s cene can 
be anyp l ac e ,  for examp l e ,  at the seashore . . .  The important thing i s  
that i t  i s  one which you find to be pl easant . Now I want you to picture 
yoursel f  re laxing in this s cene . . .  Make this scene as vivid and as real 
as you possib ly  can . . .  For examp l e ,  imagine the white- capped waves ro l ­
l ing in s l owly ,  one b y  one , and gradual ly cur l ing and breaking onto the 
sand . . .  A l l the whi l e ,  continue to breathe regular ly  and evenly . Pic­
ture yours e l f  in your scene for about five minutes . 
Part I I  I 
Cue-Contro l l ed Re l axing 
Continue to pi cture yourse l f  in your pl easant scene . Continue to 
breathe norma l l y  and evenly . Now I want you to focus on your breathing . 
"Each t ime you begin to exhal e  or let out a breath , say the word "Calm" 
Cor "Rel ax" or "Let Go") to yourse lf  so that the word wi l l  become a cue 
for deep , deep re l axation CRimm and Masters , 1 979 , p .  38) . "  Now exha l e  
and repeat "Ca lm" to yourse l f .  Pract ice thi s  for 2 - 3  minutes . W e  have 
now comp l eted the rel axat ion exercises . When you are ready , get up and 
resume your normal activities . 
Part IV 
Addit ional Instructions 
Re l axation as Coping 
Now that you have l earned how to re lax ,  begin to use these ski l l s 
in your everyday l i fe when you notice you are beginning to tense up . 
In part icular ,  i t  may be he lp fu l  if  YOll use these ski l l s  at the first 
sign of an oncoming asthma attack .  The mo st pract ical  ski l l s  to use at 
such t imes are : breathing exercises ; pos itive imaging ; and cue- contro l led 
rel axing . 
Dai ly Practice 
In order that you l earn to relax deeply and quick ly ,  I am recommend­
ing that you practice these re laxation techniques every day for at l east 
one-ha l f  hour . Jus t before you go to s l eep each night might be the mos t  
pract ica l  time . Don ' t  forget to keep a record of this practice t ime in 
your dai ly  log . 
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Rel axation Thermometer 
(Adap ted from A l exander et a l . ,  1 972 )  
the 
you 
Before we begin 
fol lowing scale .  
fee l righ t  now :  
1 2 3 
Very Re l axed/ 
Drowsy 
Rat ing : 
Rel axation Thermometer 
today ' s  session,  I want you to rate yourse l f  on 
Your rating should reflect how relaxed or tense 
4 5 6 7 
Awake/Alert 
8 9 1 0  
Very Tense/ 
Hyper 
Now that we have comp l eted today ' s  sess ion, I want you to rate 
yourse l f  again on the same scale  as before . Once again,  your rating 
shoul d  refl e ct how re l axed or tense you fee l at this moment : 
Rat ing : 
Session Number :  Patient : 
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Dai ly Practi ce Log 
Dai ly Practice Log 
Each day throughout th e course of thi s  program , p l ease record the 
fo l l owing informati on :  
Pre-Practice 
Practice  Re l axat ion Rating 
Sunday Yes No 
Monday Yes No 
Tuesday Yes No 
Wednesday Yes No 
Thursday Yes No 
Friday Yes No 
Saturday Yes No 
Tota l : Days Practiced 
Week Number : 
Pat ient : 
----------------------
Amount of Practice 
Time C in minutes)  
Time 
Pos t  Practice  
'Rating 
Before you begin each pract ice sess ion , p l ease rate yoursel f on the 
fo l l owing scale . Your rating should  reflect how rel axed or tense you 
fee l Ri ght Now : 
1 2 
Very Re l axed/ 
Drowsy 
3 4 5 
Awake/Al ert 
6 7 8 9 1 0  
Very Tense/ 
Hyper 
After you comp l ete your practice  session ,  p l ease rate yours e l f  again 
on thi s same sca l e .  Once again , your rating should  reflect how rel axed 
or tense you fee l At Thi s  �1oment .  
APPENDI X  L 
Asthma Type Form 
Asthma Type Form 
Please  indicate whi ch category be low ( Intrinsi c ,  Extrinsi c ,  Other Asthma 
Type) is mos t  descriptive of  
----������--�----------
In addition , 
(Pat ient ' s  Name) 
please indicate the cri teria upon which this categori zat ion is based . 
I .  Intrinsi c  Asthma 
Criteria 
Negative reaction to antigen skin test 
------ No known re lat ionship between external agents and 
asthmati c  symptoms (with exception o f  aspirin sensit ivity) 
______ Other (p lease specify) 
I I .  Extrinsi c  Asthma 
Criteria 
Positive react ion to ant i gen skin test 
Demonstrated relationship between external agents and 
asthmatic  symptoms 
Fami ly His tory of asthma and other atopic  disorders 
Other (p lease speci fy) 
I I I .  Other as thma type (s ) (e . g . exerc ise induced) . P l ease spec i fy 
type and criteria : 
APPENDIX  M 
Art i c l e  Length Draft 
Re l axation Therapy as an Adj unct Strategy for the Treatment 
of Bronchia l  Asthma : An Examination of Pertinent 
Psycho logical and I l lness Variab l es 
Robert Joseph Marce l lo 
Virginia Commonweal th Univers ity 
Running Head : Re laxat ion Therapy for Asthma 
Abs tract 
Bronchia l  asthma i s  a heterogeneous and comp lex disorder with mul t i ­
p l e  etiological  and prec ipitat ing factors . Rel axat ion Therapy (and its  
variants ) has been emp loyed successful l y  as  an  adj unct  treatment for this 
di sorder . Recent s tudies have suggested , however , that the uti l ity of 
this t echnique may be l imited by : asthma type ; asthma severity;  person­
a l i ty  variab les ; and relaxation type . The obj ect ives o f  the current in­
ves t igation were to : 1) reconfirm the ut i l ity of  re l axation therapy for 
treat ing asthma ; 2 )  examine the degree to which asthma severity and panic ­
fear personal it y  style  rel ated to succes s ful  outcome . F i fteen asthmatics 
(primari ly  e xtrinsics )  of  varying severity and panic- fear style were 
treated with relaxation therapy . Resul ts  on se l f-report , pulmonary func­
t ion , and phys ician rat ings part ial ly  confirmed the ut i l i ty of  rel axat ion 
therapy with this  population , however , were only suggestive of the pre­
di ctive abi l ity of severity and panic- fear type . The resul ts  are di s ­
cus sed i n  terms of  the neces s ity o f  further and larger scale investigat ions . 
Re l axati on Therapy as an Adj unct Strategy for the 
Treatment of Bronchial Asthma : 
An Examinat ion of Pert inent Psycho logical and I l lness Variab les 
Asthma is a relat ive l y  common disorder which affects  approximately one 
to five percent of the general populat ion (Graham et a l . ,  1 967 ; Wi l l iams , 
1 9 73 ) . I t  has been described as a heterogeneous di sorder which "defies 
easy categori zation (Dirks et al . ,  1 979 ,  p . 7 1 ) "  because of its : complex 
pathophysiology (Go l d ,  1 976) ; wide range of  symptom severity (e . g . , from a 
mi l d  wheeze  to severe status asthmat icus and possibly  death (Wi l l iams , 
1 973 ) ; variety of c l inical subtypes (e . g . ; intrins ic , extrins i c ,  exercise 
induced ) ; Scadding , 1 977 ) ; and divers ity of etiological  prec ipitants (e . g . ; 
infection . exercise , a l l ergies , anxiety ; Wi l l i ams , 1973 ) . 
Behavior Therapy techniques have been uset.l as adj unct treatments 
for bronchia l  as thma for over 20 years (see Wa l ton , 1 960) . Research has 
cons istent l y  demonstrated the ut i l ity of techniques such as : fronta l i s  
e l ectromyograph (EMG ) bio feedback ( Kotses et a l . ,  1 9 76 ; Kotses e t  al . ,  1978 ; 
Scherr et a l . ,  1 9 7 5 ) ; progress ive musc l e  re laxation (Alexander ,  1 972 ; 
Alexander et a l . ,  1 972 ) : systemat ic desensiti zat ion (Cooper,  1 964 ; Sergeant 
and Yorkston , 1 969 ) : and assert iveness training (Wal ton , 1 960 ; Hook et a 1 . ,  
1978 )  for this  purpose . Each of these techniques can be considered an 
arousal  reduction strategy wh ich is  based upon the rationa l e  that intense 
emotional arousa l  can precipitate and exacerbate asthmat ic symptoms 
(Matus , 1 98 1 )  and the reduction or minimi zat ion of such arousal can be 
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helpful  in achieving : decreased frequency,  durati on and intens ity of asthma 
attacks ; decreased medi cation usage and emergency room visits ; and increased 
respiratory functioning (see B lanchard & Ahl es , 1 9 79 ;  Knapp & Wel l s ,  1 978 ; 
Erskine-Mi l l i s  & Schone l l ,  1 98 1 ' and Spevack 1 978 for 1 1  t . f ' , exce en reVIews 0 
thi s l i terature ) . Despite the substant ial  evidence in support of the 
ut i l i ty of such arousal reduction techniques , recent studies have 
suggested that this ut i l ity may be l imited by such variables  as : 
asthma type ( Ph i l l ip et al . ,  1 972 ) ; asthma severity (Davi s et al . ,  1 973 ) ; 
panic - fear personal i ty type (Kinsman et al . ,  1 980a) ; and treatment type 
(Erskine -Mi l l i s and Schone l l , 1 98 1 ) . 
As thma Type 
Asthmatics  are commonly  p laced into one of  several c l inical subtypes 
on the bas i s  of etio logical  precipi tants .  The two maj or subtypes are in -
trins ic  and extrinsic  asthma and this distinction i s  made upon the bas is  
o f  whether o r  n ot  externa l factors (i . e . , a l lergies)  can be  readi ly  iden -
t i fied as prec ipi tants of asthmatic  symptoms (Scadding , 1976) . 
Thus far , on l y  one study (i . e . , Phi l l ip et al . ,  1 972 )  in the behavioral 
treatment l i terature has sys temat ical ly examined the di fferential effects 
of arousal reduction strategies upon asthma subtypes . In this study , 
2 0  nonsevere ast hmatic s were assigned to the Fo l l owing group s : 1 )  
Intrins ic-Rel axation ;_ 2 )  Intrinsic-No Relaxat ion ; 3 )  Extrins ic ­
Re laxa t io n ;  4 )  Extrinsic -No Re l axat ion . A fter five sessions of  pro -
gress ive musc l e  re l axation training an overal l  rel axat Ion e ffect was 
found fo r the t
-
rea tment groups when compared to the no - treatment contro l 
groups on  a mea sure o f  pul monary funct ion ( i . e . , Forced Exp iratory Vo l ume in 
one second or FEVI ) .  Further , the greatest improvements occurred among the 
intrinsic  asthmat ics which suggested the po tential importance of this  va riab le  
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as a predictor o f  successful /unsuccessful response to technl· o,ues o f  this  type . 
As thma Severity 
Asthmati c s  can di ffer widely in terms of  the severity of symptoms they 
exPerience . and two s tudies  have suggested that only nonsevere asthmatics  
may respond we l l  to techniques such as relaxation therapy . For examp l e ,  
Davis  et  a l . ( 1 9 7 3 )  categori zed 2 0  as thmatic  chi l dren (ages 6 through 1 5 )  
a� nonsevere/severe on the basi s  of  whether or not they were currently 
receiving steri od therapy . Subj ects were then assigned to the fol lowing 
groups : 1 )  Relaxat ion training on ly ;  2 )  Re laxation training with EMG 
feedback ; 3 )  No treatment control . After five 30 minute treatment sessions 
sessions , both the re laxation on ly and the re laxat ion plus EMG feed-
fack groups improved s i gn i ficantly  greater than the  contro l group on a 
measure o f  Peak Expi ratory Fl ow Rate ( PEFR) . I t  is  interest ing to note , 
however, that these resul ts were observed on ly among the nonsevere 
asthmat i c s . On the bas i s  of  these findings , Davis  et al . suggested 
that re laxation therapy (with or wi thout EMG feedback) may be o f  
l imited ut i l i ty for severe asthmatics . A maj or probl em with this 
conc lusion , however , i s  that these authors fai led to contro l fo r asthma 
type . I f  as suggested by Phi l l ip et al . ( 1 972 ) , intrinsics  and extrinsics  
respond di fferenti a l l y  to re laxat ion therapy , it  is  qui te possib le  that the 
equivocal  resul t s  observed among the severe asthmatics  were the funct ion o f  
a "wash out effect"  a s  a result of  the heterogene ity of  the samp l e .  Indeed , 
these authors commented that : 
"Extreme response vari ab i l ity d i s p l ayed by r.1cr.1b ers 0 "  t h c  
severe group accounts for the  lack o f  s i gni fi cant improve -
ment in the group (p . 1 26) . " 
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Such "extreme vari ab i l ity" i s  exact ly  what one wOul d  expect from a group 
composed o f  di fferent asthma types . 
A lexander et a l . ( 1 979)  a l so attempted to evaluate the usefulness of 
rel axation therapy with severe asthmatic  chi l dren and fai l ed to obtain 
s i gn i fic an t  improvements . On the basis  of these resul ts , they concluded 
that the sugges tions of Davis  et a l . ( 1 973)  had been confirmed and suggested 
further that s ince relaxation theoretical l y  operates via parasympathetic 
nervous system (PNS) innervation , and that PNS innervation norma l l y  resul ts 
in bronchoconstrict ion , we shouldn ' t  expect that rel axation would be effec­
t ive with  asthmatics , rather , we  should anticipate a worsening of  symptoms . 
The result s  of  this s tudy can be critici zed upon several grounds . 
Firs t ,  l ike Davis  et a l . ( 1 973) , these authors fai led to di fferentiate sub ­
j ects  according to asthma type whi ch could have contributed to their nons ig ­
n ificant findings . Second ,  some res earch has demonstrated that relaxat ion 
strategies are di fficult  to imp lement successful ly  wi th chi ldren because of  
the  attention and concentrat ion required (e . g . , Hat zenbuehler and Schroeder , 
1978 ) . As such , the four sess ions of  rel axat ion given to subj ects in this 
study may not have been adequate .  Final ly ,  in cha l l enging the theoretical  
rat iona l e  o f  relaxat ion therapy these authors have apparent l y  assumed that 
the bronchoconstrict ion assoc iated with asthma is  caused uni formly by PNS 
activity . As stated previous ly ,  the pathophys iol ogy underlying as thmatic 
symptomato logy i s  very comp l ex and does not operate in such a straight for­
ward manner ( i . e . , bronchoconstrict ion may be a function o f :  PNS overreac ­
tivi ty ;  Sympathet i c  Nervous Sys tem (SNS) - beta adrenergic hypoact ivi ty ; 
SNS - alpha adrenergic hyperact ivity ; Wi l l iams , 1973) . It may be that re ­
l axat ion therapy is effect ive with certain asthmatics  because it serves to 
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minimi ze  physio logical  arousal which adversely effects SNS - adrenergic 
receptors . 
Panic-Fear Type 
Kinsman et al . ( 1 980b) have s tated : "As thmatic pat ients s imply  are not 
a homogeneous psychological  group (p . 403 ) " and that the use of arousa l  
reduct ion s trategies  may be l i mited by  the  psychol ogical heterogeneity of 
thi s  population . In  a series  of studies  (e . g . , D irks , et al . ,  1978 ; 
Jones et  a l . ,  1 9 79 ;  Kinsman et a l . ,  1 980a) they have investi gated a 
psycho l ogical  s ty l e  upon whi ch asthmati cs vary dramati ca l l y .  They have 
l abe l l ed thi s  the pan i c - fear personal i ty style . 
Pan i c - fear i s  measured in terms of  symptom vigi l ance (a "state" vari ­
abl e ) and personal i ty (a "tra i t "  variab l e ) . These  variables  can be assessed 
rel iably via the use of the Asthma Symptom Check l i st  (ASC ; Kinsman et al . 
1 9 7 3 ;  Kinsman et a l . ,  1 974 ) and an MMP I subsca l e  (the 20  P - F ;  D irks et al . ,  
1 977 )  respec t i ve l y .  Ac cording to Kinsman and his  assoc iates , a moderate 
to h i gh l evel  of symptoms vig i lance is cons idered to be adapt ive "because 
it acts l ike a s i gna l  energi z ing the pat i ent to act" (p . 4 20 )  and l ow 
l eve l s  are con s idered ma ladaptive because the pat i ent i gnores the seve -
rity o f  symptoms . Regarding the "trait"  pan i c - fear var iab l e ,  both 
extreme l y  l ow and h i gh leve l s  are cons idered to be ma lad�ptive ( i . e . , 
I .ow P - F  oat i ents underreact to severi ty of symptoms ; H igh P - F  pat i ents 
pan ic  and over-reacLJ . Ut I L I z Ing these two variab l e s , 9 asthma subtypes 
have been i dent i fied each carrying with it  di fferent treatment needs 
and recommendations . For examp l e ,  Kinsman et al . ( l 980a) have suggested 
that arousa l  reduct ion strategies  are indicated for on l y  2 of these 9 sub ­
groups ; i . e . , Moderate -Hi gh and High -High ; and are contraindicated for 
pat i ents who measure l ow on symptom v i g i l ance (i . e . , Low- Low ; Low-Moderate ; 
Low- High) . Th i s  i s  based on the assumpt ion that re l axation in these cases 
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might s erve to decrease an a lready maladaptive l evel o f  symptom vig i l ance 
( Kinsman et a l . ,  1 980b ; Staudemayer et al . ,  1 979) . 
Treatment Type 
One fina l l imitat i on to the use of  re l axati on therapy concerns the 
method by whi ch such relaxation is achieved . Evidence to date has , for the 
mos t  part , supported the use of a var i ety of relaxati on procedures with 
asthmat i c s  inc l ud ing : EMG-as s i sted relaxat ion (Scherr et a l . ,  1 975) ; 
progres s ive mus c l e  re laxation (Al exander , 1 972 ) ; Transcendental Medi tation 
(Wi l son et a l . ,  1 975) ; Autogeni c  training (Schwobe l ,  1 948) ; and systemati c  
desensit i zat i on (Sergeant and Yorkston , 1 969) . Erskine-Mi l l i s  and Schone l l  
( 1 9 8 1 ) ,  however , cha l l enged th i s  b l anket endors ement in a recent review 
and conc luded that on l y  "menta l "  techniques (e . g . , autogeni c  training) 
resul ted in  c l in i c a l ly  and stat i st ical ly s i gn i ficant improvement . A review 
of  the evidence presented in  support of this  c l aim suggests that it may 
be premature to draw th i s  conclus ion . In part i cular , the extreme response 
vari ab i l i ty found in the studi es reviewed (e . g . , Al exander ,  1 9 72 ; 
Al exander et a l . ,  1 972 ; Alexander et al . ,  1 979 ) suggests , rather ,  the 
importance of potent i a l  treatment by subj ect- type interact ion . 
Conc lus ion and Recommendat ions 
The b l anket app l i cation of re l axat ion therapy has been cha l l enged 
on several grounds , however , no chal lenge has been strong enough to 
serious ly  res trict  its usage with asthmatics  at this  time .  For examp l e ,  
asthma type has been suggested a s  potent i a l ly l imit ing the e ffec tiveness 
of  re laxa t ion therapy , however, only one study has examined this var i ­
ab l e  t o  date and further repl ications are required . Simi l arly , as thma 
severity has been suggested as a l imit ing variab le , however , no study 
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has e xamined this  variab l e  simultaneous l y  with asthma type which prec ludes 
the conc lusiveness of this suggest ion . Pan i c - fear �ype has a lso  been 
suggested as a potent i a l l y  l imit ing variab l e , however ,  the re l at ionship 
between this variab l e  and respons iveness to re laxation therapy has yet 
to be systemati ca l ly  examined . Fina l l y ,  treatment type has been sug­
ges ted as a further restrict ion , however ,  the reviewers who suggested 
this res triction fai l ed to adequate l y  account for treatment by subj ect 
type interact ions . At this point one could  conc lude that the res tric­
t ions suggested above can be accepted as tentative at best and the task 
of  i den tifying whi ch pat ients wi l l  respond most favorably  to which 
intervention techniques (c . f . Kies ler , 1 966 ; Paul , 1 970 )  has only begun 
in the asthma treatment l i terature . The maj or shortcoming of  research 
in this  area thus far appears to be the fai l ure to eva luate two or more 
o f  these  restri ct ive variab les s imultaneous l y .  Thus , pending further 
and more adequate ly  contro l led research of thi s typ e , Statements con­
cern ing the "b lanket indictment of anxiety reduct ion techniques in 
asthma" and the "indictment of bl anket appl ication"  (Kinsman et a l . ,  
1 980b)  of such techniques cannot be made conc lus ively . 
Given the importance o f  the. i s sues and cha l l enges whi ch have been 
raised by the above authors ,  such investi gat ions mus t be imp l emented i f  
further progress  i s  t o  be made i n  this  area of  the asthma-treatment l i ter ­
ature . What appears to be ca l l ed for ,  then , are a series of mul t i factorial  
eva luations which wi l l  examine the fo l lowing variables (minima l ly) in a 
systemat ic  fashion : 1 )  Intrins ic  versus Extrins ic  asthma typ e ; 2 )  Nonsevere 
versus Severe intensity ; 3) Muscular versus Mental Re l axat ion strategies 
4 )  Pan ic - Fear asthma subtypes .  The present study represent s an ini t ia l  
step in  th is  series . 
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The Present Study 
The obj ectives o f  the current investigation were to : 1 )  reconfirm the 
uti l i ty of re l axation therapy as an adj unct t reatment strategy for asthmatics ; 
2 )  examine the degree to whi ch asthma severity and panic-fear type were use-
ful as predictors of  respons iveness t h o treatment w i l e· contro l l ing for asthma 
type (i . e . , subj ects were primarily extrinsics )  and treatment type (i . e . , 
rel axat ion therapy inc luded both muscular and mental component s ) . 
Several hypotheses were made for each of the stated obj ect ives of this 
investigation . 
First  and foremost , it  was predicted that al l subj ects who participated 
in th is program would  demonstrate the acquisit ion of the rel axat ion ski l l  
as indi cated by decreased se l f- rat ings o f  tens ion/re laxat ion fo l l owing a l l  
treatment sess ions . As suming the acqui s i t ion o f  this ski l l ,  it  was a lso  
hypothes i zed that re l axat ion therapy would effect the fo l l owing outcomes : 
1 )  Decreased frequency ,  durat ion , and intensity of asthma attacks ; 2 )  
Decreased medicat ion usage ; 3 )  Improved resp i ratory function in g ;  4 )  Decreased 
pani c -fear symptom vigi l ance scores ; 5) Decreased panic-fear personality 
scores . In  addition , it  was hypothesi zed that both panic - fear persona l i ty 
type and asthma severity would be s igni ficant ly re lated to favorab le  out -
come . Fina l l y ,  it  was hypothesi zed that compl iance to treatment instruct ions 
( i . e . , as indicated by t ime spent practicing re laxat ion training independent-
ly)  would  a l so be  pos i tive ly  re lated to improvement of asthmat ic symptoms . 
Method 
Subj ects  
Source . Subj ects were vo lunteers recruited from one of two sources : 
1 )  An adu l t  Al l ergy C l inic affi l iated with the Medical  Col lege of Virgini a ;  
2 )  The case l oads of private physic ian ' s  who treat asthmat ics in the Richmond 
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Met ropol itan Area . A brief description of the proj ect was initia l l y  given 
to patients  from either source and persons interested in participating were 
l ater contacted direct ly  by the principal investigator . Invo lvement in this 
treatment program was coordinated. with the primary care physician of  each 
individua l . At no time were subj ects asked to change their medicat ion regi ­
mens by the principal invest i gator . Any changes in medicat ion made during 
the period of this study were solely  the resu l t  of patient -doctor consultations . 
Pretreatment Ratings .  Subj ects who part icipated in this investigation 
were rated in terms of asthma typ e ,  severity , and panic-fear type prior to 
treatment according to the fo l l owing criteria : 
A) As thma Type :  
1 )  Intrinsic : nonreaction to an ant igen skin test ; no known re lat ionship 
between external agents and asthmatic  symptoms (with the exception of  
aspirin sens i t ivity) ; 
2 )  Extrins ic : posit ive ( i . e . , wheal and flare) reaction to an antigen 
skin tes t ; in absence of such a react ion , a demonstrated re l at ionship be­
tween external  agents and asthmatic  symptoms ; fami ly history of asthma or 
other atopic disorders such as hay fever , rh initis  and eczema ; 
3 )  Other : this  category was to inc lude either mixed or exerc ise- induced 
asthmat ics . Mixed as thmatics were defined as those who possessed both 
intrins i c  and extrins ic trai ts . Exerc ise- induced asthma is s e l f  exp lanatory . 
B) Severi ty : 
1 )  Severe : rating of at least level 4 (i . e . , "Requi res stero ids , 
mos t ,  not a l l o f  the time")  on the Physician ' s  Severi ty Rating Sca le (PSRS ; 
P lutchik et a l . ,  1 9 78 ) ; 
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2 )  Nonsevere : Physrcian ' s  Severity Rating of  3 o r  less . 
C )  Pan i c - Fear Type :  Subj ects were categori zed based upon symptom 
vigi l ance and pan i c - fear personal i ty scores ( i . e . , ASC and 20 P-F  respectively) 
according to the guidel ines suggested by Jones et al . ( 1 979) ; 
1 )  Symptom Vigi l ance : 
a )  Low-Mean score of  less  than 2 . 4 3 ;  
b )  Moderate-mean score of  greater than o r  equal to 
2 . 4 3  or less  than or equa l to 3 . 29 ;  
c )  High - mean score greater than 3 . 29 .  
2 )  Personal ity : 
a )  Low - raw score less  than or equa l to  2 ;  
b )  Moderate - raw score between the range of 3 and 8 ;  
c )  High - raw score equal t o  o r  greater than 9 .  
Number .  Attempts were made t o  recruit 4 0  subj ects for this invest i ­
gat ion . An ini tial  l i st  of  over 50 names of  potential  part ic ipants \va s  ob­
tained from the above sources . Of this tota l ,  50 individua l s  were contacted 
and 40 agreed to part icipate in this program . Of th i s  40 , on ly  28  attended 
the pretreatment assessment sess ion and further attri tion at various po ints 
in the study resu lted in a fina l samp l e  of  15  participants who comp l eted · 
the ent ire 1 0 -week program . 
Descript ion of  Final Sampl e .  The fina l sampl e  was composed o f  1 2  fema les 
and 3 ma l es who ranged in age from 1 5  to 61  years o ld �= 32 . 33 ;  S . D . = 1 1 . 1 7 ) . 
Three of  the part icipants were Bl ack and the remaining 1 2  were Wh ite and 
were rated as fo l lows on the pretreatment variables : 
Re l axat ion Therapy 
A) Asthma Type - 1 3  extrinsic  asthmatics ; 2 mixed asthmat ics with 
dominant extrinsic  factors . 
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B) As thma Severity - 1 0  nons evere and 5 severe �= 3 . 33 , S . D . = 1 . 40 ) . 
C )  Pani c - Fear Type - 1 Low-Moderate ;  7 Moderate-Moderate ;  
2 Moderate-High ;  1 High-High 
A l l s ubj ects  were being treated with varying types of asthma medication 
inc l ud ing : Bronchodi l ators ; Antihistamines ; and Cort icosteroids . Pretreat ­
ment performanc e  on the FEVl / FVC pulmonary function measure suggest that 
this  was a samp l e  o f  ep isodic asthmatics  since 14 of 1 5  subj ects perform-
ed within normal l imi ts  (i . e . , range of 6 1 . 33%  to 98 . 67% ; � 85 . 78% , S . D . = 9 . 5 8 ) . 
Dependent Measures 
Sel f-Report . Four s e l f- report measur� were emp loyed in this s tudy and 
are described be low : 
1 )  Re l axation Thermometer (RT) - the RT i s  a 1 0  po int rat ing scale  
ranging from 1 (Very re l axed)  to  1 0  (Ext remely  tense) which was admini stered 
before and after each treatment session .  
2 )  As thma Symptom Check l i st  - the ASC i s  a 5 0  i tem quest ionnaire which 
measures the fo l l owing i l lnes s - specific factors assoc iated with as thma : 1 )  
Pan i c - Fear ; 2 )  Irritabi l ity ; 3 )  Fat igue ; 4 )  Hypervent i l at ion-Hypocapnia ; 
5 )  Airway obstruction .  Each item on the check l i s t  i s  a symptom common l y  
associated with asthma (e . g . , short o f  breath ,  afraid o f  dying) and the sub -
j ec t  is asked to rate the degree to wh ich e�ch symptom affects h i m  o r  her 
on a five-point sca le  ranging from "never ( 1 ) "  to "always ( 5 ) " .  Of these 
five factors , the Panic- Fear factor was of primary int erest in the current 
study . The ASC was deve l oped by Kinsman et a l . ( 1 973)  and information 
concerning i t s  psychometric properties can be found e lsewhere ( Kinsman et a l . ,  
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1 973 ; Kinsman et a 1 . ,  1 974 ; Jones et a 1 . ,  1 9 79 ) . 
3 )  2 0  P-F :  The 20 P-F i s  a twenty i tem, true-false  scale  consi st ing 
of i tems from the Minnesota Mul t iphas i c  Personal ity Inventory (MMP I )  de-
s i gned to measure a persona l ity variab l e  ca l l ed pan i c - fear . The scale  was 
devel oped by Dirks et a l . ( 1 977b ; 1 978 )  and i t s  val i di ty and re l i ab i l i ty 
have been reported e l sewhere (Dirks et al . ,  1 9 78 ; Jones et al . ,  1 979 ; 
Kinsman et a l . 1 980 ) . 
4 )  Dai ly As sessment Form : The DAF i s  a se l f-report quest i onnai re 
deve l oped for use in the current inves t igation . The DAF was uti l i zed to 
col l e ct : number of  attacks per day ; duration of  each attack ; intens ity  
rat ing ( l : mi ld- l O : severe)  of  each attack ; amount and type of medications 
ingested each day . For the purpose of  this study , an attack was defined 
minima l l y  as the initial  onset o f :  wheezing , t i ghtening of the chest , and 
dyspnea . The DAF was comp l eted by pat i ents on a dai ly bas i s  throughout the 
ent ire course of this s tudy . 
Pulmonary Funct ion . F ive separate measures of pulmonary function were 
used in this  inves t i gation . They were : Peak Expiratory Flow Rate (PEFR) ; 
Forced Vital  Capacity (FVC ) ; Forced Expi ratory Vo lume in one second (FEV1
) ;  
FEV ! FVC ; and Maxima l  Mid -Expiratory Flow Rate  (MMEFR) (see Cherni ack , 
1 
1977 ; Ruppe l ,  1979) . 
Physi ci an Rat ings . The PSRS was ut i l i zed as an independent assessment 
of pat i ent functioning based upon their current l evel of medi cation require -
ments . The PSRS i s  a nine-point scale  ranging from ( 1 )  "Mi l d" to (9)  "Con-
stant ly  di sab l ed" . I t  was deve loped by P lutchik et al . ( 1 978 ) "to provide 
an overa l l  index of as thma severity in terms of dependence of the pat ient on 
medi cation (p . 4 26 ) " .  The PSRS was comp l eted by the primary care phys ic ian 
(or nurse )  o f  each patient invo lved in this invest i gation . 
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Additional Measures 
Th e A sthma Survey Schedu le  (AmSS ; Caut e l a ,  1 98 1 )  is  a 39- item ques ­
tionnaire which asks patients to provide a wide range of  information such 
as : age , heigh t , medication (dosage and type ) , a l l ergies , typical  symptoms , 
and particul ar t imes of year the patient may consider to be especia l l y  
t roubl e some . The AmSS was emp loyed primari l y  because i t  provided the in­
vest igator with information whi ch was helpful  in evaluating other asses sment 
variab l e s  (e . g . ,  time of year information was useful when examining data 
regarding outcome on the frequency of attacks variabl e) . 
The 24 Hour History was used to assess and contro l for variables  which 
could potential ly  con found the above measures of pulmonary funct ion (e . g . , 
s t imul ants such as caffeine might result  in a temporary improvement ) . The 
24  History is  an I I - item quest ionnaire adapted for use in this  investigation . 
I t  asks ques tions such as : How many hours s ince your l ast  mea l ?  Beverage ? 
I t  was comp l eted by subj ects prior to each pulmonary asses sment sess ion in 
this investi gat ion . 
Apparatus 
A Col l ins 1 3 . 5  l iter water-seal spirometer was used to assess a l l  
measures o f  pu lmonary function with the except ion of PEFR . The spirometer 
features a bel l -counterweight pul ley system, recording pens and a variab le  
speed kymograph . The Col l ins spirometer and i ts features is described more 
fu l ly e l sewhere (Ruppe l ,  1 9 79) . A Wright Peak F l ow Meter (Wright , 1959)  was 
used to measure the fina l pulmonary funct ion variab l e  ( i . e . , PEFR) . 
Procedure 
As ses sment Schedule . Approximately  one-week prior to the first treatment 
sess ion , subj ects were asked to complete : 1 )  An Informed Consent Form ; 2 )  
The Asthma Symptom Check l i st ; 3)  The 20  P- F ;  4 )  The 24-Hour Hi story ; and 5 )  
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The Pul monary Function Battery . Subj ects were a l so asked to begin col l ecting  
bas e l ine data on  the  DAF and to comp lete the  AmSS and bring it  to the  first 
session .  Fina l l y ,  a copy o f  the PSRS was sent to the appropriate  physicians  
for comp l etion .  
Al l post - treatment sessions were arranged within one -week o f  the final 
treatment sess ion and a l l  fo l low-up sess ions , with one except ion , were 
schedul ed for at l east 4 weeks after the pos t -treatment sess ion (the excep­
t ion was one 3 week fo l low-up due to an unavoidable  schedul ing confl i ct ) . 
Except for comp leting the Informed Consent and the AmSS , the procedures for 
these two sessions  fo l l owed exact ly  the same format of the pretreatment 
sess ion . 
Treatment .  Al l treatment sess ions were conducted by the principal in­
ves t i gator who had comp leted 3 years of  graduate training in C l inical Psy­
cho logy .  These  sess ions were conducted in a group format with a minimum o f  
two persons i n  addi tion t o  the investigator present at al l ses s ions . Decisions 
as to which subj ects would  attend which sess ions were made solely  on the bas is  
of  convenience for the pat ients ( i . e . , membership was not determined accord­
ing to asthma sever ity or pan i c - fear type ) . Subj ects  were given the cho ice 
of s i gning up for 1 of 4 c l ass times but were a l l owed to rotate their  meeting 
times from week to week because of varying schedules and committments . 
Treatment cons i sted of a total  of five week ly  sess ions with each sess ion 
lasting between 60 and 90 minutes . The therapist  was b l ind to the asthma 
type , severity ,  and pan i c - fear type of part icipants unti l  the comp l etion of  
the treatment period . 
Components of the re laxat ion training employed in this investigat ion 
inc luded ; Progres s ive Mus c l e  Re laxation (Jacobson , 1 938 ; Wo lpe and Lazarus , 
1 966 ) : Cue-Control l ed Re l axat ion (Russe l l  and Sipich , 1973) : and Posit ive 
Imaging (Shoemaker , 1979) . 
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At the i n i t i a l  session ,  the general process of  progress ive rel axat ion 
was described to the subj ects and each subj ect was provi ded with a manual 
whi ch described each component of the training program . Subj ects were 
asked to use this manual as a guide l ine for i ndependent prac t icing of the 
re l axati on techniques . Each subj ect was encouraged to pract ice  these tech­
n i ques for 30  minutes dai ly  throughout the course of the investigat ion and 
to keep a record o f  thei r  efforts . As a part ia l  check on the effect iveness 
of the re laxat i on exerc i ses , subj ects were asked to rate themse lves on the 
Re l axat i on Thermometer (RT) before and after each treatment and pract i ce 
sess ion . 
Onc e  subj ects  were taught the steps of  the rel axat ion procedure , they 
were instructed to employ their  rel axat ion sk i l l s ,  part i cularly cue-con­
tro l l ed relaxat i on ,  as acti ve coping mechan i sms in the face of  day to day 
stressful s ituat ions . Part i cu lar emphas i s  was made upon the ut i l i zat ion of  
re laxat ion sk i l l s when faced with the in it ia l  cues of  an oncoming asthma 
attack (e . g . , ches t  t ightening , dyspnea ; s l i ght wheeze)  ( cf .  Sirota and 
Mahoney , 1 9 74 ) . 
Sp i rometry . With the except ion of  one session at the pretreatment 
assessment , pulmonary funct ion sess ions for a l l  subj ects were conducted by 
a research as s i stant ln order that the principal invest igator would remain 
b l ind to the outcome of these assessments .  Thi s  research ass i stant was 
b l ind to the hypotheses of the invest i gation as a further attempt to min imi ze 
the potent i a l  for experimenter bias . Al l sessions were conducted in the 
Psychophys i o logy Laboratory of the C l inical Psycho logy Program and were per­
formed at the same t ime of day (p lus or minus 14 hours)  for any given sub­
j ect  in an attempt to ho l d  c i rcadian cyc l e  effects constant . 
Pr ior to each assessment ses s i on : 1 )  the peak- flow meter was c leaned ; 
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2 )  the spirometer was checked in order t o  ensure i t  was working  properl y ;  
and 3 )  the t ime ,  temperature of  the spirometer , and the barometri c pressure 
were recorded . The temperature and barometric  pres sure were needed to con-
vert obtained resul t s  from Ambient Temperature Pressure Saturated (ATPS) to 
Body Temperature Pres sure Saturated ( BTPS) . 
Subj ects were asked to refrain from ingesting the fol lowing i tems for at 
l east 3 hours prior to  each assessment : foods , l i quids (with the exception 
o f  water and j uices ) ; ci garet tes . A 24-Hour Hi story was completed before 
each sess ion in order to moni tor such intake . Subj ects were asked to s i t  
qui t e l y  and comp l ete this  questionnai re whi l e  the research assis tant was 
preparing the equipment . This  procedure was intended to a l low subj ects t ime 
to adapt to the surroundings of  the l aboratory before the pulmonary asses s -
ment began . 
The pulmonary funct ion maneuver was exp l ained to each subj ect prior to 
the pretreatment assessment sess ion . Subj ects were a l l owed to practice  the 
proc edure unt i l  ( in the j udgement of the examiner) they were fami l iar with 
the process  in order to e l iminate learning effects . An addit iona l practice 
trial  was given prior to the pos t -treatment and fo l low-up sess ions . At each 
sess ion ,  three maneuvers on both the spirometer and the peak - flow meter were 
performed and the resu lts  of these tri a l s  were averaged . Subj ects were 
encouraged to give maximum effort on a l l  trial s .  
Resu l t s  
O f  the 1 5  subj ects who part ic ipated in the ent i re l O-week treatment and 
1 . 1 t " at : \ on a l l measures were ava i L.lb l e  fo r  eva uat lon program,  comp c c u . • 
o n l y  1 3  suh j e c t s (e . g . , one subj ect inac cura t e l y  recorded the frequency 
of attacks experienced during the ba sel ine period ; some fo l l ow-up data 
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o f  ano ther subj ec t  wa s l o st i n  the mai l ) .  As a re sul t ,  the number o f  
subj ects invo lved i n  each stat i st i cal analys i s  varied from 1 3  to I S  depend­
i ng upon the variab l e  under study .  
Treatment E ffi cacy 
The ana lyses in  thi s  sect ion addressed the i s sue of  whether re laxat ion 
training resul ted In s igni fi cant improvement for al l subj ec ts  regard l ess o f  
asthma type , severi t y ,  duration o f  the i l lnes s ,  or Panic - Fear persona l i ty 
type . Change in  s tatus was eva luated from pretreatment to posttreatment 
and po s t - t reatment to fo l l ow-up f;r al l dependent measure s .  The primary 
stat i s t i cal  analyses emp loyed we re P lannetl Compa.ri sons . The results  of 
these analyses are s ummari zed in Tab le  1 .  
I n sert Tab le 1 about here 
Acquis it ion of the Re laxat ion Sk i l l . As a check on the degree to 
which  subj ects  l earned to re lax during treatment sess ions , pre-post RT 
rat i ngs were ana lyzed fo r a i l S re laxation ses s i ons . The resu lt s o f  this  
analys i s  indicated tha t sel f-rat ings decreased s ign i f icant ly in a I l S 
sessions (�[ 1 4 1 = - 6 . 95 ,  � �  . 00 0 1 ; �[ 1 4 1 = - 5 . 7 0 ,  P � . 000 1 ; �[ 1 4 1 = - 8 . 07 ,  E 4 
. 00 0 1 ; � [ 1 4 1 = -6 . 92 , � < . 00 0 1 ; �[ 1 4 1 = - 6 . 6 1 , � <  . 00 0 1 , respect ively ) . These 
d ·  this  investigat ion acqui red the results  suggest that the subj ect s i nvo l ve In
rel axat ion ski l l  suffi c i ent ly within the treatment sess ions. 
Frequency of Attacks . 
The frequency of  attacks experi enced during pre-
and fo l low -up periods were ana lyzed for change i n  trea tment , post - trea tment , 
respon se to treatment . The pre-t reatment basel ine was def ined as the period 
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between the i n i t ia l  assessment sess ion and the fi rst treatment session . In  
most  case s ,  this  invo lved a 7-day period , however , in those cases in whi ch 
a ful l 7 days d id  not transp ire (i . e . , due to schedu l i ng di fficult i es ) ,  the 
number o f  attacks recorded were prorated for 7 days . The post - treatment 
period cons i sted o f  the 7 days immediately fo l lowing the final treatment 
sess ion and fo l low-up was defined as the 7 days immediately  preceding the 
fina l puJmonary assessment session . 
The resul ts  o f  this  analysis  indicated that the frequency o f  attacks 
decreased s i g n i fi cant ly  from pre-treatment to post- treatment (�[ 1 2 ] = - 2 . 0 l ,  
� � . 05 1  Contrary to expectations , a two - tai l ed T-Test indicated that fre ­
quency  o f  attacks increased s i gni ficant ly between post treatment and 
fo l l ow-up (�( 1 2 ) = 2 . l 9 ,  £ . 05 ) , suggest ing that treatment gains were not 
maintained on this  variabl e .  It is important to note that a l though sub ­
j ec ts  "re lapsed" during the fo l l ow-up period , they apparently  were no worse 
off than when treatment began ( i . e . , pret reatment �= 5 . 46 ; Fo l low-up �=4 . 85 ) . 
Phys ic i an Rat ings/Medi cat ion Usage . PSRS rat ings from pre-treatment , 
po st-treatment , and fo l low-up were exami ned to see i f  re laxat ion therapy re­
su l ted in decreased asthma severity ( i . e . , in terms of med icat ion dependence ) .  
Results i nd i cate that a s igni ficant decrease in these rat ings occurred bet -
ween pret reatment and post -treatment (�[ 1 4 ] = - 2 . 8 3 ,  e.. <. . 0 1 ) and a further 
nons i gn i fi cant decrease occurred between post -treatment and fo l l ow-up . 
These results  suggest that in the opinion o f  the ir respective phys ic ians , 
subj ects  were l es s  dependent upon their  medi cat ions for contro l o f  asthmatic  
symptoms as a function of  part ic ipat ion i n  this treatment program . 
I n  addi t i on to PSRS rat ings , the da i ly se l f-monitori ng o f  med ication in­
take (as recorded by each subj ect ) was examined . Thes e data were not analyzed 
as a dependent variab l e  but rather , were us ed to monitor medi cat ion patterns 
throughout the study . The primary purpose of thi s was to enabl e  the invest i -
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gator t o  address whether change on add i t ional dependent measures was a func ­
t ion o f  part i c ipat ion i n  the treatment program or changes in  l eve l s  o f  medica­
tion intake . 
Dec i s ions as to whether a given subj ect ' s  medi cat ion had changed were 
made on a weekly bas i s  according to the fo l l owing criteria : A g iven week 
was ass igned an " increase" rat ing i f :  a )  a part icular dosage was increased;  
b )  a new med i cat ion was added w ithout discont inuat ion or decreas ing other 
medicat ions ; c) usage of inhalers ( i . e . , number of sprays per day) increased . 
A "decrease" rat ing was assigned i f :  a) dosage leve l decreased ; b )  a med ica­
t ion was d i scont inued ; c) use of inhal ers decreased . A rat ing o f  " same" was 
g iven when med i cat ion usage patterns remained ident ical  from one week to the 
next . An overa l l rat ing was ass igned to each pat i ent on the bas is  of 
a comparison of week 6 (post-treatment ) and week 1 0  ( fo l low-up ) medicat ion 
l eve l s  with week 1 (base l ine)  l eve l s . 
On the bas i s  of  th i s  procedure the fol lowing resu lts  were obta ined 
At week 6 :  2 subj ects  had increased med icat ion intake ; 3 had decreased ;  
9 had remained the same . At  week 1 0 :  2 subj ects were rated as increased , 
7 decreased , and 5 remained the same . These  results  taken together with 
the decreased phys i c ian rat ings , ru l e  out medicat ion increases as a 
confound when eva l uat ing improvement on addit iona l variab l es .  
Pu l monary Funct ion . F ive measures o f  �ulmonary func t ion ( i . e . , PEFR ; 
FEV l , FVC , FEV l/ FVC , �1MEFR )  were ana lyzed to eva l uate Ivhether relaxat ion 
therapy resul ted in i mproved resp iratory func t ioning . Th e fo l lowing re sul ts 
were obta ined : 1 )  no signi fi cant improvement was found on three measures of 
flow rate ( i . e . , PE FR ; FEV l ; �1ME FR ) ,  however , non-signi ficant increases Ivere 
observed on two of these measures at the fo l low -up eva l uat ion ( i . e . , PEFR ; 
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FEVl ) ;  2 )  a sign i fi cant increase was found on the measure o f  lung vo lume 
(i . e . ,  FVC ) between po st- treatment and fo l low-up (!.[ 14 ] = 2 . 5 l ,  £ <'  . 05 ) ; and 
3) on the FEVl / FVC measure , a nons ignificant increase at post- treatment was 
fO l l owed by a s i gn i ficant decrease at fo l l ow-up (!.( 1 4 ) =-4 .87 ,  £ <. . 00 1 ; 
two-tai l ed test )  as subj ects returned to essent i a l l y  pre-treatment 
performance  leve l s  (pretreatment �=85 . 78% ; posttreatment �=8 7 . 24% ; 
fo l low-up �=8 3 . 93%) . These results  suggest that re laxat ion therapy may 
have been o f  l imited benefit  to resp iranory functioning and , for the 
most part , this  benefit  occurred on a del ayed bas i s . 
Percent -predicted va l ues for 4 of  the above measures (i . e . , FEVl ; 
FVC ; FEV l/ FVC ; MMEFR) were cal culated to assess the degree to which sub­
j ects  changed as a result  of  treatment when compared to normative 
standards estab l i shed for persons o f  s imi lar age , height and sex . The 
largest increase on these measures was a 5 . 4 %  increase on the percent ­
predic ted FVC variab l e  at fo l low-up (pretreatment �= 75 . 56 ;  fo l low-up 
�=80 . 98 ) . Increases on other measures were cons i derably sma l l er and some 
even showed a decrease (e . g . , FEV l / FVC decreased at fo l low-up ,  however ,  
performance was s t i l l  above norma l ) . Given that a 1 5 %  improvement i s  
genera l ly cons i dered to  be  a minimal ly acceptance leve l of  c l inical  s i g ­
n i fi cance , these findings suggest that re laxation therapy resul ted in  
only l i mited improvements . 
Pan i c -Fear Vari ables . Two meas ures of pani c - fear ( i . e  . .  symptom v i g i l ance 
and persona l i ty) were ana l yzed to assess whe ther such variables were suscept i b l e  
to change i n  response to re l axat i on therapy . On the measure of  symptom v igi ­
l ance ( i . e . , the ASC) , a s igni ficant decrease was observed from pre-t reatment 
to po st-treatment (!. [ 1 3 ] =- � . 67 ' E
.
< . 0 1 ) . A further nons ignificant decrease 
was observed between po st-treatment and fo l lOw -up . On the Pan i c  Fear Person-
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al ity measure ( i . e . , the 20  P - F ) , nonsigifi cant decreases occurred at  both 
the post- treatment and fol low-up as sessments . These findings are consistent 
with the  description of the l atter variable  being a "trai t" measure of panic­
fear and the former being a " state" measure (Dirk s ,  et al . ,  1977) . Whi l e  a 
sign i fi cant decrease in t he " trai t" measure could  be vi ewed as adaptive ( ie . , 
because i t  would  indicate decreased panic  in response to symptoms ) ,  the 
adtaptiveness o f  decreased symptom vigi l ance has been quest ioned (e . g . , 
Kinsman et a l . ,  1 98� and wi l l  be di scussed present l y .  
Vari abl es Re l ated to Outcome 
The purpose o f  this  section was to assess the degree to which var iab les 
such as : asthma sever i t y ;  pani c - fear sty l e ;  and comp liance to treatment in-
struct ions , predi cted respons iveness to re laxation therapy . The primary 
statistica l  ana lys i s  emp l oyed for this purpose was a Hiera rchical  Multiple  
Regress ion Analysis . Three dependent measures (i . e . , frequency of  attacks ; 
physi can rat ings ; FEV l/ FVC ) were ut i l i zed in these eva luat ions and were 
chos en because they were j udged to be the mo st re l evant from th eir  respect-
ive c l asses o f  dependent measures ( i . e . , FEVl/ FVC was chosen over other pu l -
monary funct ion measures because i t  is  more frequent ly  ut i l i zed than these 
other measures in t he asthma-treatment res earch l i terature) . [n al l c ases , 
two sets o f  ana lyses were computed for each dependent measure . F irst , pre -
treatment scores on the independent measures were used to predi ct post -
treatment va l ues  on the dependent measures after pretre
atment leve l s  on 
the dependent measures were pa rt i a l  l ed out . 
Second , fo l l ow-up va lues 
ere Predi cted with post -treatment va lues on the dependent meaSures w 
part ia l led out . The results  o f  these analyses ar
e summari zed in Tab le 2 .  
- - - - - - - - - - - - -
Insert Tab l e  2 about here 
- - - - - - - - - - - - -
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Pan i c - Fear Sty l e .  S i nce K insman et a l . (e . g . , 1 980)  have recommended 
that o n l y  spec i fi c  pani c - fear types be "prescribed" re l axati on therapy , i t  
was pred i cted  that pani c - fear a t  pretreatment wou l d  be  r e l ated to treatment 
outcome . The r es u l t s  o f  the c urrent ana ly s i s  i n d i cate t hat nei ther symptom 
v i g i l ance nor panic - fear persona l i ty were s igni fi cant l y  r e l ated to as thma 
severi ty rat i ngs  ( i . e . , PSRS) or frequency of attacks at e i ther pos t -treatment 
or fo l l ow - up . On t he p u l monary funct ion  measure ( FEV1 / FVC ) , whi l e  symp tom 
v ig i l ance  d i d  not s i gni fi cant l y  i ncrease pred i c t ive  ab i l i t y  at e i ther po s t ­
treatment or  fo l low-up , pan i c - fear persona l i ty w a s  found t o  be s ign i f i cant l y  
re l ated  t o  imp rovement on  t h i s  vari ab l e  a t  po st-treatment (f( I , 1 0 ) = 5 . 96 ,  
£ < . 0 5 ) . The comb i ned R2 for pretest  va l ues o n  FEVI / FVC , symptom v i g i l ance , 
and pani c - fear persona l i ty was . 74 w i th the  l atter vari ab l e  accoun t i ng for 
1 6 %  o f  the t o t a l  vari ance . W ith  the except ion o f  t h i s  l atter find ing , the 
above res u l t s  do no t s upport the hypot hes i s  that pani c - fear persona l i ty type 
pred i c t s  respons i veness/ unrespons iveness to re l a xat ion therapy . 
Sever ity . I t  was a l so hypothes i z ed that as thma severity at pretreatment 
wo u l d  p red i c t  response to  re l axa t i on therapy among e xt r i n s i c  asthmat ics . A 
Hierarchi ca l  Mu l t i p l e  Rc gres s i on was emp l oyed to exami ne th i s  hynot hes i s  and 
the resu l t s  i n d i c ate that there was no s i gn i ficant re l a t i onship  between 
as thma severi t y  and e i ther dependent meas ure ( i . e . , frequency of attacks ; 
FEV 1 /FVC )  at pos t - t reatment o r  fo l l Olv-up eva l uat ions . Thus , the hypothe ­
s i zed  r e l at ionship  between ast hma severity  and respons i veness to re l a xa­
t ion the rapy was not s uppo rted in  t h i �  ins tance . 
A v i s ua l  inspect i on o f  outcome data for severc and nonsevere subj ects  
on the frequency of  attacks  measure was  r'erfo rmerl in  a furt h e r  att empt  t o  
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eval uate any di fferentia l  response to re laxation therapy . The mean number 
of attacks reported per week were' calculated for the 5 severe and 8 non­
severe subj ects over a 9 week period (data for 2 subj ects was unavai lable) . 
Onl y  the first 9 weeks of  this 1 0  week study were ut i l i zed s ince the number 
o f  days this  information was recorded in week 1 0  varied from 1 to 7 and i t  
was fe l t  that prorating wou ld  b e  inappropriate . These week l y  means are 
presented in F igure 1 .  
Insert Figure l about here 
A revi ew o f  F i gure 1 revea l s  the fo l l owi ng . F Irst , the nonsevere group o f  
asthmat ics  ac tua l ly averaged a greater number of  attacks per week than the 
severe asthmat ics  in each week of the compari son period . Second , with the ex­
cep t i on o f  week 5 ,  the nonsevere group shows a cons is tent downward trend in 
the frequency of attacks whereas the severe group rema ins at a fairly cons is tent 
l eve l . I t  shou l d  be noted that in week 5 ,  two o f  the nonsevere subj ects ex­
peri enced 17  and 21  attacks , respect ive ly , and together accounted for 38 out 
of the 56 total  attacks fo r th i s  group . Th i s  inspect ion suggests  that the 
nonsevere subj ects may have been more respons ive to rel axat ion therapy than 
the ir  severe counterparts ,  however ,  this conc l u s ion i s  comp l i cated by the fact 
that the severe subj ects were at a cons istent l y  l ower frequency of attacks 
throughout the compari son period and may not have had any room for further 
improvement on th i s  part icular var iabl e .  
Compl iance . A fina l pred ict ion was made regarding the re l at ionsh i p  bet­
ween comp l ianc e to treatment instruct ions and favorabl e response to treat-
ment . Total  pract ice t ime o f  the re l axat ion techni que wa s used as  a measure of  
comp l i ance and a Hi erarchica l Mu l t i p l e  Regression was emp loyed to  exam ine the 
re lat ionship between this measure of comp l i ance and favorab l e  outcome as measured 
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by the PSRS , FEVI/ FVC , and frequency o f  asthma attacks . The results  of  these 
ana lyses are as fo l lows : I }  On the Phys i c ian ' s  Severity Rat ing Scale  Practice 
Time was s i gn i fi cant ly rel ated to improvement at the �ost - treatment assessment 
(�[ 1 , 1 1 ] = 1 0 . 49 ,  � � . Ol ) . The combined R2 for pretreatment severity rat ings 
and Pract i ce Time was . 69with Practice  Time accounting for 30% of  the tota l 
var iance . Resu lts  at the fo l l ow-up period did not demonstrate a s i gn i ficant 
re lat i onship between Pract i ce Time and severi ty rat i ngs ; 2 }  No such re l ation­
sh ip  was found between Pract ice Time and frequency of attacks or FEV I / FVC at 
either the pos t - treatment or fo l l ow-up periods . These resu lts  suggest that 
regu lar prac t i ce of the re laxation technique can s ignif icant ly reduce the 
amount of medi cation required to contro l asthmatic  symptoms even though i t  
may not resul t in  improvement of those symptoms direct ly . 
D i s cuss i on 
The current invest i gation attempted to : I }  reconfi rm the ut i l i ty of 
rel axation therapy as an adj unct treatment strategy for asthmat i c s ; and 
2 )  examine the degree to whi ch asthma severi ty and pan i c - fear style were 
useful in pred i c t ing respons iveness to such a treatment strategy . In 
general , t he resul ts of th i s  inves t i gation were incons is tent and some ­
what less  than robust and did  not c l early resolve these is sues . In sp i te  
of  t� i s  lack o f  robustness , severa l import ant findings were revea led and 
wi l l  be di scussed in terms o f :  I }  Treatment Imp l i cat ions ; 2 }  Pert inent 
Psycho logical  and I l l ness  Var i abl es (re lated to favorab l e  outcome ) ; and 
3 }  Research Imp l i cations . 
Treatment Impl i cat ions 
Whi l e the overa l l  resu lts  of this investigation do not unequivoca l ly 
support the efficacy of rel axat ion therapy as an adj unct treatment for bron-
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chial asthma , certain findings do support i t s  uti l ity . The most 
con s i stent  and perhaps most important finding was that re l axat ion therapy 
resul ted in decreased l eve l s  of medication needed to contro l asthmatic symp ­
toms ( i . e . , as indicated by se l f-monitoring of medication intake and PSRS 
ratings ) . I f  one considers the potential  s ide effects  associated with higher 
dosages and l eve l s  of asthma medication , this finding a lone supports the 
ut i l i ty of rel axation therapy with this population . In addition , these re-
su Its  a l l owed the investigator to rul e  out medicat ion increases an being 
respons i b l e  for improvement on additional dependent measures . 
The findings on the frequency of attacks variable did not support the 
ut i l i ty of re l axation therapy as c learly . Part icipation in the re laxation 
program resul ted in a s i gni ficant decrease " in the frequency o f  asthma 
attacks when the post - treatment period was compared with the pre -treatment 
base l ine period and that this improvement was not maintained at a one-
month fo l low-up period . Such a "re lapse" might  cause one to quest ion 
the l ong term efficacy of re l axat ion the rapy and the efficacy of re l ax-
at ion therapy beyond its  serving as a p lacebo . However , when one con -
s iders that : 1 )  the invest i gation was conducted during the peak of  po l l en 
season and at a part icular l y  humid t ime of  year ; 2 )  the maj ority of  subj ects 
( i . e . , 1 1  o f  1 3) who comp l eted the AmSS reported that their asthma was 
affected by pol l en and/or humidi t y ;  3) the maj ority of subj ects were extrins ic 
asthmati cs  and hence may not be as respons ive as other asthma types (i . e . , 
intrins i c s )  to re laxat ion therapy ; and 4 )  that previ ous research has attested 
to the efficacy of  re l axat ion therapy with as thmat ics above and beyond p lacebo 
effect s  (e . g . , Knapp and We l l s ,  1 978) ; the above quest ions can be dismissed . 
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The results  of  the pulmonary function asses sments were s imi l arly  incon ­
c lus ive . The reader wi l l  reca l l  that the onl y  s i gni ficant finding in the 
expected direction was on the Forced Vital  Capaci ty (FVC) variable  at 
fO l low-up . (A 5 . 4% increase was a l so observed on the percent -predicted 
FVC at fo l low-up)  and that nonsigni ficant trends in the expected direct ion 
were observed on other measures (e . g . , PEFR ; FEV1 ) .  These findings sug­
gest that : 1 )  re l axat ion therapy may have on l y  a l imited direct effect 
upon resp iratory functioning ; 2) what e ffects it  does have may be o f  
stat ist ical  rather than c l inical  s i gni ficance (e . g . , the improvement 
rea l i zed on the FVC measure was approximate l y  a 5% increase and l ess  than 
1 5 %  is not c onsi dered to be c l inica l ly s igni ficant ; and 3 )  those bene fits 
that were achieved appeared on a de layed bas is (i . e . , at fo l low-up rather 
than pos t - treatment ) .  I t  may be that re laxat ion therapy s l ows down the 
phys io l o g ical  process in a gradua l fashion and hence immediate bene fits 
should  not be expected . In add it ion , it i s  pos s ib le  that the as thmat i c  
symptoms o f  the extrins ic  asthmat i c  may be the resu l t  of  a Parasympathet ic  
Nervous System ( PNS) ma l function in  wh ich case , d irect improvement on 
measures of respiratory funct ioning might not be expected ( i . e . , because 
re laxat ion therapy increases PNS dominance wh ich has been imp l icated as 
one cause of bronchoconstri ct ion) . Th is  l atter cons iderat ion is specu­
l atory in nature and warrant s further inves t i gat ion . 
The hypotheses regarding the panic - fear variab l es were a l so not c l ear­
ly  supported . I t  was predicted that symptom vi gi l ance would  decrease in 
response to re l axat ion therapy s ince i t  has been described as a "state" 
measure o f  pan i c - fear by i ts  deve lopers (e . g . , D irks et a l . ,  1977c)  
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and that pan ic - fear personal ity scores would  decrease i n  response to 
re l axation therapy becaus e learning such a ski l l  would  result  in an 
increased sense of mastery over one ' s  symptoms and a subsequent decrease 
in the fee l ing  of helplessness associated with high panic - fear persona­
l ity . The former �ypothesis  was confirmed whi le  the latter was not . 
Whi le the description of symptom vigi l ance has been supported , some 
would  question whether it cou ld  be viewed as an improvement .  For examp l e ,  
Kinsman et  al . ( 1 980a) have suggested that high symptom vi gi l ance i s  adaptive 
and that re laxation therapy may be detrimental i f  i t  reduces such vigi lance . 
However ,  considering the posit ive resu l t s  obtained on other outcome vari ­
abl es in this study (e . g . , Physician Severity Rating Scale ; frequency of  
attacks ; Forced V ita l  Capacity) ; it  does not appear that such a pos it ion 
can be suppo rted . 
Fina l l y ,  the analysis  of  the rel ationship between comp l iance with treat ­
ment instruct ions ( i . e . , dai l y  practice of relaxat ion ski l l s )  does not cons i s ­
tent l y  support the ut i l i ty of re l axat ion therapy for treating asthma (i . e . , 
comp l i ance was not s ign i ficant ly  re lated to frequency of attacks or FEVI/ FVC) . 
However ,  the finding that comp l iance was re lated to decreased dosages of 
asthma medicat ion wi thout subsequent worsening of  symptoms does strongly sup ­
port the value of  the '�omework" portion o f  this treatment program i n  part i ­
cular, and o f  re laxat ion therapy in general .  
Pert inent Psycho logical  and I l lness Variab les 
The resul ts  of this invest i gat ion did not c learly support the usefu lness 
of asthma severity and panic -fear style  for predicting favorabl e/unfavorab l e  
response t o  re l axation therapy . A primary reason for this l ess  than succes s ful  
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outcome may have been the smal l samp l e  s i ze and consequent reduced 
power of the statist ical  analysis  emp l oyed . This  difficulty potent ial ly  
effected each of the  predict  variabl es discussed below . 
Regarding the predicted re lationship between panic - fear style and 
outcome , with the exception of the s ignificant re lat ionship found between 
pan l c - fear personal ity and F EVI / FVC at post-treatment , the importance of this 
variab l e  as a predictor of  treatment outcome was not supported . Despite the 
general l ack of s i gnificance , thi s one s i gni ficant re lationship was precisely 
in the direct ion predicted by Kinsman and his  associates (e . g . , Kinsman et a l . ,  
1 980a) and i s  consi stent with their recommendation that re l axation therapy i s  
on ly  appropriate for asthmatics  categori zed as  high panic-fear persona l i ty 
type s .  Since the current study invo lved a re latively  ,sma l l  number of part i c i ­
pants with a somewhat l imited range of  panic-fear types , more work i s  c l ear ly 
required to examine the importance of this variable . 
The predict ive value of  asthma severity at pretreatment was even less  
useful than the  panic-fear styl e .  The reader wi l l  reca l l  that neither the 
regress ion analyses nor the vi sua l inspect ions supported the uti l i ty of asthma 
severity for predicting respons e to re l axation therapy . In spite of this 
l ack of support , several  fac tors prec lude the dismi ssal  of this variab le  as 
a pertinent predictive factor vis -� - v l s  re l a xat t on therap y .  First , the non­
severe group of  subj ects experienced a substant ial ly higher number of attacks 
per week than the severe group throughout the ent ire course of this invest i ­
gat ion . Thus , it may be that severe subj ects in this compari son were on high 
enough leve l s  of medication that the frequency of  attacks they experienced 
had "bot tomed out " and hence it would have been difficult  to demons trate 
further improvement on th is  variabl e .  In contras t ,  the nonsevere subj ects 
had a greater opportunity to demonstrate improvement on this variable . Second , 
a di fferent prob lem was associated with the FEVI/ FVC variab l e  in that severe 
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and non severe subj ects did not di ffer substantia l l y  on this measure throughout 
the s tudy . Since neither group improved dramatica l l y  on thi s measure and both 
performed within normal l imits , it is quite  possible  that further improvement s  
were . lOt l ike ly  due t o  a "topping out" phenomenon . Fina l l y ,  i t  appears 
that the participants in this s tudy were of the episodic versus the 
chroni c  type given that none of the subj ects could  be categori zed as severe 
according to accepted pulmonary standards (e . g . ,  the Intermountain Thoraci c 
Soci ety defines severe as an FEVI / FVC of  less  than 4 5 % ;  Cooper, 1 982 ) . One 
woul d  not expect dramatic  improvements  on this variab l e  from episodic asth -
mat i cs s ince , by definition , they usua l l y  perform within normal l imits except 
when e xperiencing attacks . 
Res earch Impl icat ions 
The inconsistency and inconclus iveness of  the resul ts of this invest i -
gation attest t o  the need for addit ional research i n  this area . One crucial  
area for investigation concerns the further identi ficat ion and del ineation of  
variab l es which predict response to  re l axat ion therapy . The current s tudy 
attempted an initial  examinat ion of the re l ationship between : panic-fear 
personal ity type ; asthma severity ; and responsiveness to treatment . However , 
whi l e  the findings of this study are suggestive , they are a lso l imited in that 
the subj ect samp l e  did not represent a wide enough range of  panic- fear types 
or i l lness severity . 
Another quest ion which requires further examination i s  the re l ationship 
between asthma type and success ful response to re laxat ion therapy . Th is 
question was not addressed in the current study and has been addressed only 
once e l sewhere ( i . e . , Phi l l ip et al . ,  1 972 ) . Given the potent ia l  degree that 
a variab l e  such as asthma type could  pervade findings in other inves tigat ions , 
it  seems crucial  that its  ro le  be c larified . Simi l ar ly ,  the specul ation that 
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there may be a' different ia l  physio logical  bas i s  for the  symptoms experi -
enced by intrinsi c  and extrins i c  asthmat ics , and the possibi l i ty that 
this  differential  cause could be re l ated to responsiveness to rel axation 
therapy cal l s  for further invest i gat ion . 
Conclus ion 
In conc lusion , it seems that the most  important i s sues whi ch remain 
inadequate l y  addres sed are those whi ch attempt to de l ineate whi ch subj ects 
wi l l  respond favorably to whi ch treatments under what cond itions (c . f . , 
Kies ler ,  1 966 ; Pau l , 1 970 ) . Unt i l  such variab les have been adequat ely  
assessed ,  s tatements concern ing the "b lanket indictment of anxiety reduction 
techniques in as thma" and the "indictment of b lanket app l ication" ( Kinsman 
et al . ,  1 980a) of  such techniques can not be made conclus ive ly .  I n  addit ion , 
c l inicians  and researchers would do we l l  to pay more heed to the complex 
and heterogeneous nature of  the asthmat i c  population . 
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Tabl e  2 
Rel at ionships Between Predictor Variab l es : Pani c - Fear Style  (ASC ; 20  P - F) ; As thma Severity (PSRS) ; 
Compl iance (Pract i ce Time) ; and Outcome Variab l es : Asthma Severity (PSRS ) ; Frequency 
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F igure 1 .  Mean Weekly  Frequency o f  Asthma Attacks for Nonsevere 
(NS) and Severe (S) Subj ects . 
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